add biotab XML files
Browse filesdownloaded from TCGA portal on June 13th, 2024
This view is limited to 50 files because it contains too many changes. See raw diff
- biotab-xml/nationwidechildrens.org_clinical.TCGA-2A-A8VL.xml +154 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-2A-A8VO.xml +155 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-2A-A8VT.xml +206 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-2A-A8VV.xml +154 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-2A-A8VX.xml +153 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-2A-A8W1.xml +154 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-2A-A8W3.xml +165 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-2A-AAYF.xml +155 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-2A-AAYO.xml +154 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-2A-AAYU.xml +155 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-4L-AA1F.xml +151 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5737.xml +121 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5738.xml +153 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5739.xml +153 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5740.xml +121 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5741.xml +183 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5743.xml +184 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5744.xml +121 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5745.xml +121 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5746.xml +153 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5748.xml +121 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5750.xml +153 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5751.xml +241 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5752.xml +183 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5753.xml +121 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5754.xml +121 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5761.xml +121 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5762.xml +153 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5763.xml +153 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5764.xml +121 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5765.xml +153 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5766.xml +121 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5767.xml +153 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5768.xml +153 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5769.xml +121 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5494.xml +185 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5495.xml +185 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5496.xml +186 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5497.xml +184 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5498.xml +184 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5499.xml +186 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5501.xml +185 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5502.xml +185 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5503.xml +185 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5504.xml +186 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5505.xml +155 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5506.xml +186 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5507.xml +186 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5508.xml +185 -0
- biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5509.xml +186 -0
biotab-xml/nationwidechildrens.org_clinical.TCGA-2A-A8VL.xml
ADDED
|
@@ -0,0 +1,154 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">7E2ED8FD-7842-4722-A070-37896CF6ABD5</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">389.51.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516490">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516507">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516500">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516545">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-18658</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">621</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4216678">WHITE</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-2A-A8VL</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">2A</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">A8VL</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">49197847-CC83-4CE1-8397-D09CEA4C4928</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516508">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8140/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516501">NO</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516502">YES</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">51</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516511">2010</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516556">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4217282">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">29</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516491">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="3516492" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516493">Peripheral Zone</prad:zone_of_origin>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516498">Left</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516499">Middle</prad:tumor_level>
|
| 55 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516499">Base</prad:tumor_level>
|
| 56 |
+
</prad:tumor_levels>
|
| 57 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516512">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 58 |
+
<prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">21</prad:days_to_bone_scan_performed>
|
| 59 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516521">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
|
| 60 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516522">NO</prad:diagnostic_ct_abd_pelvis_performed>
|
| 61 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Not Available" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000"/>
|
| 62 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 63 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3516527"/>
|
| 64 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 65 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516528">NO</prad:diagnostic_mri_performed>
|
| 66 |
+
<prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
|
| 67 |
+
<prad:diagnostic_mri_results>
|
| 68 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3516533"/>
|
| 69 |
+
</prad:diagnostic_mri_results>
|
| 70 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516540">YES</prad:lymphnodes_examined>
|
| 71 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516542">15</prad:number_of_lymphnodes_examined>
|
| 72 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516543">0</prad:number_of_lymphnodes_positive_by_he>
|
| 73 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516544">R0</clin_shared:residual_tumor>
|
| 74 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3516554"/>
|
| 75 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3516555"/>
|
| 76 |
+
<shared_stage:stage_event system="AJCC">
|
| 77 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 78 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 80 |
+
<shared_stage:tnm_categories>
|
| 81 |
+
<shared_stage:clinical_categories>
|
| 82 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="3516513"/>
|
| 83 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 84 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516534">M0</shared_stage:clinical_M>
|
| 85 |
+
</shared_stage:clinical_categories>
|
| 86 |
+
<shared_stage:pathologic_categories>
|
| 87 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516536">T2b</shared_stage:pathologic_T>
|
| 88 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516541">N0</shared_stage:pathologic_N>
|
| 89 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 90 |
+
</shared_stage:pathologic_categories>
|
| 91 |
+
</shared_stage:tnm_categories>
|
| 92 |
+
<shared_stage:psa>
|
| 93 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516561">0.05</shared_stage:psa_value>
|
| 94 |
+
<shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">585</shared_stage:days_to_psa>
|
| 95 |
+
</shared_stage:psa>
|
| 96 |
+
<shared_stage:gleason_grading>
|
| 97 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516496">6</shared_stage:gleason_score>
|
| 98 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516494">3</shared_stage:primary_pattern>
|
| 99 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516495">3</shared_stage:secondary_pattern>
|
| 100 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516497">4</shared_stage:tertiary_pattern>
|
| 101 |
+
</shared_stage:gleason_grading>
|
| 102 |
+
<shared_stage:ann_arbor>
|
| 103 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 104 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 105 |
+
</shared_stage:ann_arbor>
|
| 106 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 107 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 109 |
+
</shared_stage:stage_event>
|
| 110 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516564">NO</clin_shared:postoperative_rx_tx>
|
| 111 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516563">NO</clin_shared:radiation_therapy>
|
| 112 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3516565"/>
|
| 113 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516562">NO</prad:biochemical_recurrence>
|
| 114 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 115 |
+
<prad_nte:new_tumor_events>
|
| 116 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516566">NO</nte:new_tumor_event_after_initial_treatment>
|
| 117 |
+
</prad_nte:new_tumor_events>
|
| 118 |
+
<rx:drugs/>
|
| 119 |
+
<rad:radiations/>
|
| 120 |
+
<prad:follow_ups>
|
| 121 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 122 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-2A-A8VL-F71759</clin_shared:bcr_followup_barcode>
|
| 123 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">6E1A6CED-30C0-4A4D-A550-82214C73826D</clin_shared:bcr_followup_uuid>
|
| 124 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4136738">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 125 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4136739">NO</clin_shared:lost_follow_up>
|
| 126 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136740"/>
|
| 127 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136741"/>
|
| 128 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4136743">Alive</clin_shared:vital_status>
|
| 129 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136742"/>
|
| 130 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">621</clin_shared:days_to_last_followup>
|
| 131 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 132 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136752"/>
|
| 133 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136753"/>
|
| 134 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136754"/>
|
| 135 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4136779">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 136 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4136755">NO</nte:new_tumor_event_after_initial_treatment>
|
| 137 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 138 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136756"/>
|
| 139 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136765"/>
|
| 140 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136766"/>
|
| 141 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136777"/>
|
| 142 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136778"/>
|
| 143 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 144 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 145 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 146 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136767"/>
|
| 147 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136768"/>
|
| 148 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">31</clin_shared:day_of_form_completion>
|
| 149 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
|
| 150 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2015</clin_shared:year_of_form_completion>
|
| 151 |
+
</follow_up_v1.0:follow_up>
|
| 152 |
+
</prad:follow_ups>
|
| 153 |
+
</prad:patient>
|
| 154 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-2A-A8VO.xml
ADDED
|
@@ -0,0 +1,155 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">13F0E1EF-4F73-442C-A662-9143555CBE82</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">389.51.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516775">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516792">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516785">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516830">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-20958</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1332</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4216227">WHITE</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-2A-A8VO</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">2A</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">A8VO</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">91C0D161-2B59-4B7A-8C19-6D26DEA31849</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516793">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8140/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516786">NO</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516787">YES</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">57</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516796">2010</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516841">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4217001">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">30</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516776">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="3516777" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516778">Overlapping / Multiple Zones</prad:zone_of_origin>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516783">Bilateral</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516784">Apex</prad:tumor_level>
|
| 55 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516784">Middle</prad:tumor_level>
|
| 56 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516784">Base</prad:tumor_level>
|
| 57 |
+
</prad:tumor_levels>
|
| 58 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516797">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 59 |
+
<prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">22</prad:days_to_bone_scan_performed>
|
| 60 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516806">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
|
| 61 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516807">YES</prad:diagnostic_ct_abd_pelvis_performed>
|
| 62 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">11</prad:days_to_diagnostic_computed_tomography_performed>
|
| 63 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 64 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516812">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
|
| 65 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 66 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516813">YES</prad:diagnostic_mri_performed>
|
| 67 |
+
<prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Completed" preferred_name="days_to_mri" display_order="46" cde_ver="1.000">84</prad:days_to_diagnostic_mri_performed>
|
| 68 |
+
<prad:diagnostic_mri_results>
|
| 69 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516818">Extraprostatic Extension Localized (e.g. seminal vesicles)</prad:diagnostic_mri_result>
|
| 70 |
+
</prad:diagnostic_mri_results>
|
| 71 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516825">NO</prad:lymphnodes_examined>
|
| 72 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3516827"/>
|
| 73 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3516828"/>
|
| 74 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516829">R1</clin_shared:residual_tumor>
|
| 75 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3516839"/>
|
| 76 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3516840"/>
|
| 77 |
+
<shared_stage:stage_event system="AJCC">
|
| 78 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 80 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 81 |
+
<shared_stage:tnm_categories>
|
| 82 |
+
<shared_stage:clinical_categories>
|
| 83 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516798">T1c</shared_stage:clinical_T>
|
| 84 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 85 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516819">M0</shared_stage:clinical_M>
|
| 86 |
+
</shared_stage:clinical_categories>
|
| 87 |
+
<shared_stage:pathologic_categories>
|
| 88 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516823">T3a</shared_stage:pathologic_T>
|
| 89 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3516826"/>
|
| 90 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 91 |
+
</shared_stage:pathologic_categories>
|
| 92 |
+
</shared_stage:tnm_categories>
|
| 93 |
+
<shared_stage:psa>
|
| 94 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516846">0.05</shared_stage:psa_value>
|
| 95 |
+
<shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">1332</shared_stage:days_to_psa>
|
| 96 |
+
</shared_stage:psa>
|
| 97 |
+
<shared_stage:gleason_grading>
|
| 98 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516781">6</shared_stage:gleason_score>
|
| 99 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516779">3</shared_stage:primary_pattern>
|
| 100 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516780">3</shared_stage:secondary_pattern>
|
| 101 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516782">4</shared_stage:tertiary_pattern>
|
| 102 |
+
</shared_stage:gleason_grading>
|
| 103 |
+
<shared_stage:ann_arbor>
|
| 104 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 105 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 106 |
+
</shared_stage:ann_arbor>
|
| 107 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 109 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 110 |
+
</shared_stage:stage_event>
|
| 111 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516849">NO</clin_shared:postoperative_rx_tx>
|
| 112 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516848">NO</clin_shared:radiation_therapy>
|
| 113 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3516850"/>
|
| 114 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516847">NO</prad:biochemical_recurrence>
|
| 115 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 116 |
+
<prad_nte:new_tumor_events>
|
| 117 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516851">NO</nte:new_tumor_event_after_initial_treatment>
|
| 118 |
+
</prad_nte:new_tumor_events>
|
| 119 |
+
<rx:drugs/>
|
| 120 |
+
<rad:radiations/>
|
| 121 |
+
<prad:follow_ups>
|
| 122 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 123 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-2A-A8VO-F71780</clin_shared:bcr_followup_barcode>
|
| 124 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">3A8226A3-E762-4CD4-A32A-64E485053187</clin_shared:bcr_followup_uuid>
|
| 125 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4136608">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 126 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4136609">NO</clin_shared:lost_follow_up>
|
| 127 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4136610">NO</clin_shared:radiation_therapy>
|
| 128 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4136611">NO</clin_shared:postoperative_rx_tx>
|
| 129 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4136613">Alive</clin_shared:vital_status>
|
| 130 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136612"/>
|
| 131 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1701</clin_shared:days_to_last_followup>
|
| 132 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 133 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136622"/>
|
| 134 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136623"/>
|
| 135 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136624"/>
|
| 136 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4136649">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 137 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4136625">NO</nte:new_tumor_event_after_initial_treatment>
|
| 138 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 139 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136626"/>
|
| 140 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136635"/>
|
| 141 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136636"/>
|
| 142 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136647"/>
|
| 143 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136648"/>
|
| 144 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 145 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 146 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 147 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136637"/>
|
| 148 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136638"/>
|
| 149 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">31</clin_shared:day_of_form_completion>
|
| 150 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
|
| 151 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2015</clin_shared:year_of_form_completion>
|
| 152 |
+
</follow_up_v1.0:follow_up>
|
| 153 |
+
</prad:follow_ups>
|
| 154 |
+
</prad:patient>
|
| 155 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-2A-A8VT.xml
ADDED
|
@@ -0,0 +1,206 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">89B056B9-2922-4AB0-A282-83A2D28DEE09</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">389.51.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517155">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517172">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517165">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517210">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-17365</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">995</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4217095">ASIAN</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-2A-A8VT</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">2A</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">A8VT</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">931B549F-B9F2-4E8D-83ED-FF663671883C</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517173">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8140/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517166">NO</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517167">YES</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">47</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517176">2011</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Discrepancy" restricted="false" source_system_identifier="3517221" xsi:nil="true"/>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4216488">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">29</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517156">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="3517157" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517158">Overlapping / Multiple Zones</prad:zone_of_origin>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517163">Bilateral</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517164">Apex</prad:tumor_level>
|
| 55 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517164">Middle</prad:tumor_level>
|
| 56 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517164">Base</prad:tumor_level>
|
| 57 |
+
</prad:tumor_levels>
|
| 58 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517177">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 59 |
+
<prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">4</prad:days_to_bone_scan_performed>
|
| 60 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517186">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
|
| 61 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517187">YES</prad:diagnostic_ct_abd_pelvis_performed>
|
| 62 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">-2</prad:days_to_diagnostic_computed_tomography_performed>
|
| 63 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 64 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517192">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
|
| 65 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 66 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517193">YES</prad:diagnostic_mri_performed>
|
| 67 |
+
<prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Completed" preferred_name="days_to_mri" display_order="46" cde_ver="1.000">4</prad:days_to_diagnostic_mri_performed>
|
| 68 |
+
<prad:diagnostic_mri_results>
|
| 69 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517198">No Evidence of Extraprostatic Extension</prad:diagnostic_mri_result>
|
| 70 |
+
</prad:diagnostic_mri_results>
|
| 71 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517205">YES</prad:lymphnodes_examined>
|
| 72 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517207">16</prad:number_of_lymphnodes_examined>
|
| 73 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517208">2</prad:number_of_lymphnodes_positive_by_he>
|
| 74 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517209">R1</clin_shared:residual_tumor>
|
| 75 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3517219"/>
|
| 76 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3517220"/>
|
| 77 |
+
<shared_stage:stage_event system="AJCC">
|
| 78 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 80 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 81 |
+
<shared_stage:tnm_categories>
|
| 82 |
+
<shared_stage:clinical_categories>
|
| 83 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517179">T2c</shared_stage:clinical_T>
|
| 84 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 85 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517199">M0</shared_stage:clinical_M>
|
| 86 |
+
</shared_stage:clinical_categories>
|
| 87 |
+
<shared_stage:pathologic_categories>
|
| 88 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517204">T4</shared_stage:pathologic_T>
|
| 89 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517206">N1</shared_stage:pathologic_N>
|
| 90 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 91 |
+
</shared_stage:pathologic_categories>
|
| 92 |
+
</shared_stage:tnm_categories>
|
| 93 |
+
<shared_stage:psa>
|
| 94 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517226">0.05</shared_stage:psa_value>
|
| 95 |
+
<shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">995</shared_stage:days_to_psa>
|
| 96 |
+
</shared_stage:psa>
|
| 97 |
+
<shared_stage:gleason_grading>
|
| 98 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517161">9</shared_stage:gleason_score>
|
| 99 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517159">4</shared_stage:primary_pattern>
|
| 100 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517160">5</shared_stage:secondary_pattern>
|
| 101 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3517162"/>
|
| 102 |
+
</shared_stage:gleason_grading>
|
| 103 |
+
<shared_stage:ann_arbor>
|
| 104 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 105 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 106 |
+
</shared_stage:ann_arbor>
|
| 107 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 109 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 110 |
+
</shared_stage:stage_event>
|
| 111 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517229">YES</clin_shared:postoperative_rx_tx>
|
| 112 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517228">YES</clin_shared:radiation_therapy>
|
| 113 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Discrepancy" restricted="false" source_system_identifier="3517230" xsi:nil="true"/>
|
| 114 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517227">NO</prad:biochemical_recurrence>
|
| 115 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 116 |
+
<prad_nte:new_tumor_events>
|
| 117 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517231">NO</nte:new_tumor_event_after_initial_treatment>
|
| 118 |
+
</prad_nte:new_tumor_events>
|
| 119 |
+
<rx:drugs>
|
| 120 |
+
<rx:drug>
|
| 121 |
+
<rx:tx_on_clinical_trial preferred_name="" display_order="9999" cde="3925111" cde_ver="" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3842930">NO</rx:tx_on_clinical_trial>
|
| 122 |
+
<rx:regimen_number preferred_name="" display_order="9999" cde="2744948" cde_ver="" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 123 |
+
<rx:bcr_drug_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-2A-A8VT-D64628</rx:bcr_drug_barcode>
|
| 124 |
+
<rx:bcr_drug_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">9804256C-57A6-4DD3-9AAA-5E51F57DAA41</rx:bcr_drug_uuid>
|
| 125 |
+
<rx:total_dose preferred_name="total_dose" display_order="999" cde="1515" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 126 |
+
<rx:total_dose_units preferred_name="pharmaceutical_tx_total_dose_units" display_order="999" cde="3088785" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 127 |
+
<rx:prescribed_dose preferred_name="prescribed_dose" display_order="999" cde="2184728" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 128 |
+
<rx:prescribed_dose_units preferred_name="pharmaceutical_tx_dose_units" display_order="999" cde="3065815" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 129 |
+
<rx:number_cycles preferred_name="pharma_adjuvant_cycles_count" display_order="999" cde="62590" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 130 |
+
<rx:days_to_drug_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3392465" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_started_days_to" display_order="26" cde_ver="1.000">85</rx:days_to_drug_therapy_start>
|
| 131 |
+
<rx:days_to_drug_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3392470" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_ended_days_to" display_order="16" cde_ver="1.000">1086</rx:days_to_drug_therapy_end>
|
| 132 |
+
<rx:therapy_types>
|
| 133 |
+
<rx:therapy_type preferred_name="pharmaceutical_therapy_type" display_order="7" cde="2793530" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3842933">Hormone Therapy</rx:therapy_type>
|
| 134 |
+
<rx:therapy_type_notes preferred_name="pharma_type_other" display_order="999" cde="2001762" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 135 |
+
</rx:therapy_types>
|
| 136 |
+
<rx:drug_name preferred_name="pharmaceutical_therapy_drug_name" display_order="22" cde="2975232" cde_ver="1.000" xsd_ver="1.10" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3842931">Lupron</rx:drug_name>
|
| 137 |
+
<rx:clinical_trail_drug_classification preferred_name="clinical_trial_drug_classification" display_order="6" cde="3378323" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3842932"/>
|
| 138 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 139 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 140 |
+
<rx:route_of_administrations>
|
| 141 |
+
<rx:route_of_administration preferred_name="route_of_administration" display_order="999" cde="2003586" cde_ver="6.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 142 |
+
</rx:route_of_administrations>
|
| 143 |
+
<rx:therapy_ongoing preferred_name="pharmaceutical_tx_ongoing_indicator" display_order="12" cde="3103479" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3842938">NO</rx:therapy_ongoing>
|
| 144 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3842943">Stable Disease</clin_shared:measure_of_response>
|
| 145 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">4</clin_shared:day_of_form_completion>
|
| 146 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">12</clin_shared:month_of_form_completion>
|
| 147 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
|
| 148 |
+
</rx:drug>
|
| 149 |
+
</rx:drugs>
|
| 150 |
+
<rad:radiations>
|
| 151 |
+
<rad:radiation>
|
| 152 |
+
<rad:bcr_radiation_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-2A-A8VT-R64625</rad:bcr_radiation_barcode>
|
| 153 |
+
<rad:bcr_radiation_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">75D9201B-00AF-41E6-BD55-F4093E8698EA</rad:bcr_radiation_uuid>
|
| 154 |
+
<rad:days_to_radiation_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3008313" owner="TSS" procurement_status="Completed" preferred_name="radiation_therapy_started_days_to" display_order="33" cde_ver="1.000">137</rad:days_to_radiation_therapy_start>
|
| 155 |
+
<rad:days_to_radiation_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3008333" owner="TSS" procurement_status="Completed" preferred_name="radiation_therapy_ended_days_to" display_order="17" cde_ver="1.000">193</rad:days_to_radiation_therapy_end>
|
| 156 |
+
<rad:radiation_type preferred_name="radiation_therapy_type" display_order="4" cde="2842944" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3842891">External</rad:radiation_type>
|
| 157 |
+
<rad:radiation_type_notes preferred_name="radiation_type_other" display_order="999" cde="2195477" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 158 |
+
<rad:radiation_dosage preferred_name="radiation_total_dose" display_order="6" cde="2721441" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3842893">7200</rad:radiation_dosage>
|
| 159 |
+
<rad:units preferred_name="radiation_adjuvant_units" display_order="7" cde="61446" cde_ver="3.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3842894">cGy</rad:units>
|
| 160 |
+
<rad:numfractions preferred_name="radiation_adjuvant_fractions_total" display_order="8" cde="61465" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3842895"/>
|
| 161 |
+
<rad:anatomic_treatment_site preferred_name="radiation_therapy_site" display_order="5" cde="2793522" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3842892">Primary Tumor Field</rad:anatomic_treatment_site>
|
| 162 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 163 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 164 |
+
<rad:radiation_treatment_ongoing preferred_name="radiation_therapy_ongoing_indicator" display_order="13" cde="2842745" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3842900">NO</rad:radiation_treatment_ongoing>
|
| 165 |
+
<rad:course_number preferred_name="course_number" display_order="999" cde="2732184" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 166 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3842905">Stable Disease</clin_shared:measure_of_response>
|
| 167 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">4</clin_shared:day_of_form_completion>
|
| 168 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">12</clin_shared:month_of_form_completion>
|
| 169 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
|
| 170 |
+
</rad:radiation>
|
| 171 |
+
</rad:radiations>
|
| 172 |
+
<prad:follow_ups>
|
| 173 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 174 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-2A-A8VT-F71798</clin_shared:bcr_followup_barcode>
|
| 175 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">2194A7E8-9DD7-4E55-9EF6-BACD266E1E90</clin_shared:bcr_followup_uuid>
|
| 176 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4137453">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 177 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4137454">NO</clin_shared:lost_follow_up>
|
| 178 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137455"/>
|
| 179 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137456"/>
|
| 180 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4137458">Alive</clin_shared:vital_status>
|
| 181 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137457"/>
|
| 182 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1373</clin_shared:days_to_last_followup>
|
| 183 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 184 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137467"/>
|
| 185 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137468"/>
|
| 186 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137469"/>
|
| 187 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4137529">Stable Disease</clin_shared:followup_treatment_success>
|
| 188 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4137470">NO</nte:new_tumor_event_after_initial_treatment>
|
| 189 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 190 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137471"/>
|
| 191 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137480"/>
|
| 192 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137481"/>
|
| 193 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137527"/>
|
| 194 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137528"/>
|
| 195 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 196 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 197 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 198 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137482"/>
|
| 199 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137483"/>
|
| 200 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">31</clin_shared:day_of_form_completion>
|
| 201 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
|
| 202 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2015</clin_shared:year_of_form_completion>
|
| 203 |
+
</follow_up_v1.0:follow_up>
|
| 204 |
+
</prad:follow_ups>
|
| 205 |
+
</prad:patient>
|
| 206 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-2A-A8VV.xml
ADDED
|
@@ -0,0 +1,154 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">456E0D8B-3028-41AC-B751-075FA99E7A91</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">389.51.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517250">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517267">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517260">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517305">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-19065</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">671</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="4216771"/>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-2A-A8VV</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">2A</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">A8VV</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">75A7AFB5-66D5-47E3-8A8A-3E3A1E749A96</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517268">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8140/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517261">NO</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517262">YES</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">52</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517271">2010</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517316">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4216166">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">29</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517251">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="3517252" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517253">Peripheral Zone</prad:zone_of_origin>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517258">Right</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517259">Apex</prad:tumor_level>
|
| 55 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517259">Middle</prad:tumor_level>
|
| 56 |
+
</prad:tumor_levels>
|
| 57 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517272">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 58 |
+
<prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">167</prad:days_to_bone_scan_performed>
|
| 59 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517281">Equivocal</prad:bone_scan_results>
|
| 60 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517282">YES</prad:diagnostic_ct_abd_pelvis_performed>
|
| 61 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">29</prad:days_to_diagnostic_computed_tomography_performed>
|
| 62 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 63 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517287">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
|
| 64 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 65 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517288">YES</prad:diagnostic_mri_performed>
|
| 66 |
+
<prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Completed" preferred_name="days_to_mri" display_order="46" cde_ver="1.000">204</prad:days_to_diagnostic_mri_performed>
|
| 67 |
+
<prad:diagnostic_mri_results>
|
| 68 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517293">No Evidence of Extraprostatic Extension</prad:diagnostic_mri_result>
|
| 69 |
+
</prad:diagnostic_mri_results>
|
| 70 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517300">YES</prad:lymphnodes_examined>
|
| 71 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517302">16</prad:number_of_lymphnodes_examined>
|
| 72 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517303">0</prad:number_of_lymphnodes_positive_by_he>
|
| 73 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517304">R0</clin_shared:residual_tumor>
|
| 74 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3517314"/>
|
| 75 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3517315"/>
|
| 76 |
+
<shared_stage:stage_event system="AJCC">
|
| 77 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 78 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 80 |
+
<shared_stage:tnm_categories>
|
| 81 |
+
<shared_stage:clinical_categories>
|
| 82 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517274">T2b</shared_stage:clinical_T>
|
| 83 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 84 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517294">M0</shared_stage:clinical_M>
|
| 85 |
+
</shared_stage:clinical_categories>
|
| 86 |
+
<shared_stage:pathologic_categories>
|
| 87 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517296">T2b</shared_stage:pathologic_T>
|
| 88 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517301">N0</shared_stage:pathologic_N>
|
| 89 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 90 |
+
</shared_stage:pathologic_categories>
|
| 91 |
+
</shared_stage:tnm_categories>
|
| 92 |
+
<shared_stage:psa>
|
| 93 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517321">0.05</shared_stage:psa_value>
|
| 94 |
+
<shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">560</shared_stage:days_to_psa>
|
| 95 |
+
</shared_stage:psa>
|
| 96 |
+
<shared_stage:gleason_grading>
|
| 97 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517256">6</shared_stage:gleason_score>
|
| 98 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517254">3</shared_stage:primary_pattern>
|
| 99 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517255">3</shared_stage:secondary_pattern>
|
| 100 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517257">4</shared_stage:tertiary_pattern>
|
| 101 |
+
</shared_stage:gleason_grading>
|
| 102 |
+
<shared_stage:ann_arbor>
|
| 103 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 104 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 105 |
+
</shared_stage:ann_arbor>
|
| 106 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 107 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 109 |
+
</shared_stage:stage_event>
|
| 110 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517324">NO</clin_shared:postoperative_rx_tx>
|
| 111 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517323">NO</clin_shared:radiation_therapy>
|
| 112 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3517325"/>
|
| 113 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517322">NO</prad:biochemical_recurrence>
|
| 114 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 115 |
+
<prad_nte:new_tumor_events>
|
| 116 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517326">NO</nte:new_tumor_event_after_initial_treatment>
|
| 117 |
+
</prad_nte:new_tumor_events>
|
| 118 |
+
<rx:drugs/>
|
| 119 |
+
<rad:radiations/>
|
| 120 |
+
<prad:follow_ups>
|
| 121 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 122 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-2A-A8VV-F71800</clin_shared:bcr_followup_barcode>
|
| 123 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">FC901101-A4AB-466A-BBE9-8ADC403ECF47</clin_shared:bcr_followup_uuid>
|
| 124 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4137533">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 125 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4137534">NO</clin_shared:lost_follow_up>
|
| 126 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137535"/>
|
| 127 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137536"/>
|
| 128 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4137538">Alive</clin_shared:vital_status>
|
| 129 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137537"/>
|
| 130 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">671</clin_shared:days_to_last_followup>
|
| 131 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 132 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137547"/>
|
| 133 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137548"/>
|
| 134 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137549"/>
|
| 135 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4137574">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 136 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4137550">NO</nte:new_tumor_event_after_initial_treatment>
|
| 137 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 138 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137551"/>
|
| 139 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137560"/>
|
| 140 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137561"/>
|
| 141 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137572"/>
|
| 142 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137573"/>
|
| 143 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 144 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 145 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 146 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137562"/>
|
| 147 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137563"/>
|
| 148 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">31</clin_shared:day_of_form_completion>
|
| 149 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
|
| 150 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2015</clin_shared:year_of_form_completion>
|
| 151 |
+
</follow_up_v1.0:follow_up>
|
| 152 |
+
</prad:follow_ups>
|
| 153 |
+
</prad:patient>
|
| 154 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-2A-A8VX.xml
ADDED
|
@@ -0,0 +1,153 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">04172A7C-2055-4D30-A222-7DBF32487EB6</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">389.51.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517440">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517457">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517450">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517495">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-25904</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1033</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4216403">WHITE</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-2A-A8VX</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">2A</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">A8VX</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">942F1788-D977-4AC0-A177-659F9D4CD077</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517458">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8140/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517451">NO</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517452">YES</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">70</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517461">2011</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517506">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4217187">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">29</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517441">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="3517442" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517443">Peripheral Zone</prad:zone_of_origin>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517448">Bilateral</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517449">Middle</prad:tumor_level>
|
| 55 |
+
</prad:tumor_levels>
|
| 56 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517462">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 57 |
+
<prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">32</prad:days_to_bone_scan_performed>
|
| 58 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517471">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
|
| 59 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517472">YES</prad:diagnostic_ct_abd_pelvis_performed>
|
| 60 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">32</prad:days_to_diagnostic_computed_tomography_performed>
|
| 61 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 62 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517477">Extraprostatic Extension Localized (e.g. seminal vesicles)</prad:diagnostic_ct_abd_pelvis_result>
|
| 63 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 64 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517478">YES</prad:diagnostic_mri_performed>
|
| 65 |
+
<prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Completed" preferred_name="days_to_mri" display_order="46" cde_ver="1.000">89</prad:days_to_diagnostic_mri_performed>
|
| 66 |
+
<prad:diagnostic_mri_results>
|
| 67 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517483">Extraprostatic Extension Localized (e.g. seminal vesicles)</prad:diagnostic_mri_result>
|
| 68 |
+
</prad:diagnostic_mri_results>
|
| 69 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517490">YES</prad:lymphnodes_examined>
|
| 70 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517492">16</prad:number_of_lymphnodes_examined>
|
| 71 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517493">0</prad:number_of_lymphnodes_positive_by_he>
|
| 72 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517494">R0</clin_shared:residual_tumor>
|
| 73 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3517504"/>
|
| 74 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3517505"/>
|
| 75 |
+
<shared_stage:stage_event system="AJCC">
|
| 76 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 77 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 78 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:tnm_categories>
|
| 80 |
+
<shared_stage:clinical_categories>
|
| 81 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517464">T2c</shared_stage:clinical_T>
|
| 82 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 83 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517484">M0</shared_stage:clinical_M>
|
| 84 |
+
</shared_stage:clinical_categories>
|
| 85 |
+
<shared_stage:pathologic_categories>
|
| 86 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517488">T3b</shared_stage:pathologic_T>
|
| 87 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517491">N0</shared_stage:pathologic_N>
|
| 88 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 89 |
+
</shared_stage:pathologic_categories>
|
| 90 |
+
</shared_stage:tnm_categories>
|
| 91 |
+
<shared_stage:psa>
|
| 92 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517511">0.05</shared_stage:psa_value>
|
| 93 |
+
<shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">1033</shared_stage:days_to_psa>
|
| 94 |
+
</shared_stage:psa>
|
| 95 |
+
<shared_stage:gleason_grading>
|
| 96 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517446">8</shared_stage:gleason_score>
|
| 97 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517444">4</shared_stage:primary_pattern>
|
| 98 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517445">4</shared_stage:secondary_pattern>
|
| 99 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3517447"/>
|
| 100 |
+
</shared_stage:gleason_grading>
|
| 101 |
+
<shared_stage:ann_arbor>
|
| 102 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 103 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 104 |
+
</shared_stage:ann_arbor>
|
| 105 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 106 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 107 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
</shared_stage:stage_event>
|
| 109 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517514">NO</clin_shared:postoperative_rx_tx>
|
| 110 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517513">NO</clin_shared:radiation_therapy>
|
| 111 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3517515"/>
|
| 112 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517512">NO</prad:biochemical_recurrence>
|
| 113 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 114 |
+
<prad_nte:new_tumor_events>
|
| 115 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517516">NO</nte:new_tumor_event_after_initial_treatment>
|
| 116 |
+
</prad_nte:new_tumor_events>
|
| 117 |
+
<rx:drugs/>
|
| 118 |
+
<rad:radiations/>
|
| 119 |
+
<prad:follow_ups>
|
| 120 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 121 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-2A-A8VX-F71804</clin_shared:bcr_followup_barcode>
|
| 122 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">24877403-12D1-40B7-8F7F-67714B8EAC8A</clin_shared:bcr_followup_uuid>
|
| 123 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4137672">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 124 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4137673">NO</clin_shared:lost_follow_up>
|
| 125 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137674"/>
|
| 126 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137675"/>
|
| 127 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4137677">Alive</clin_shared:vital_status>
|
| 128 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137676"/>
|
| 129 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1378</clin_shared:days_to_last_followup>
|
| 130 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 131 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137686"/>
|
| 132 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137687"/>
|
| 133 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137688"/>
|
| 134 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4137713">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 135 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4137689">NO</nte:new_tumor_event_after_initial_treatment>
|
| 136 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 137 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137690"/>
|
| 138 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137699"/>
|
| 139 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137700"/>
|
| 140 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137711"/>
|
| 141 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137712"/>
|
| 142 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 143 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 144 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 145 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137701"/>
|
| 146 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137702"/>
|
| 147 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">31</clin_shared:day_of_form_completion>
|
| 148 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
|
| 149 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2015</clin_shared:year_of_form_completion>
|
| 150 |
+
</follow_up_v1.0:follow_up>
|
| 151 |
+
</prad:follow_ups>
|
| 152 |
+
</prad:patient>
|
| 153 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-2A-A8W1.xml
ADDED
|
@@ -0,0 +1,154 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">FA6BCFE6-BB77-4097-B610-AF2F2494EAB8</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">389.51.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517820">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517837">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517830">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517875">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-19964</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">112</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4216482">ASIAN</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-2A-A8W1</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">2A</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">A8W1</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">F5319FD5-BEAE-4CA8-8F42-45FCA5E6A2D2</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517838">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8140/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517831">NO</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517832">YES</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">54</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517841">2011</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="3517886"/>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4217091">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">29</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517821">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="3517822" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517823">Peripheral Zone</prad:zone_of_origin>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517828">Left</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517829">Middle</prad:tumor_level>
|
| 55 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517829">Base</prad:tumor_level>
|
| 56 |
+
</prad:tumor_levels>
|
| 57 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517842">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 58 |
+
<prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">27</prad:days_to_bone_scan_performed>
|
| 59 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517851">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
|
| 60 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517852">NO</prad:diagnostic_ct_abd_pelvis_performed>
|
| 61 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Not Available" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000"/>
|
| 62 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 63 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3517857"/>
|
| 64 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 65 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517858">NO</prad:diagnostic_mri_performed>
|
| 66 |
+
<prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
|
| 67 |
+
<prad:diagnostic_mri_results>
|
| 68 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3517863"/>
|
| 69 |
+
</prad:diagnostic_mri_results>
|
| 70 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517870">YES</prad:lymphnodes_examined>
|
| 71 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517872">12</prad:number_of_lymphnodes_examined>
|
| 72 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517873">0</prad:number_of_lymphnodes_positive_by_he>
|
| 73 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517874">R1</clin_shared:residual_tumor>
|
| 74 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3517884"/>
|
| 75 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3517885"/>
|
| 76 |
+
<shared_stage:stage_event system="AJCC">
|
| 77 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 78 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 80 |
+
<shared_stage:tnm_categories>
|
| 81 |
+
<shared_stage:clinical_categories>
|
| 82 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517843">T1c</shared_stage:clinical_T>
|
| 83 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 84 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517864">M0</shared_stage:clinical_M>
|
| 85 |
+
</shared_stage:clinical_categories>
|
| 86 |
+
<shared_stage:pathologic_categories>
|
| 87 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517868">T3a</shared_stage:pathologic_T>
|
| 88 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517871">N0</shared_stage:pathologic_N>
|
| 89 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 90 |
+
</shared_stage:pathologic_categories>
|
| 91 |
+
</shared_stage:tnm_categories>
|
| 92 |
+
<shared_stage:psa>
|
| 93 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517891">0.05</shared_stage:psa_value>
|
| 94 |
+
<shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">-122</shared_stage:days_to_psa>
|
| 95 |
+
</shared_stage:psa>
|
| 96 |
+
<shared_stage:gleason_grading>
|
| 97 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517826">7</shared_stage:gleason_score>
|
| 98 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517824">4</shared_stage:primary_pattern>
|
| 99 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517825">3</shared_stage:secondary_pattern>
|
| 100 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3517827"/>
|
| 101 |
+
</shared_stage:gleason_grading>
|
| 102 |
+
<shared_stage:ann_arbor>
|
| 103 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 104 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 105 |
+
</shared_stage:ann_arbor>
|
| 106 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 107 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 109 |
+
</shared_stage:stage_event>
|
| 110 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="3517894"/>
|
| 111 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="3517893"/>
|
| 112 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3517895"/>
|
| 113 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517892">NO</prad:biochemical_recurrence>
|
| 114 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 115 |
+
<prad_nte:new_tumor_events>
|
| 116 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517896">NO</nte:new_tumor_event_after_initial_treatment>
|
| 117 |
+
</prad_nte:new_tumor_events>
|
| 118 |
+
<rx:drugs/>
|
| 119 |
+
<rad:radiations/>
|
| 120 |
+
<prad:follow_ups>
|
| 121 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 122 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-2A-A8W1-F71808</clin_shared:bcr_followup_barcode>
|
| 123 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">8ECE00DC-877F-4CF3-9B4E-99CD261A68A6</clin_shared:bcr_followup_uuid>
|
| 124 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4137852">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 125 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4137853">NO</clin_shared:lost_follow_up>
|
| 126 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137854"/>
|
| 127 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137855"/>
|
| 128 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4137857">Alive</clin_shared:vital_status>
|
| 129 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137856"/>
|
| 130 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">112</clin_shared:days_to_last_followup>
|
| 131 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 132 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137866"/>
|
| 133 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137867"/>
|
| 134 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137868"/>
|
| 135 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="4137893" xsi:nil="true"/>
|
| 136 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4137869">NO</nte:new_tumor_event_after_initial_treatment>
|
| 137 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 138 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137870"/>
|
| 139 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137879"/>
|
| 140 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137880"/>
|
| 141 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137891"/>
|
| 142 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137892"/>
|
| 143 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 144 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 145 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 146 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137881"/>
|
| 147 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137882"/>
|
| 148 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">31</clin_shared:day_of_form_completion>
|
| 149 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
|
| 150 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2015</clin_shared:year_of_form_completion>
|
| 151 |
+
</follow_up_v1.0:follow_up>
|
| 152 |
+
</prad:follow_ups>
|
| 153 |
+
</prad:patient>
|
| 154 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-2A-A8W3.xml
ADDED
|
@@ -0,0 +1,165 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">9C2D1395-B78A-4290-91AA-0C6887C0172E</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">389.51.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518010">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518027">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518020">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518065">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-25557</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">771</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4217183">WHITE</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-2A-A8W3</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">2A</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">A8W3</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">5A790086-4887-4D2B-9C28-0FDD5DD1F1FB</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518028">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8140/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518021">NO</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518022">YES</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">69</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518031">2011</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Discrepancy" restricted="false" source_system_identifier="3518076" xsi:nil="true"/>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4216400">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">29</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518011">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="3518012" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518013">Peripheral Zone</prad:zone_of_origin>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518018">Left</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518019">Apex</prad:tumor_level>
|
| 55 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518019">Middle</prad:tumor_level>
|
| 56 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518019">Base</prad:tumor_level>
|
| 57 |
+
</prad:tumor_levels>
|
| 58 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518032">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 59 |
+
<prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">13</prad:days_to_bone_scan_performed>
|
| 60 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518041">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
|
| 61 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518042">YES</prad:diagnostic_ct_abd_pelvis_performed>
|
| 62 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">13</prad:days_to_diagnostic_computed_tomography_performed>
|
| 63 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 64 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518047">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
|
| 65 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 66 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518048">YES</prad:diagnostic_mri_performed>
|
| 67 |
+
<prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Completed" preferred_name="days_to_mri" display_order="46" cde_ver="1.000">-14</prad:days_to_diagnostic_mri_performed>
|
| 68 |
+
<prad:diagnostic_mri_results>
|
| 69 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518053">No Evidence of Extraprostatic Extension</prad:diagnostic_mri_result>
|
| 70 |
+
</prad:diagnostic_mri_results>
|
| 71 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518060">YES</prad:lymphnodes_examined>
|
| 72 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518062">3</prad:number_of_lymphnodes_examined>
|
| 73 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518063">0</prad:number_of_lymphnodes_positive_by_he>
|
| 74 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518064">R0</clin_shared:residual_tumor>
|
| 75 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3518074"/>
|
| 76 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3518075"/>
|
| 77 |
+
<shared_stage:stage_event system="AJCC">
|
| 78 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 80 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 81 |
+
<shared_stage:tnm_categories>
|
| 82 |
+
<shared_stage:clinical_categories>
|
| 83 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518034">T2b</shared_stage:clinical_T>
|
| 84 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 85 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518054">M0</shared_stage:clinical_M>
|
| 86 |
+
</shared_stage:clinical_categories>
|
| 87 |
+
<shared_stage:pathologic_categories>
|
| 88 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518058">T3a</shared_stage:pathologic_T>
|
| 89 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518061">N0</shared_stage:pathologic_N>
|
| 90 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 91 |
+
</shared_stage:pathologic_categories>
|
| 92 |
+
</shared_stage:tnm_categories>
|
| 93 |
+
<shared_stage:psa>
|
| 94 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518081">.36</shared_stage:psa_value>
|
| 95 |
+
<shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">771</shared_stage:days_to_psa>
|
| 96 |
+
</shared_stage:psa>
|
| 97 |
+
<shared_stage:gleason_grading>
|
| 98 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518016">9</shared_stage:gleason_score>
|
| 99 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518014">4</shared_stage:primary_pattern>
|
| 100 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518015">5</shared_stage:secondary_pattern>
|
| 101 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3518017"/>
|
| 102 |
+
</shared_stage:gleason_grading>
|
| 103 |
+
<shared_stage:ann_arbor>
|
| 104 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 105 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 106 |
+
</shared_stage:ann_arbor>
|
| 107 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 109 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 110 |
+
</shared_stage:stage_event>
|
| 111 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518084">NO</clin_shared:postoperative_rx_tx>
|
| 112 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518083">NO</clin_shared:radiation_therapy>
|
| 113 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3518085"/>
|
| 114 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518082">YES</prad:biochemical_recurrence>
|
| 115 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Completed" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000">198</prad:days_to_first_biochemical_recurrence>
|
| 116 |
+
<prad_nte:new_tumor_events>
|
| 117 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518086">YES</nte:new_tumor_event_after_initial_treatment>
|
| 118 |
+
<prad_nte:new_tumor_event>
|
| 119 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518087">Biochemical evidence of disease</nte:new_neoplasm_event_type>
|
| 120 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 121 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3518092"/>
|
| 122 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3518093"/>
|
| 123 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3518094"/>
|
| 124 |
+
<prad_shared:type_of_progression_after_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3518095"/>
|
| 125 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3518100"/>
|
| 126 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3518101"/>
|
| 127 |
+
</prad_nte:new_tumor_event>
|
| 128 |
+
</prad_nte:new_tumor_events>
|
| 129 |
+
<rx:drugs/>
|
| 130 |
+
<rad:radiations/>
|
| 131 |
+
<prad:follow_ups>
|
| 132 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 133 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-2A-A8W3-F71815</clin_shared:bcr_followup_barcode>
|
| 134 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">50CC6A78-1576-40D2-AC0B-EEDFE398939F</clin_shared:bcr_followup_uuid>
|
| 135 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4138074">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 136 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4138075">NO</clin_shared:lost_follow_up>
|
| 137 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4138076"/>
|
| 138 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4138077"/>
|
| 139 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4138079">Alive</clin_shared:vital_status>
|
| 140 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4138078"/>
|
| 141 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">863</clin_shared:days_to_last_followup>
|
| 142 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 143 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4138088"/>
|
| 144 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4138089"/>
|
| 145 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4138090"/>
|
| 146 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="4138136"/>
|
| 147 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4138109">YES</nte:new_tumor_event_after_initial_treatment>
|
| 148 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Completed" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000">198</nte:days_to_new_tumor_event_after_initial_treatment>
|
| 149 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4138110">Biochemical evidence of disease</nte:new_neoplasm_event_type>
|
| 150 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4138119"/>
|
| 151 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4138120"/>
|
| 152 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="4138134"/>
|
| 153 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="4138135"/>
|
| 154 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Completed" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000">198</follow_up_v1.0:days_to_first_biochemical_recurrence>
|
| 155 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 156 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 157 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4138121"/>
|
| 158 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4138122"/>
|
| 159 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">31</clin_shared:day_of_form_completion>
|
| 160 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
|
| 161 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2015</clin_shared:year_of_form_completion>
|
| 162 |
+
</follow_up_v1.0:follow_up>
|
| 163 |
+
</prad:follow_ups>
|
| 164 |
+
</prad:patient>
|
| 165 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-2A-AAYF.xml
ADDED
|
@@ -0,0 +1,155 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">E7A83F64-D527-4BC2-ABF7-9435FFE54E3E</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">429.43.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696290">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696307">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696300">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696345">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-20866</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">972</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4216315">WHITE</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-2A-AAYF</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">2A</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">AAYF</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">490E84ED-3C02-4593-990E-ADE5C109DF44</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696308">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8140/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696301">NO</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696302">YES</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">57</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696311">2011</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696356">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4216940">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">7</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">7</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696291">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="3696292" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696293">Overlapping / Multiple Zones</prad:zone_of_origin>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696298">Right</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696299">Apex</prad:tumor_level>
|
| 55 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696299">Middle</prad:tumor_level>
|
| 56 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696299">Base</prad:tumor_level>
|
| 57 |
+
</prad:tumor_levels>
|
| 58 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696312">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 59 |
+
<prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Not Available" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000"/>
|
| 60 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3696321"/>
|
| 61 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696322">NO</prad:diagnostic_ct_abd_pelvis_performed>
|
| 62 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Not Available" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000"/>
|
| 63 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 64 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3696327"/>
|
| 65 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 66 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696328">YES</prad:diagnostic_mri_performed>
|
| 67 |
+
<prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Completed" preferred_name="days_to_mri" display_order="46" cde_ver="1.000">186</prad:days_to_diagnostic_mri_performed>
|
| 68 |
+
<prad:diagnostic_mri_results>
|
| 69 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696333">Extraprostatic Extension Localized (e.g. seminal vesicles)</prad:diagnostic_mri_result>
|
| 70 |
+
</prad:diagnostic_mri_results>
|
| 71 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696340">NO</prad:lymphnodes_examined>
|
| 72 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3696342"/>
|
| 73 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3696343"/>
|
| 74 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696344">R0</clin_shared:residual_tumor>
|
| 75 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3696354"/>
|
| 76 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3696355"/>
|
| 77 |
+
<shared_stage:stage_event system="AJCC">
|
| 78 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 80 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 81 |
+
<shared_stage:tnm_categories>
|
| 82 |
+
<shared_stage:clinical_categories>
|
| 83 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696313">T1c</shared_stage:clinical_T>
|
| 84 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 85 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696334">M0</shared_stage:clinical_M>
|
| 86 |
+
</shared_stage:clinical_categories>
|
| 87 |
+
<shared_stage:pathologic_categories>
|
| 88 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696338">T3a</shared_stage:pathologic_T>
|
| 89 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3696341"/>
|
| 90 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 91 |
+
</shared_stage:pathologic_categories>
|
| 92 |
+
</shared_stage:tnm_categories>
|
| 93 |
+
<shared_stage:psa>
|
| 94 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696361">.05</shared_stage:psa_value>
|
| 95 |
+
<shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">972</shared_stage:days_to_psa>
|
| 96 |
+
</shared_stage:psa>
|
| 97 |
+
<shared_stage:gleason_grading>
|
| 98 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696296">7</shared_stage:gleason_score>
|
| 99 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696294">3</shared_stage:primary_pattern>
|
| 100 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696295">4</shared_stage:secondary_pattern>
|
| 101 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3696297"/>
|
| 102 |
+
</shared_stage:gleason_grading>
|
| 103 |
+
<shared_stage:ann_arbor>
|
| 104 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 105 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 106 |
+
</shared_stage:ann_arbor>
|
| 107 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 109 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 110 |
+
</shared_stage:stage_event>
|
| 111 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696364">NO</clin_shared:postoperative_rx_tx>
|
| 112 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696363">NO</clin_shared:radiation_therapy>
|
| 113 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696365">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 114 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696362">NO</prad:biochemical_recurrence>
|
| 115 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 116 |
+
<prad_nte:new_tumor_events>
|
| 117 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696366">NO</nte:new_tumor_event_after_initial_treatment>
|
| 118 |
+
</prad_nte:new_tumor_events>
|
| 119 |
+
<rx:drugs/>
|
| 120 |
+
<rad:radiations/>
|
| 121 |
+
<prad:follow_ups>
|
| 122 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 123 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-2A-AAYF-F71830</clin_shared:bcr_followup_barcode>
|
| 124 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">F16D469B-D8E9-4719-BAF8-5C0BFBD68D3C</clin_shared:bcr_followup_uuid>
|
| 125 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4138879">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 126 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4138880">NO</clin_shared:lost_follow_up>
|
| 127 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4138881"/>
|
| 128 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4138882"/>
|
| 129 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4138937">Alive</clin_shared:vital_status>
|
| 130 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4138883"/>
|
| 131 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1364</clin_shared:days_to_last_followup>
|
| 132 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 133 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4138946"/>
|
| 134 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4138947"/>
|
| 135 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4138948"/>
|
| 136 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4138973">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 137 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4138949">NO</nte:new_tumor_event_after_initial_treatment>
|
| 138 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 139 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4138950"/>
|
| 140 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4138959"/>
|
| 141 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4138960"/>
|
| 142 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4138971"/>
|
| 143 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4138972"/>
|
| 144 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 145 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 146 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 147 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4138961"/>
|
| 148 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4138962"/>
|
| 149 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">31</clin_shared:day_of_form_completion>
|
| 150 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
|
| 151 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2015</clin_shared:year_of_form_completion>
|
| 152 |
+
</follow_up_v1.0:follow_up>
|
| 153 |
+
</prad:follow_ups>
|
| 154 |
+
</prad:patient>
|
| 155 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-2A-AAYO.xml
ADDED
|
@@ -0,0 +1,154 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">0581FFE4-B58F-4219-82A0-7A34D573E254</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">429.43.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699909">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699926">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699919">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699964">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-21183</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">922</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4216397">WHITE</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-2A-AAYO</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">2A</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">AAYO</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">8C0D361F-EAAB-4768-90F2-B7A610E2BBB1</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699927">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8140/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699920">NO</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699921">YES</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">57</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699930">2011</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699975">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4217188">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">7</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">7</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699910">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="3699911" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699912">Overlapping / Multiple Zones</prad:zone_of_origin>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699917">Bilateral</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699918">Apex</prad:tumor_level>
|
| 55 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699918">Middle</prad:tumor_level>
|
| 56 |
+
</prad:tumor_levels>
|
| 57 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699931">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 58 |
+
<prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Not Available" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000"/>
|
| 59 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3699940"/>
|
| 60 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699941">NO</prad:diagnostic_ct_abd_pelvis_performed>
|
| 61 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Not Available" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000"/>
|
| 62 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 63 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3699946"/>
|
| 64 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 65 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699947">YES</prad:diagnostic_mri_performed>
|
| 66 |
+
<prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Completed" preferred_name="days_to_mri" display_order="46" cde_ver="1.000">180</prad:days_to_diagnostic_mri_performed>
|
| 67 |
+
<prad:diagnostic_mri_results>
|
| 68 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699952">No Evidence of Extraprostatic Extension</prad:diagnostic_mri_result>
|
| 69 |
+
</prad:diagnostic_mri_results>
|
| 70 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699959">NO</prad:lymphnodes_examined>
|
| 71 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3699961"/>
|
| 72 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3699962"/>
|
| 73 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699963">R0</clin_shared:residual_tumor>
|
| 74 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3699973"/>
|
| 75 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3699974"/>
|
| 76 |
+
<shared_stage:stage_event system="AJCC">
|
| 77 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 78 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 80 |
+
<shared_stage:tnm_categories>
|
| 81 |
+
<shared_stage:clinical_categories>
|
| 82 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699932">T1c</shared_stage:clinical_T>
|
| 83 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 84 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699953">M0</shared_stage:clinical_M>
|
| 85 |
+
</shared_stage:clinical_categories>
|
| 86 |
+
<shared_stage:pathologic_categories>
|
| 87 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699955">T2c</shared_stage:pathologic_T>
|
| 88 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3699960"/>
|
| 89 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 90 |
+
</shared_stage:pathologic_categories>
|
| 91 |
+
</shared_stage:tnm_categories>
|
| 92 |
+
<shared_stage:psa>
|
| 93 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699980">.05</shared_stage:psa_value>
|
| 94 |
+
<shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">922</shared_stage:days_to_psa>
|
| 95 |
+
</shared_stage:psa>
|
| 96 |
+
<shared_stage:gleason_grading>
|
| 97 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699915">6</shared_stage:gleason_score>
|
| 98 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699913">3</shared_stage:primary_pattern>
|
| 99 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699914">3</shared_stage:secondary_pattern>
|
| 100 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3699916"/>
|
| 101 |
+
</shared_stage:gleason_grading>
|
| 102 |
+
<shared_stage:ann_arbor>
|
| 103 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 104 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 105 |
+
</shared_stage:ann_arbor>
|
| 106 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 107 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 109 |
+
</shared_stage:stage_event>
|
| 110 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699983">NO</clin_shared:postoperative_rx_tx>
|
| 111 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699982">NO</clin_shared:radiation_therapy>
|
| 112 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699984">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 113 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699981">NO</prad:biochemical_recurrence>
|
| 114 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 115 |
+
<prad_nte:new_tumor_events>
|
| 116 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699985">NO</nte:new_tumor_event_after_initial_treatment>
|
| 117 |
+
</prad_nte:new_tumor_events>
|
| 118 |
+
<rx:drugs/>
|
| 119 |
+
<rad:radiations/>
|
| 120 |
+
<prad:follow_ups>
|
| 121 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 122 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-2A-AAYO-F71840</clin_shared:bcr_followup_barcode>
|
| 123 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">9380832C-00A8-4C1A-A816-28B764D77FA1</clin_shared:bcr_followup_uuid>
|
| 124 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4139345">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 125 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4139346">NO</clin_shared:lost_follow_up>
|
| 126 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139347"/>
|
| 127 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139348"/>
|
| 128 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4139350">Alive</clin_shared:vital_status>
|
| 129 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139349"/>
|
| 130 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1272</clin_shared:days_to_last_followup>
|
| 131 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 132 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139359"/>
|
| 133 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139360"/>
|
| 134 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139361"/>
|
| 135 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4139386">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 136 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4139362">NO</nte:new_tumor_event_after_initial_treatment>
|
| 137 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 138 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139363"/>
|
| 139 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139372"/>
|
| 140 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139373"/>
|
| 141 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139384"/>
|
| 142 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139385"/>
|
| 143 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 144 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 145 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 146 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139374"/>
|
| 147 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139375"/>
|
| 148 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">31</clin_shared:day_of_form_completion>
|
| 149 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
|
| 150 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2015</clin_shared:year_of_form_completion>
|
| 151 |
+
</follow_up_v1.0:follow_up>
|
| 152 |
+
</prad:follow_ups>
|
| 153 |
+
</prad:patient>
|
| 154 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-2A-AAYU.xml
ADDED
|
@@ -0,0 +1,155 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">6509FB0F-B2DD-414A-A3AB-1E448422D27B</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">429.43.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701200">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701217">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701210">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701255">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-20582</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">615</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4216826">WHITE</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-2A-AAYU</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">2A</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">AAYU</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">AA1A3A43-2F9C-456C-BA74-81C29B9801CB</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701218">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8140/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701211">NO</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701212">YES</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">56</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701221">2012</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701266">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4216050">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">7</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">7</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701201">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="3701202" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701203">Overlapping / Multiple Zones</prad:zone_of_origin>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701208">Left</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701209">Apex</prad:tumor_level>
|
| 55 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701209">Middle</prad:tumor_level>
|
| 56 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701209">Base</prad:tumor_level>
|
| 57 |
+
</prad:tumor_levels>
|
| 58 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701222">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 59 |
+
<prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Not Available" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000"/>
|
| 60 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3701231"/>
|
| 61 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701232">NO</prad:diagnostic_ct_abd_pelvis_performed>
|
| 62 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Not Available" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000"/>
|
| 63 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 64 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3701237"/>
|
| 65 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 66 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701238">YES</prad:diagnostic_mri_performed>
|
| 67 |
+
<prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Completed" preferred_name="days_to_mri" display_order="46" cde_ver="1.000">52</prad:days_to_diagnostic_mri_performed>
|
| 68 |
+
<prad:diagnostic_mri_results>
|
| 69 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701243">Extraprostatic Extension Localized (e.g. seminal vesicles)</prad:diagnostic_mri_result>
|
| 70 |
+
</prad:diagnostic_mri_results>
|
| 71 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701250">YES</prad:lymphnodes_examined>
|
| 72 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701252">28</prad:number_of_lymphnodes_examined>
|
| 73 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701253">0</prad:number_of_lymphnodes_positive_by_he>
|
| 74 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701254">R1</clin_shared:residual_tumor>
|
| 75 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3701264"/>
|
| 76 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3701265"/>
|
| 77 |
+
<shared_stage:stage_event system="AJCC">
|
| 78 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 80 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 81 |
+
<shared_stage:tnm_categories>
|
| 82 |
+
<shared_stage:clinical_categories>
|
| 83 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701223">T1c</shared_stage:clinical_T>
|
| 84 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 85 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701244">M0</shared_stage:clinical_M>
|
| 86 |
+
</shared_stage:clinical_categories>
|
| 87 |
+
<shared_stage:pathologic_categories>
|
| 88 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701248">T3a</shared_stage:pathologic_T>
|
| 89 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701251">N0</shared_stage:pathologic_N>
|
| 90 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 91 |
+
</shared_stage:pathologic_categories>
|
| 92 |
+
</shared_stage:tnm_categories>
|
| 93 |
+
<shared_stage:psa>
|
| 94 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701271">.05</shared_stage:psa_value>
|
| 95 |
+
<shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">269</shared_stage:days_to_psa>
|
| 96 |
+
</shared_stage:psa>
|
| 97 |
+
<shared_stage:gleason_grading>
|
| 98 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701206">6</shared_stage:gleason_score>
|
| 99 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701204">3</shared_stage:primary_pattern>
|
| 100 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701205">3</shared_stage:secondary_pattern>
|
| 101 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701207">4</shared_stage:tertiary_pattern>
|
| 102 |
+
</shared_stage:gleason_grading>
|
| 103 |
+
<shared_stage:ann_arbor>
|
| 104 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 105 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 106 |
+
</shared_stage:ann_arbor>
|
| 107 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 109 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 110 |
+
</shared_stage:stage_event>
|
| 111 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701274">NO</clin_shared:postoperative_rx_tx>
|
| 112 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701273">NO</clin_shared:radiation_therapy>
|
| 113 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Discrepancy" restricted="false" source_system_identifier="3701275" xsi:nil="true"/>
|
| 114 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701272">NO</prad:biochemical_recurrence>
|
| 115 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 116 |
+
<prad_nte:new_tumor_events>
|
| 117 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701276">NO</nte:new_tumor_event_after_initial_treatment>
|
| 118 |
+
</prad_nte:new_tumor_events>
|
| 119 |
+
<rx:drugs/>
|
| 120 |
+
<rad:radiations/>
|
| 121 |
+
<prad:follow_ups>
|
| 122 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 123 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-2A-AAYU-F71848</clin_shared:bcr_followup_barcode>
|
| 124 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">7A3178ED-1B80-4624-AD64-F48A46BC6C4B</clin_shared:bcr_followup_uuid>
|
| 125 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4139648">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 126 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4139649">NO</clin_shared:lost_follow_up>
|
| 127 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139650"/>
|
| 128 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139651"/>
|
| 129 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4139653">Alive</clin_shared:vital_status>
|
| 130 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139652"/>
|
| 131 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">615</clin_shared:days_to_last_followup>
|
| 132 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 133 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139662"/>
|
| 134 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139663"/>
|
| 135 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139664"/>
|
| 136 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="4139707"/>
|
| 137 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4139676">NO</nte:new_tumor_event_after_initial_treatment>
|
| 138 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 139 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139677"/>
|
| 140 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139686"/>
|
| 141 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139687"/>
|
| 142 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139705"/>
|
| 143 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139706"/>
|
| 144 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 145 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 146 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 147 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139688"/>
|
| 148 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139689"/>
|
| 149 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">31</clin_shared:day_of_form_completion>
|
| 150 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
|
| 151 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2015</clin_shared:year_of_form_completion>
|
| 152 |
+
</follow_up_v1.0:follow_up>
|
| 153 |
+
</prad:follow_ups>
|
| 154 |
+
</prad:patient>
|
| 155 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-4L-AA1F.xml
ADDED
|
@@ -0,0 +1,151 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">92B5D7DB-2B0F-452C-ACE5-0C1D7D009D46</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">429.43.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969002">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969019">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969012">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969057">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-23665</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">350</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4217344">WHITE</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-4L-AA1F</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">4L</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">AA1F</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">47ABCD03-C6FF-4777-AC26-F880474092FF</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969020">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8140/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969013">YES</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969014">NO</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">64</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969023">2013</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969068">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4216564">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">14</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">11</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969003">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="3969004" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969005">Overlapping / Multiple Zones</prad:zone_of_origin>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969010">Bilateral</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969011">Middle</prad:tumor_level>
|
| 55 |
+
</prad:tumor_levels>
|
| 56 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969024">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 57 |
+
<prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">0</prad:days_to_bone_scan_performed>
|
| 58 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969033">Abnormal (not related to prostate cancer)</prad:bone_scan_results>
|
| 59 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969034">YES</prad:diagnostic_ct_abd_pelvis_performed>
|
| 60 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">4</prad:days_to_diagnostic_computed_tomography_performed>
|
| 61 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 62 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969039">Extraprostatic Extension Localized (e.g. seminal vesicles)</prad:diagnostic_ct_abd_pelvis_result>
|
| 63 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 64 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969040">YES</prad:diagnostic_mri_performed>
|
| 65 |
+
<prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Completed" preferred_name="days_to_mri" display_order="46" cde_ver="1.000">5</prad:days_to_diagnostic_mri_performed>
|
| 66 |
+
<prad:diagnostic_mri_results>
|
| 67 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969045">Extraprostatic Extension Localized (e.g. seminal vesicles)</prad:diagnostic_mri_result>
|
| 68 |
+
</prad:diagnostic_mri_results>
|
| 69 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969052">YES</prad:lymphnodes_examined>
|
| 70 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969054">4</prad:number_of_lymphnodes_examined>
|
| 71 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969055">0</prad:number_of_lymphnodes_positive_by_he>
|
| 72 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969056">R1</clin_shared:residual_tumor>
|
| 73 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3969066"/>
|
| 74 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3969067"/>
|
| 75 |
+
<shared_stage:stage_event system="AJCC">
|
| 76 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 77 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 78 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:tnm_categories>
|
| 80 |
+
<shared_stage:clinical_categories>
|
| 81 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969026">T2c</shared_stage:clinical_T>
|
| 82 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 83 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969046">M1a</shared_stage:clinical_M>
|
| 84 |
+
</shared_stage:clinical_categories>
|
| 85 |
+
<shared_stage:pathologic_categories>
|
| 86 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969050">T3b</shared_stage:pathologic_T>
|
| 87 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969053">N0</shared_stage:pathologic_N>
|
| 88 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 89 |
+
</shared_stage:pathologic_categories>
|
| 90 |
+
</shared_stage:tnm_categories>
|
| 91 |
+
<shared_stage:psa>
|
| 92 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969101">3.5</shared_stage:psa_value>
|
| 93 |
+
<shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">350</shared_stage:days_to_psa>
|
| 94 |
+
</shared_stage:psa>
|
| 95 |
+
<shared_stage:gleason_grading>
|
| 96 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969008">8</shared_stage:gleason_score>
|
| 97 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969006">4</shared_stage:primary_pattern>
|
| 98 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969007">4</shared_stage:secondary_pattern>
|
| 99 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3969009"/>
|
| 100 |
+
</shared_stage:gleason_grading>
|
| 101 |
+
<shared_stage:ann_arbor>
|
| 102 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 103 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 104 |
+
</shared_stage:ann_arbor>
|
| 105 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 106 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 107 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
</shared_stage:stage_event>
|
| 109 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969131">YES</clin_shared:postoperative_rx_tx>
|
| 110 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969130">NO</clin_shared:radiation_therapy>
|
| 111 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969132">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 112 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969102">NO</prad:biochemical_recurrence>
|
| 113 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 114 |
+
<prad_nte:new_tumor_events>
|
| 115 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969137">NO</nte:new_tumor_event_after_initial_treatment>
|
| 116 |
+
</prad_nte:new_tumor_events>
|
| 117 |
+
<rx:drugs>
|
| 118 |
+
<rx:drug>
|
| 119 |
+
<rx:tx_on_clinical_trial preferred_name="" display_order="9999" cde="3925111" cde_ver="" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3985925">NO</rx:tx_on_clinical_trial>
|
| 120 |
+
<rx:regimen_number preferred_name="" display_order="9999" cde="2744948" cde_ver="" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 121 |
+
<rx:bcr_drug_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-4L-AA1F-D67927</rx:bcr_drug_barcode>
|
| 122 |
+
<rx:bcr_drug_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">00CA7115-7773-4773-9AC4-FFCCD1CCF33B</rx:bcr_drug_uuid>
|
| 123 |
+
<rx:total_dose preferred_name="total_dose" display_order="999" cde="1515" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 124 |
+
<rx:total_dose_units preferred_name="pharmaceutical_tx_total_dose_units" display_order="999" cde="3088785" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 125 |
+
<rx:prescribed_dose preferred_name="prescribed_dose" display_order="999" cde="2184728" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 126 |
+
<rx:prescribed_dose_units preferred_name="pharmaceutical_tx_dose_units" display_order="999" cde="3065815" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 127 |
+
<rx:number_cycles preferred_name="pharma_adjuvant_cycles_count" display_order="999" cde="62590" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 128 |
+
<rx:days_to_drug_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3392465" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_started_days_to" display_order="26" cde_ver="1.000">15</rx:days_to_drug_therapy_start>
|
| 129 |
+
<rx:days_to_drug_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3392470" owner="TSS" procurement_status="Not Available" preferred_name="pharmaceutical_tx_ended_days_to" display_order="16" cde_ver="1.000"/>
|
| 130 |
+
<rx:therapy_types>
|
| 131 |
+
<rx:therapy_type preferred_name="pharmaceutical_therapy_type" display_order="7" cde="2793530" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3985928">Hormone Therapy</rx:therapy_type>
|
| 132 |
+
<rx:therapy_type_notes preferred_name="pharma_type_other" display_order="999" cde="2001762" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 133 |
+
</rx:therapy_types>
|
| 134 |
+
<rx:drug_name preferred_name="pharmaceutical_therapy_drug_name" display_order="22" cde="2975232" cde_ver="1.000" xsd_ver="1.10" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3985926">Zoladex</rx:drug_name>
|
| 135 |
+
<rx:clinical_trail_drug_classification preferred_name="clinical_trial_drug_classification" display_order="6" cde="3378323" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3985927"/>
|
| 136 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 137 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 138 |
+
<rx:route_of_administrations>
|
| 139 |
+
<rx:route_of_administration preferred_name="route_of_administration" display_order="999" cde="2003586" cde_ver="6.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 140 |
+
</rx:route_of_administrations>
|
| 141 |
+
<rx:therapy_ongoing preferred_name="pharmaceutical_tx_ongoing_indicator" display_order="12" cde="3103479" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3985933">YES</rx:therapy_ongoing>
|
| 142 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="3985938" xsi:nil="true"/>
|
| 143 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">12</clin_shared:day_of_form_completion>
|
| 144 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">11</clin_shared:month_of_form_completion>
|
| 145 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
|
| 146 |
+
</rx:drug>
|
| 147 |
+
</rx:drugs>
|
| 148 |
+
<rad:radiations/>
|
| 149 |
+
<prad:follow_ups/>
|
| 150 |
+
</prad:patient>
|
| 151 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5737.xml
ADDED
|
@@ -0,0 +1,121 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">0FE3727F-29E5-4498-B028-DF7525AB8259</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827619">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827635">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827629">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827670">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="month" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-26753</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">91</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827633">WHITE</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5737</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5737</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">4f9f1fce-d96e-407b-a873-56129985aece</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827640">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827688">YES</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827689">NO</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">73</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827638">2007</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827677">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827634">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827617">16</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827616">3</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827618">2012</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827620">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1827621" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827622">Peripheral Zone</prad:zone_of_origin>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827627">Bilateral</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827628"/>
|
| 55 |
+
</prad:tumor_levels>
|
| 56 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827639">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 57 |
+
<prad:days_to_bone_scan_performed precision="month" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">91</prad:days_to_bone_scan_performed>
|
| 58 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827648">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
|
| 59 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827649">YES</prad:diagnostic_ct_abd_pelvis_performed>
|
| 60 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="month" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">91</prad:days_to_diagnostic_computed_tomography_performed>
|
| 61 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 62 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827653">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
|
| 63 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 64 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827654">YES</prad:diagnostic_mri_performed>
|
| 65 |
+
<prad:days_to_diagnostic_mri_performed precision="month" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Completed" preferred_name="days_to_mri" display_order="46" cde_ver="1.000">91</prad:days_to_diagnostic_mri_performed>
|
| 66 |
+
<prad:diagnostic_mri_results>
|
| 67 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827658">No Evidence of Extraprostatic Extension</prad:diagnostic_mri_result>
|
| 68 |
+
</prad:diagnostic_mri_results>
|
| 69 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827665">YES</prad:lymphnodes_examined>
|
| 70 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827667">8</prad:number_of_lymphnodes_examined>
|
| 71 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827668">0</prad:number_of_lymphnodes_positive_by_he>
|
| 72 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827669">R0</clin_shared:residual_tumor>
|
| 73 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827678"/>
|
| 74 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827679"/>
|
| 75 |
+
<shared_stage:stage_event system="AJCC">
|
| 76 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 77 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 78 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:tnm_categories>
|
| 80 |
+
<shared_stage:clinical_categories>
|
| 81 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1827641"/>
|
| 82 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 83 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827659">M0</shared_stage:clinical_M>
|
| 84 |
+
</shared_stage:clinical_categories>
|
| 85 |
+
<shared_stage:pathologic_categories>
|
| 86 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827661">T2c</shared_stage:pathologic_T>
|
| 87 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827666">N0</shared_stage:pathologic_N>
|
| 88 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 89 |
+
</shared_stage:pathologic_categories>
|
| 90 |
+
</shared_stage:tnm_categories>
|
| 91 |
+
<shared_stage:psa>
|
| 92 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827683">14.69</shared_stage:psa_value>
|
| 93 |
+
<shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Discrepancy" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000"/>
|
| 94 |
+
</shared_stage:psa>
|
| 95 |
+
<shared_stage:gleason_grading>
|
| 96 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827625">7</shared_stage:gleason_score>
|
| 97 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827623">4</shared_stage:primary_pattern>
|
| 98 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827624">3</shared_stage:secondary_pattern>
|
| 99 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827626"/>
|
| 100 |
+
</shared_stage:gleason_grading>
|
| 101 |
+
<shared_stage:ann_arbor>
|
| 102 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 103 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 104 |
+
</shared_stage:ann_arbor>
|
| 105 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 106 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 107 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
</shared_stage:stage_event>
|
| 109 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 110 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 111 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 112 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827684">NO</prad:biochemical_recurrence>
|
| 113 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 114 |
+
<prad_nte:new_tumor_events>
|
| 115 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 116 |
+
</prad_nte:new_tumor_events>
|
| 117 |
+
<rx:drugs/>
|
| 118 |
+
<rad:radiations/>
|
| 119 |
+
<prad:follow_ups/>
|
| 120 |
+
</prad:patient>
|
| 121 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5738.xml
ADDED
|
@@ -0,0 +1,153 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">A8CEBDF0-643F-428E-8B0D-996D15FAD25D</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826793">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826809">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826803">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826844">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="month" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-26329</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">212</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826807">WHITE</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5738</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5738</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">5828401b-0901-4a73-9d0c-1e85d3431475</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826814">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826862">YES</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826863">NO</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">72</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826812">2006</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826851">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826808">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826791">16</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826790">3</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826792">2012</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826794">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1826795" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1826796"/>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826801">Bilateral</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826802"/>
|
| 55 |
+
</prad:tumor_levels>
|
| 56 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826813">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 57 |
+
<prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Not Available" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000"/>
|
| 58 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826822"/>
|
| 59 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826823">NO</prad:diagnostic_ct_abd_pelvis_performed>
|
| 60 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Not Available" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000"/>
|
| 61 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 62 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826827"/>
|
| 63 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 64 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826828">NO</prad:diagnostic_mri_performed>
|
| 65 |
+
<prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
|
| 66 |
+
<prad:diagnostic_mri_results>
|
| 67 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826832"/>
|
| 68 |
+
</prad:diagnostic_mri_results>
|
| 69 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826839">NO</prad:lymphnodes_examined>
|
| 70 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826841"/>
|
| 71 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826842"/>
|
| 72 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826843">R0</clin_shared:residual_tumor>
|
| 73 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826852"/>
|
| 74 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826853"/>
|
| 75 |
+
<shared_stage:stage_event system="AJCC">
|
| 76 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 77 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 78 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:tnm_categories>
|
| 80 |
+
<shared_stage:clinical_categories>
|
| 81 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1826815"/>
|
| 82 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 83 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826833">M0</shared_stage:clinical_M>
|
| 84 |
+
</shared_stage:clinical_categories>
|
| 85 |
+
<shared_stage:pathologic_categories>
|
| 86 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Discrepancy" restricted="false" source_system_identifier="1826835"/>
|
| 87 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826840"/>
|
| 88 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 89 |
+
</shared_stage:pathologic_categories>
|
| 90 |
+
</shared_stage:tnm_categories>
|
| 91 |
+
<shared_stage:psa>
|
| 92 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826857">0.01</shared_stage:psa_value>
|
| 93 |
+
<shared_stage:days_to_psa precision="month" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">195</shared_stage:days_to_psa>
|
| 94 |
+
</shared_stage:psa>
|
| 95 |
+
<shared_stage:gleason_grading>
|
| 96 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826799">6</shared_stage:gleason_score>
|
| 97 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826797">3</shared_stage:primary_pattern>
|
| 98 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826798">3</shared_stage:secondary_pattern>
|
| 99 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826800">4</shared_stage:tertiary_pattern>
|
| 100 |
+
</shared_stage:gleason_grading>
|
| 101 |
+
<shared_stage:ann_arbor>
|
| 102 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 103 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 104 |
+
</shared_stage:ann_arbor>
|
| 105 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 106 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 107 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
</shared_stage:stage_event>
|
| 109 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 110 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 111 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 112 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826858">NO</prad:biochemical_recurrence>
|
| 113 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 114 |
+
<prad_nte:new_tumor_events>
|
| 115 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 116 |
+
</prad_nte:new_tumor_events>
|
| 117 |
+
<rx:drugs/>
|
| 118 |
+
<rad:radiations/>
|
| 119 |
+
<prad:follow_ups>
|
| 120 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 121 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5738-F28982</clin_shared:bcr_followup_barcode>
|
| 122 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">b795c2c5-c509-4ba5-92ed-b0ea8df8ebf7</clin_shared:bcr_followup_uuid>
|
| 123 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777672">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 124 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 125 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777673">NO</clin_shared:radiation_therapy>
|
| 126 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777674">NO</clin_shared:postoperative_rx_tx>
|
| 127 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777676">Alive</clin_shared:vital_status>
|
| 128 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777675">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 129 |
+
<clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">212</clin_shared:days_to_last_followup>
|
| 130 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 131 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777683">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 132 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777684"/>
|
| 133 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777685"/>
|
| 134 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777706">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 135 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777686">NO</nte:new_tumor_event_after_initial_treatment>
|
| 136 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 137 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777687"/>
|
| 138 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777694"/>
|
| 139 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777695"/>
|
| 140 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777704"/>
|
| 141 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777705"/>
|
| 142 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 143 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 144 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 145 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777696"/>
|
| 146 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777697"/>
|
| 147 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777670">15</clin_shared:day_of_form_completion>
|
| 148 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777669">2</clin_shared:month_of_form_completion>
|
| 149 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777671">2012</clin_shared:year_of_form_completion>
|
| 150 |
+
</follow_up_v1.0:follow_up>
|
| 151 |
+
</prad:follow_ups>
|
| 152 |
+
</prad:patient>
|
| 153 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5739.xml
ADDED
|
@@ -0,0 +1,153 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">6C4F20AE-407F-489E-8680-5E46643FB777</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826565">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826581">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826575">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826616">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="month" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-23953</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">671</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826579">WHITE</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5739</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5739</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">79601d90-b198-4b94-b60f-4cff329c7a10</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826586">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826634">YES</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826635">NO</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">65</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826584">2006</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826623">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826580">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826563">16</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826562">3</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826564">2012</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826566">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1826567" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826568">Peripheral Zone</prad:zone_of_origin>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826573">Left</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826574"/>
|
| 55 |
+
</prad:tumor_levels>
|
| 56 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826585">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 57 |
+
<prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Not Available" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000"/>
|
| 58 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826594"/>
|
| 59 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826595">NO</prad:diagnostic_ct_abd_pelvis_performed>
|
| 60 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Not Available" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000"/>
|
| 61 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 62 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826599"/>
|
| 63 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 64 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826600">NO</prad:diagnostic_mri_performed>
|
| 65 |
+
<prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
|
| 66 |
+
<prad:diagnostic_mri_results>
|
| 67 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826604"/>
|
| 68 |
+
</prad:diagnostic_mri_results>
|
| 69 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826611">YES</prad:lymphnodes_examined>
|
| 70 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826613">8</prad:number_of_lymphnodes_examined>
|
| 71 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826614">0</prad:number_of_lymphnodes_positive_by_he>
|
| 72 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826615">R0</clin_shared:residual_tumor>
|
| 73 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826624"/>
|
| 74 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826625"/>
|
| 75 |
+
<shared_stage:stage_event system="AJCC">
|
| 76 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 77 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 78 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:tnm_categories>
|
| 80 |
+
<shared_stage:clinical_categories>
|
| 81 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1826587"/>
|
| 82 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 83 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826605">M0</shared_stage:clinical_M>
|
| 84 |
+
</shared_stage:clinical_categories>
|
| 85 |
+
<shared_stage:pathologic_categories>
|
| 86 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826609">T3a</shared_stage:pathologic_T>
|
| 87 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826612">N0</shared_stage:pathologic_N>
|
| 88 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 89 |
+
</shared_stage:pathologic_categories>
|
| 90 |
+
</shared_stage:tnm_categories>
|
| 91 |
+
<shared_stage:psa>
|
| 92 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826629">0.02</shared_stage:psa_value>
|
| 93 |
+
<shared_stage:days_to_psa precision="month" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">586</shared_stage:days_to_psa>
|
| 94 |
+
</shared_stage:psa>
|
| 95 |
+
<shared_stage:gleason_grading>
|
| 96 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826571">7</shared_stage:gleason_score>
|
| 97 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826569">3</shared_stage:primary_pattern>
|
| 98 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826570">4</shared_stage:secondary_pattern>
|
| 99 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826572"/>
|
| 100 |
+
</shared_stage:gleason_grading>
|
| 101 |
+
<shared_stage:ann_arbor>
|
| 102 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 103 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 104 |
+
</shared_stage:ann_arbor>
|
| 105 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 106 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 107 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
</shared_stage:stage_event>
|
| 109 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 110 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 111 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 112 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826630">NO</prad:biochemical_recurrence>
|
| 113 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 114 |
+
<prad_nte:new_tumor_events>
|
| 115 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 116 |
+
</prad_nte:new_tumor_events>
|
| 117 |
+
<rx:drugs/>
|
| 118 |
+
<rad:radiations/>
|
| 119 |
+
<prad:follow_ups>
|
| 120 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 121 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5739-F28977</clin_shared:bcr_followup_barcode>
|
| 122 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">7265f7ed-c47f-4bc0-8772-95ac505b493b</clin_shared:bcr_followup_uuid>
|
| 123 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777520">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 124 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 125 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777521">NO</clin_shared:radiation_therapy>
|
| 126 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777522">NO</clin_shared:postoperative_rx_tx>
|
| 127 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777524">Alive</clin_shared:vital_status>
|
| 128 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777523">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 129 |
+
<clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">671</clin_shared:days_to_last_followup>
|
| 130 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 131 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777531">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 132 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777532"/>
|
| 133 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777533"/>
|
| 134 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777554">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 135 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777534">NO</nte:new_tumor_event_after_initial_treatment>
|
| 136 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 137 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777535"/>
|
| 138 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777542"/>
|
| 139 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777543"/>
|
| 140 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777552"/>
|
| 141 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777553"/>
|
| 142 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 143 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 144 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 145 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777544"/>
|
| 146 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777545"/>
|
| 147 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777518">15</clin_shared:day_of_form_completion>
|
| 148 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777517">2</clin_shared:month_of_form_completion>
|
| 149 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777519">2012</clin_shared:year_of_form_completion>
|
| 150 |
+
</follow_up_v1.0:follow_up>
|
| 151 |
+
</prad:follow_ups>
|
| 152 |
+
</prad:patient>
|
| 153 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5740.xml
ADDED
|
@@ -0,0 +1,121 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">60A1E979-CE4C-4FB0-9254-00C5873B09FC</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826489">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826505">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826499">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826540">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="month" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-20880</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">31</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826503">WHITE</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5740</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5740</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">cd113dc4-915a-47d2-bce0-9dba915a9d29</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826510">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826558">YES</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826559">NO</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">57</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826508">2009</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826547">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826504">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826487">21</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826486">3</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826488">2012</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826490">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1826491" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1826492"/>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826497">Bilateral</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826498"/>
|
| 55 |
+
</prad:tumor_levels>
|
| 56 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826509">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 57 |
+
<prad:days_to_bone_scan_performed precision="month" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">31</prad:days_to_bone_scan_performed>
|
| 58 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826518">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
|
| 59 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826519">NO</prad:diagnostic_ct_abd_pelvis_performed>
|
| 60 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Not Available" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000"/>
|
| 61 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 62 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826523"/>
|
| 63 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 64 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826524">YES</prad:diagnostic_mri_performed>
|
| 65 |
+
<prad:days_to_diagnostic_mri_performed precision="month" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Completed" preferred_name="days_to_mri" display_order="46" cde_ver="1.000">31</prad:days_to_diagnostic_mri_performed>
|
| 66 |
+
<prad:diagnostic_mri_results>
|
| 67 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826528">No Evidence of Extraprostatic Extension</prad:diagnostic_mri_result>
|
| 68 |
+
</prad:diagnostic_mri_results>
|
| 69 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826535">YES</prad:lymphnodes_examined>
|
| 70 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826537">4</prad:number_of_lymphnodes_examined>
|
| 71 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826538">0</prad:number_of_lymphnodes_positive_by_he>
|
| 72 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826539">R0</clin_shared:residual_tumor>
|
| 73 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826548"/>
|
| 74 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826549"/>
|
| 75 |
+
<shared_stage:stage_event system="AJCC">
|
| 76 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 77 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 78 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:tnm_categories>
|
| 80 |
+
<shared_stage:clinical_categories>
|
| 81 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1826511"/>
|
| 82 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 83 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826529">M0</shared_stage:clinical_M>
|
| 84 |
+
</shared_stage:clinical_categories>
|
| 85 |
+
<shared_stage:pathologic_categories>
|
| 86 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826531">T2c</shared_stage:pathologic_T>
|
| 87 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826536">N0</shared_stage:pathologic_N>
|
| 88 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 89 |
+
</shared_stage:pathologic_categories>
|
| 90 |
+
</shared_stage:tnm_categories>
|
| 91 |
+
<shared_stage:psa>
|
| 92 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826553">1.6</shared_stage:psa_value>
|
| 93 |
+
<shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Discrepancy" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000"/>
|
| 94 |
+
</shared_stage:psa>
|
| 95 |
+
<shared_stage:gleason_grading>
|
| 96 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826495">7</shared_stage:gleason_score>
|
| 97 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826493">3</shared_stage:primary_pattern>
|
| 98 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826494">4</shared_stage:secondary_pattern>
|
| 99 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826496"/>
|
| 100 |
+
</shared_stage:gleason_grading>
|
| 101 |
+
<shared_stage:ann_arbor>
|
| 102 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 103 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 104 |
+
</shared_stage:ann_arbor>
|
| 105 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 106 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 107 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
</shared_stage:stage_event>
|
| 109 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 110 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 111 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 112 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826554">NO</prad:biochemical_recurrence>
|
| 113 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 114 |
+
<prad_nte:new_tumor_events>
|
| 115 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 116 |
+
</prad_nte:new_tumor_events>
|
| 117 |
+
<rx:drugs/>
|
| 118 |
+
<rad:radiations/>
|
| 119 |
+
<prad:follow_ups/>
|
| 120 |
+
</prad:patient>
|
| 121 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5741.xml
ADDED
|
@@ -0,0 +1,183 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">4DA4B1F8-9C51-44B8-B02F-98656B2F020C</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828412">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828428">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828422">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828463">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="month" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-20759</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">395</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828426">WHITE</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5741</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5741</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">b3bf57d4-e31a-4740-b438-fa826fb79550</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828433">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828481">YES</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828482">NO</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">56</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828431">2008</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828470">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828427">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828410">16</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828409">3</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828411">2012</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828413">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1828414" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828415">Overlapping / Multiple Zones</prad:zone_of_origin>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828420">Bilateral</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828421"/>
|
| 55 |
+
</prad:tumor_levels>
|
| 56 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828432">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 57 |
+
<prad:days_to_bone_scan_performed precision="month" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">30</prad:days_to_bone_scan_performed>
|
| 58 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828441">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
|
| 59 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828442">YES</prad:diagnostic_ct_abd_pelvis_performed>
|
| 60 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="month" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">30</prad:days_to_diagnostic_computed_tomography_performed>
|
| 61 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 62 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828446">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
|
| 63 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 64 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828447">NO</prad:diagnostic_mri_performed>
|
| 65 |
+
<prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
|
| 66 |
+
<prad:diagnostic_mri_results>
|
| 67 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828451"/>
|
| 68 |
+
</prad:diagnostic_mri_results>
|
| 69 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828458">YES</prad:lymphnodes_examined>
|
| 70 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828460">5</prad:number_of_lymphnodes_examined>
|
| 71 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828461">1</prad:number_of_lymphnodes_positive_by_he>
|
| 72 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828462">R1</clin_shared:residual_tumor>
|
| 73 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828471"/>
|
| 74 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828472"/>
|
| 75 |
+
<shared_stage:stage_event system="AJCC">
|
| 76 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 77 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 78 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:tnm_categories>
|
| 80 |
+
<shared_stage:clinical_categories>
|
| 81 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1828434"/>
|
| 82 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 83 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828452">M0</shared_stage:clinical_M>
|
| 84 |
+
</shared_stage:clinical_categories>
|
| 85 |
+
<shared_stage:pathologic_categories>
|
| 86 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828456">T3b</shared_stage:pathologic_T>
|
| 87 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828459">N1</shared_stage:pathologic_N>
|
| 88 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 89 |
+
</shared_stage:pathologic_categories>
|
| 90 |
+
</shared_stage:tnm_categories>
|
| 91 |
+
<shared_stage:psa>
|
| 92 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828476">0.02</shared_stage:psa_value>
|
| 93 |
+
<shared_stage:days_to_psa precision="month" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">339</shared_stage:days_to_psa>
|
| 94 |
+
</shared_stage:psa>
|
| 95 |
+
<shared_stage:gleason_grading>
|
| 96 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828418">9</shared_stage:gleason_score>
|
| 97 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828416">4</shared_stage:primary_pattern>
|
| 98 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828417">5</shared_stage:secondary_pattern>
|
| 99 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828419"/>
|
| 100 |
+
</shared_stage:gleason_grading>
|
| 101 |
+
<shared_stage:ann_arbor>
|
| 102 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 103 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 104 |
+
</shared_stage:ann_arbor>
|
| 105 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 106 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 107 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
</shared_stage:stage_event>
|
| 109 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 110 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 111 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 112 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828477">NO</prad:biochemical_recurrence>
|
| 113 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 114 |
+
<prad_nte:new_tumor_events>
|
| 115 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 116 |
+
</prad_nte:new_tumor_events>
|
| 117 |
+
<rx:drugs>
|
| 118 |
+
<rx:drug>
|
| 119 |
+
<rx:tx_on_clinical_trial preferred_name="" display_order="9999" cde="3925111" cde_ver="" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256041">NO</rx:tx_on_clinical_trial>
|
| 120 |
+
<rx:regimen_number preferred_name="" display_order="9999" cde="2744948" cde_ver="" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 121 |
+
<rx:bcr_drug_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5741-D37729</rx:bcr_drug_barcode>
|
| 122 |
+
<rx:bcr_drug_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">614689F1-AD81-4EDE-A7ED-BEC1E836A7DC</rx:bcr_drug_uuid>
|
| 123 |
+
<rx:total_dose preferred_name="total_dose" display_order="999" cde="1515" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 124 |
+
<rx:total_dose_units preferred_name="pharmaceutical_tx_total_dose_units" display_order="999" cde="3088785" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 125 |
+
<rx:prescribed_dose preferred_name="prescribed_dose" display_order="999" cde="2184728" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 126 |
+
<rx:prescribed_dose_units preferred_name="pharmaceutical_tx_dose_units" display_order="999" cde="3065815" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 127 |
+
<rx:number_cycles preferred_name="pharma_adjuvant_cycles_count" display_order="999" cde="62590" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 128 |
+
<rx:days_to_drug_therapy_start precision="month" xsd_ver="1.12" tier="2" cde="3392465" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_started_days_to" display_order="26" cde_ver="1.000">61</rx:days_to_drug_therapy_start>
|
| 129 |
+
<rx:days_to_drug_therapy_end precision="month" xsd_ver="1.12" tier="2" cde="3392470" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_ended_days_to" display_order="16" cde_ver="1.000">334</rx:days_to_drug_therapy_end>
|
| 130 |
+
<rx:therapy_types>
|
| 131 |
+
<rx:therapy_type preferred_name="pharmaceutical_therapy_type" display_order="7" cde="2793530" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256044">Hormone Therapy</rx:therapy_type>
|
| 132 |
+
<rx:therapy_type_notes preferred_name="pharma_type_other" display_order="999" cde="2001762" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 133 |
+
</rx:therapy_types>
|
| 134 |
+
<rx:drug_name preferred_name="pharmaceutical_therapy_drug_name" display_order="22" cde="2975232" cde_ver="1.000" xsd_ver="1.10" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256042">Leuprorelin</rx:drug_name>
|
| 135 |
+
<rx:clinical_trail_drug_classification preferred_name="clinical_trial_drug_classification" display_order="6" cde="3378323" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2256043"/>
|
| 136 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 137 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 138 |
+
<rx:route_of_administrations>
|
| 139 |
+
<rx:route_of_administration preferred_name="route_of_administration" display_order="999" cde="2003586" cde_ver="6.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 140 |
+
</rx:route_of_administrations>
|
| 141 |
+
<rx:therapy_ongoing preferred_name="pharmaceutical_tx_ongoing_indicator" display_order="12" cde="3103479" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256049">NO</rx:therapy_ongoing>
|
| 142 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256054">Complete Response</clin_shared:measure_of_response>
|
| 143 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">6</clin_shared:day_of_form_completion>
|
| 144 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">12</clin_shared:month_of_form_completion>
|
| 145 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2012</clin_shared:year_of_form_completion>
|
| 146 |
+
</rx:drug>
|
| 147 |
+
</rx:drugs>
|
| 148 |
+
<rad:radiations/>
|
| 149 |
+
<prad:follow_ups>
|
| 150 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 151 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5741-F29006</clin_shared:bcr_followup_barcode>
|
| 152 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">50d50d4b-61fb-4fdb-a345-2c2441524f1c</clin_shared:bcr_followup_uuid>
|
| 153 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778550">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 154 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 155 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778551">YES</clin_shared:radiation_therapy>
|
| 156 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778552">YES</clin_shared:postoperative_rx_tx>
|
| 157 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778554">Alive</clin_shared:vital_status>
|
| 158 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778553">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 159 |
+
<clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">395</clin_shared:days_to_last_followup>
|
| 160 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 161 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778561">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 162 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778562"/>
|
| 163 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778563"/>
|
| 164 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778584">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 165 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778564">NO</nte:new_tumor_event_after_initial_treatment>
|
| 166 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 167 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778565"/>
|
| 168 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778572"/>
|
| 169 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778573"/>
|
| 170 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778582"/>
|
| 171 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778583"/>
|
| 172 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 173 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 174 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 175 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778574"/>
|
| 176 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778575"/>
|
| 177 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778548">15</clin_shared:day_of_form_completion>
|
| 178 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778547">2</clin_shared:month_of_form_completion>
|
| 179 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778549">2012</clin_shared:year_of_form_completion>
|
| 180 |
+
</follow_up_v1.0:follow_up>
|
| 181 |
+
</prad:follow_ups>
|
| 182 |
+
</prad:patient>
|
| 183 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5743.xml
ADDED
|
@@ -0,0 +1,184 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">4633F6B7-27ED-435E-ABFC-608D0091A2CA</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828075">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828091">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828085">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828126">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="month" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-24321</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">425</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828089">WHITE</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5743</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5743</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">2dee4bd8-b00e-4f8a-bfea-5d8d1a068202</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828096">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828144">YES</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828145">NO</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">66</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828094">2008</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828133">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828090">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828073">16</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828072">3</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828074">2012</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828076">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1828077" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828078">Peripheral Zone</prad:zone_of_origin>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828083">Bilateral</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828084"/>
|
| 55 |
+
</prad:tumor_levels>
|
| 56 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828095">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 57 |
+
<prad:days_to_bone_scan_performed precision="month" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">29</prad:days_to_bone_scan_performed>
|
| 58 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828104">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
|
| 59 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828105">YES</prad:diagnostic_ct_abd_pelvis_performed>
|
| 60 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="month" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">29</prad:days_to_diagnostic_computed_tomography_performed>
|
| 61 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 62 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828109">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
|
| 63 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 64 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828110">NO</prad:diagnostic_mri_performed>
|
| 65 |
+
<prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
|
| 66 |
+
<prad:diagnostic_mri_results>
|
| 67 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828114"/>
|
| 68 |
+
</prad:diagnostic_mri_results>
|
| 69 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828121">YES</prad:lymphnodes_examined>
|
| 70 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828123">1</prad:number_of_lymphnodes_examined>
|
| 71 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828124">0</prad:number_of_lymphnodes_positive_by_he>
|
| 72 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828125">R0</clin_shared:residual_tumor>
|
| 73 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828134"/>
|
| 74 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828135"/>
|
| 75 |
+
<shared_stage:stage_event system="AJCC">
|
| 76 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 77 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 78 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:tnm_categories>
|
| 80 |
+
<shared_stage:clinical_categories>
|
| 81 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1828097"/>
|
| 82 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 83 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828115">M0</shared_stage:clinical_M>
|
| 84 |
+
</shared_stage:clinical_categories>
|
| 85 |
+
<shared_stage:pathologic_categories>
|
| 86 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828117">T2c</shared_stage:pathologic_T>
|
| 87 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828122">N0</shared_stage:pathologic_N>
|
| 88 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 89 |
+
</shared_stage:pathologic_categories>
|
| 90 |
+
</shared_stage:tnm_categories>
|
| 91 |
+
<shared_stage:psa>
|
| 92 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828139">0.1</shared_stage:psa_value>
|
| 93 |
+
<shared_stage:days_to_psa precision="month" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">394</shared_stage:days_to_psa>
|
| 94 |
+
</shared_stage:psa>
|
| 95 |
+
<shared_stage:gleason_grading>
|
| 96 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828081">7</shared_stage:gleason_score>
|
| 97 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828079">3</shared_stage:primary_pattern>
|
| 98 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828080">4</shared_stage:secondary_pattern>
|
| 99 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828082"/>
|
| 100 |
+
</shared_stage:gleason_grading>
|
| 101 |
+
<shared_stage:ann_arbor>
|
| 102 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 103 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 104 |
+
</shared_stage:ann_arbor>
|
| 105 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 106 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 107 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
</shared_stage:stage_event>
|
| 109 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 110 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 111 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 112 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828140">NO</prad:biochemical_recurrence>
|
| 113 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 114 |
+
<prad_nte:new_tumor_events>
|
| 115 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 116 |
+
</prad_nte:new_tumor_events>
|
| 117 |
+
<rx:drugs/>
|
| 118 |
+
<rad:radiations/>
|
| 119 |
+
<prad:follow_ups>
|
| 120 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 121 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5743-F29001</clin_shared:bcr_followup_barcode>
|
| 122 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">d0ad1d26-d82c-46e5-a36c-cf0f037c6749</clin_shared:bcr_followup_uuid>
|
| 123 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778368">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 124 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 125 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778369">NO</clin_shared:radiation_therapy>
|
| 126 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778370">NO</clin_shared:postoperative_rx_tx>
|
| 127 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778372">Alive</clin_shared:vital_status>
|
| 128 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778371">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 129 |
+
<clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">425</clin_shared:days_to_last_followup>
|
| 130 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 131 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778379">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 132 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778380"/>
|
| 133 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778381"/>
|
| 134 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778402">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 135 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778382">YES</nte:new_tumor_event_after_initial_treatment>
|
| 136 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="month" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Completed" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000">425</nte:days_to_new_tumor_event_after_initial_treatment>
|
| 137 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778383">New Primary Tumor</nte:new_neoplasm_event_type>
|
| 138 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778390"/>
|
| 139 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778391"/>
|
| 140 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778400">NO</nte:additional_radiation_therapy>
|
| 141 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778401">NO</nte:additional_pharmaceutical_therapy>
|
| 142 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 143 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 144 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 145 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778392"/>
|
| 146 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778393"/>
|
| 147 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778366">15</clin_shared:day_of_form_completion>
|
| 148 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778365">2</clin_shared:month_of_form_completion>
|
| 149 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778367">2012</clin_shared:year_of_form_completion>
|
| 150 |
+
</follow_up_v1.0:follow_up>
|
| 151 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="2">
|
| 152 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5743-F29000</clin_shared:bcr_followup_barcode>
|
| 153 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">36503065-1d92-471a-8aae-eaf90b5c7b42</clin_shared:bcr_followup_uuid>
|
| 154 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778318">Additional New Tumor Event</clin_shared:followup_case_report_form_submission_reason>
|
| 155 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 156 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778350"/>
|
| 157 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778351"/>
|
| 158 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778359">Alive</clin_shared:vital_status>
|
| 159 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778352"/>
|
| 160 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Not Available" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000"/>
|
| 161 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 162 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778360"/>
|
| 163 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778361"/>
|
| 164 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778362"/>
|
| 165 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778349">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 166 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778329">YES</nte:new_tumor_event_after_initial_treatment>
|
| 167 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="month" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Completed" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000">425</nte:days_to_new_tumor_event_after_initial_treatment>
|
| 168 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778330">New Primary Tumor</nte:new_neoplasm_event_type>
|
| 169 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778337"/>
|
| 170 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778338"/>
|
| 171 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778347">NO</nte:additional_radiation_therapy>
|
| 172 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778348">NO</nte:additional_pharmaceutical_therapy>
|
| 173 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 174 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 175 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 176 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778339"/>
|
| 177 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778340"/>
|
| 178 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778316">20</clin_shared:day_of_form_completion>
|
| 179 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778315">2</clin_shared:month_of_form_completion>
|
| 180 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778317">2012</clin_shared:year_of_form_completion>
|
| 181 |
+
</follow_up_v1.0:follow_up>
|
| 182 |
+
</prad:follow_ups>
|
| 183 |
+
</prad:patient>
|
| 184 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5744.xml
ADDED
|
@@ -0,0 +1,121 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">7B247DEF-FF0F-4209-A133-977C0203AC96</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827999">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828015">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828009">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828050">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="year" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-23621</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="year" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">60</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828013">WHITE</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5744</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5744</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">4e76de8e-cb0d-4b83-8ab4-53bc67a7a9d3</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828020">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828068">YES</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828069">NO</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="year" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="year" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">64</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828018">2008</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828057">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828014">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827997">16</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827996">3</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827998">2012</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828000">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1828001" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828002">Peripheral Zone</prad:zone_of_origin>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828007">Bilateral</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828008"/>
|
| 55 |
+
</prad:tumor_levels>
|
| 56 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828019">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 57 |
+
<prad:days_to_bone_scan_performed precision="year" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">60</prad:days_to_bone_scan_performed>
|
| 58 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828028">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
|
| 59 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828029">YES</prad:diagnostic_ct_abd_pelvis_performed>
|
| 60 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="year" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">60</prad:days_to_diagnostic_computed_tomography_performed>
|
| 61 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 62 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828033">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
|
| 63 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 64 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828034">NO</prad:diagnostic_mri_performed>
|
| 65 |
+
<prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
|
| 66 |
+
<prad:diagnostic_mri_results>
|
| 67 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828038"/>
|
| 68 |
+
</prad:diagnostic_mri_results>
|
| 69 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828045">YES</prad:lymphnodes_examined>
|
| 70 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828047">3</prad:number_of_lymphnodes_examined>
|
| 71 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828048">0</prad:number_of_lymphnodes_positive_by_he>
|
| 72 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828049">R0</clin_shared:residual_tumor>
|
| 73 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828058"/>
|
| 74 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828059"/>
|
| 75 |
+
<shared_stage:stage_event system="AJCC">
|
| 76 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 77 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 78 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:tnm_categories>
|
| 80 |
+
<shared_stage:clinical_categories>
|
| 81 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1828021"/>
|
| 82 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 83 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828039">M0</shared_stage:clinical_M>
|
| 84 |
+
</shared_stage:clinical_categories>
|
| 85 |
+
<shared_stage:pathologic_categories>
|
| 86 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828041">T2c</shared_stage:pathologic_T>
|
| 87 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828046">N0</shared_stage:pathologic_N>
|
| 88 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 89 |
+
</shared_stage:pathologic_categories>
|
| 90 |
+
</shared_stage:tnm_categories>
|
| 91 |
+
<shared_stage:psa>
|
| 92 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828063">9.63</shared_stage:psa_value>
|
| 93 |
+
<shared_stage:days_to_psa precision="year" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">48</shared_stage:days_to_psa>
|
| 94 |
+
</shared_stage:psa>
|
| 95 |
+
<shared_stage:gleason_grading>
|
| 96 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828005">7</shared_stage:gleason_score>
|
| 97 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828003">4</shared_stage:primary_pattern>
|
| 98 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828004">3</shared_stage:secondary_pattern>
|
| 99 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828006">5</shared_stage:tertiary_pattern>
|
| 100 |
+
</shared_stage:gleason_grading>
|
| 101 |
+
<shared_stage:ann_arbor>
|
| 102 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 103 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 104 |
+
</shared_stage:ann_arbor>
|
| 105 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 106 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 107 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
</shared_stage:stage_event>
|
| 109 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 110 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 111 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 112 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828064">NO</prad:biochemical_recurrence>
|
| 113 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 114 |
+
<prad_nte:new_tumor_events>
|
| 115 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 116 |
+
</prad_nte:new_tumor_events>
|
| 117 |
+
<rx:drugs/>
|
| 118 |
+
<rad:radiations/>
|
| 119 |
+
<prad:follow_ups/>
|
| 120 |
+
</prad:patient>
|
| 121 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5745.xml
ADDED
|
@@ -0,0 +1,121 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">B5EADF40-6F5D-4B30-80CF-2775BC3FDD4B</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828597">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828613">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828607">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828648">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="month" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-24837</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">91</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828611">WHITE</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5745</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5745</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">ac67d0df-7dc0-4a1a-8b47-beec9b94de86</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828618">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828666">YES</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828667">NO</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">68</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828616">2008</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828655">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828612">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828595">16</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828594">3</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828596">2012</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828598">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1828599" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828600">Overlapping / Multiple Zones</prad:zone_of_origin>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828605"/>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828606"/>
|
| 55 |
+
</prad:tumor_levels>
|
| 56 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828617">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 57 |
+
<prad:days_to_bone_scan_performed precision="month" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">91</prad:days_to_bone_scan_performed>
|
| 58 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828626">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
|
| 59 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828627">NO</prad:diagnostic_ct_abd_pelvis_performed>
|
| 60 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Not Available" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000"/>
|
| 61 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 62 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828631"/>
|
| 63 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 64 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828632">NO</prad:diagnostic_mri_performed>
|
| 65 |
+
<prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
|
| 66 |
+
<prad:diagnostic_mri_results>
|
| 67 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828636"/>
|
| 68 |
+
</prad:diagnostic_mri_results>
|
| 69 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828643">YES</prad:lymphnodes_examined>
|
| 70 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828645">5</prad:number_of_lymphnodes_examined>
|
| 71 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828646">0</prad:number_of_lymphnodes_positive_by_he>
|
| 72 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828647">R0</clin_shared:residual_tumor>
|
| 73 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828656"/>
|
| 74 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828657"/>
|
| 75 |
+
<shared_stage:stage_event system="AJCC">
|
| 76 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 77 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 78 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:tnm_categories>
|
| 80 |
+
<shared_stage:clinical_categories>
|
| 81 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1828619"/>
|
| 82 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 83 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828637">M0</shared_stage:clinical_M>
|
| 84 |
+
</shared_stage:clinical_categories>
|
| 85 |
+
<shared_stage:pathologic_categories>
|
| 86 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828641">T3a</shared_stage:pathologic_T>
|
| 87 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828644">N0</shared_stage:pathologic_N>
|
| 88 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 89 |
+
</shared_stage:pathologic_categories>
|
| 90 |
+
</shared_stage:tnm_categories>
|
| 91 |
+
<shared_stage:psa>
|
| 92 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828661">4.3</shared_stage:psa_value>
|
| 93 |
+
<shared_stage:days_to_psa precision="month" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">84</shared_stage:days_to_psa>
|
| 94 |
+
</shared_stage:psa>
|
| 95 |
+
<shared_stage:gleason_grading>
|
| 96 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828603">7</shared_stage:gleason_score>
|
| 97 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828601">3</shared_stage:primary_pattern>
|
| 98 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828602">4</shared_stage:secondary_pattern>
|
| 99 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828604"/>
|
| 100 |
+
</shared_stage:gleason_grading>
|
| 101 |
+
<shared_stage:ann_arbor>
|
| 102 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 103 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 104 |
+
</shared_stage:ann_arbor>
|
| 105 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 106 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 107 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
</shared_stage:stage_event>
|
| 109 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 110 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 111 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 112 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828662">NO</prad:biochemical_recurrence>
|
| 113 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 114 |
+
<prad_nte:new_tumor_events>
|
| 115 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 116 |
+
</prad_nte:new_tumor_events>
|
| 117 |
+
<rx:drugs/>
|
| 118 |
+
<rad:radiations/>
|
| 119 |
+
<prad:follow_ups/>
|
| 120 |
+
</prad:patient>
|
| 121 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5746.xml
ADDED
|
@@ -0,0 +1,153 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">7A49E2D9-0EE0-43AD-A0CA-838F02D536E9</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827467">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827483">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827477">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827518">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="year" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-20941</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="year" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">731</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827481">WHITE</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5746</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5746</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">618272c0-c2ed-4bfb-bb4b-404f0987f822</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827488">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827536">YES</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827537">NO</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="year" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="year" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">57</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827486">2007</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827525">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827482">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827465">16</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827464">3</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827466">2012</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827468">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1827469" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1827470"/>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827475">Bilateral</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827476"/>
|
| 55 |
+
</prad:tumor_levels>
|
| 56 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827487">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 57 |
+
<prad:days_to_bone_scan_performed precision="year" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">59</prad:days_to_bone_scan_performed>
|
| 58 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827496">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
|
| 59 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827497">YES</prad:diagnostic_ct_abd_pelvis_performed>
|
| 60 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="year" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">59</prad:days_to_diagnostic_computed_tomography_performed>
|
| 61 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 62 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827501">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
|
| 63 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 64 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827502">NO</prad:diagnostic_mri_performed>
|
| 65 |
+
<prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
|
| 66 |
+
<prad:diagnostic_mri_results>
|
| 67 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827506"/>
|
| 68 |
+
</prad:diagnostic_mri_results>
|
| 69 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827513">YES</prad:lymphnodes_examined>
|
| 70 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827515">2</prad:number_of_lymphnodes_examined>
|
| 71 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827516">0</prad:number_of_lymphnodes_positive_by_he>
|
| 72 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827517">R1</clin_shared:residual_tumor>
|
| 73 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827526"/>
|
| 74 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827527"/>
|
| 75 |
+
<shared_stage:stage_event system="AJCC">
|
| 76 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 77 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 78 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:tnm_categories>
|
| 80 |
+
<shared_stage:clinical_categories>
|
| 81 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1827489"/>
|
| 82 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 83 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827507">M0</shared_stage:clinical_M>
|
| 84 |
+
</shared_stage:clinical_categories>
|
| 85 |
+
<shared_stage:pathologic_categories>
|
| 86 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827509">T2c</shared_stage:pathologic_T>
|
| 87 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827514">N0</shared_stage:pathologic_N>
|
| 88 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 89 |
+
</shared_stage:pathologic_categories>
|
| 90 |
+
</shared_stage:tnm_categories>
|
| 91 |
+
<shared_stage:psa>
|
| 92 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827531">0.1</shared_stage:psa_value>
|
| 93 |
+
<shared_stage:days_to_psa precision="year" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">693</shared_stage:days_to_psa>
|
| 94 |
+
</shared_stage:psa>
|
| 95 |
+
<shared_stage:gleason_grading>
|
| 96 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827473">7</shared_stage:gleason_score>
|
| 97 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827471">3</shared_stage:primary_pattern>
|
| 98 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827472">4</shared_stage:secondary_pattern>
|
| 99 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827474"/>
|
| 100 |
+
</shared_stage:gleason_grading>
|
| 101 |
+
<shared_stage:ann_arbor>
|
| 102 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 103 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 104 |
+
</shared_stage:ann_arbor>
|
| 105 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 106 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 107 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
</shared_stage:stage_event>
|
| 109 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 110 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 111 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 112 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827532">NO</prad:biochemical_recurrence>
|
| 113 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 114 |
+
<prad_nte:new_tumor_events>
|
| 115 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 116 |
+
</prad_nte:new_tumor_events>
|
| 117 |
+
<rx:drugs/>
|
| 118 |
+
<rad:radiations/>
|
| 119 |
+
<prad:follow_ups>
|
| 120 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 121 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5746-F28996</clin_shared:bcr_followup_barcode>
|
| 122 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">90a1a1cd-057d-45ea-b417-3ba252ddbb98</clin_shared:bcr_followup_uuid>
|
| 123 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778176">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 124 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 125 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778177">YES</clin_shared:radiation_therapy>
|
| 126 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778178">NO</clin_shared:postoperative_rx_tx>
|
| 127 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778180">Alive</clin_shared:vital_status>
|
| 128 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778179">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 129 |
+
<clin_shared:days_to_last_followup precision="year" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">731</clin_shared:days_to_last_followup>
|
| 130 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 131 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778187">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 132 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778188"/>
|
| 133 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778189"/>
|
| 134 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778210">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 135 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778190">NO</nte:new_tumor_event_after_initial_treatment>
|
| 136 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 137 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778191"/>
|
| 138 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778198"/>
|
| 139 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778199"/>
|
| 140 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778208"/>
|
| 141 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778209"/>
|
| 142 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 143 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 144 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 145 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778200"/>
|
| 146 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778201"/>
|
| 147 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778174">15</clin_shared:day_of_form_completion>
|
| 148 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778173">2</clin_shared:month_of_form_completion>
|
| 149 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778175">2012</clin_shared:year_of_form_completion>
|
| 150 |
+
</follow_up_v1.0:follow_up>
|
| 151 |
+
</prad:follow_ups>
|
| 152 |
+
</prad:patient>
|
| 153 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5748.xml
ADDED
|
@@ -0,0 +1,121 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">353E756A-54D5-4ADC-BD4C-F66EBB2F4E92</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826413">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826429">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826423">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826464">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="month" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-23649</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">31</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826427">WHITE</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5748</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5748</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">0af98331-9305-41e9-af55-30390016d65e</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826434">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826482">YES</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826483">NO</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">64</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826432">2009</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826471">WITH TUMOR</clin_shared:person_neoplasm_cancer_status>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826428">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826411">21</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826410">3</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826412">2012</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826414">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1826415" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1826416"/>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826421">Bilateral</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826422"/>
|
| 55 |
+
</prad:tumor_levels>
|
| 56 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826433">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 57 |
+
<prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Not Available" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000"/>
|
| 58 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826442"/>
|
| 59 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826443">NO</prad:diagnostic_ct_abd_pelvis_performed>
|
| 60 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Not Available" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000"/>
|
| 61 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 62 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826447"/>
|
| 63 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 64 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826448">NO</prad:diagnostic_mri_performed>
|
| 65 |
+
<prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
|
| 66 |
+
<prad:diagnostic_mri_results>
|
| 67 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826452"/>
|
| 68 |
+
</prad:diagnostic_mri_results>
|
| 69 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826459">YES</prad:lymphnodes_examined>
|
| 70 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826461">2</prad:number_of_lymphnodes_examined>
|
| 71 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826462">0</prad:number_of_lymphnodes_positive_by_he>
|
| 72 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826463">R1</clin_shared:residual_tumor>
|
| 73 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826472"/>
|
| 74 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826473"/>
|
| 75 |
+
<shared_stage:stage_event system="AJCC">
|
| 76 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 77 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 78 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:tnm_categories>
|
| 80 |
+
<shared_stage:clinical_categories>
|
| 81 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1826435"/>
|
| 82 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 83 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826453"/>
|
| 84 |
+
</shared_stage:clinical_categories>
|
| 85 |
+
<shared_stage:pathologic_categories>
|
| 86 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826457">T3a</shared_stage:pathologic_T>
|
| 87 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826460">N0</shared_stage:pathologic_N>
|
| 88 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 89 |
+
</shared_stage:pathologic_categories>
|
| 90 |
+
</shared_stage:tnm_categories>
|
| 91 |
+
<shared_stage:psa>
|
| 92 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826477"/>
|
| 93 |
+
<shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Not Available" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000"/>
|
| 94 |
+
</shared_stage:psa>
|
| 95 |
+
<shared_stage:gleason_grading>
|
| 96 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826419">7</shared_stage:gleason_score>
|
| 97 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826417">4</shared_stage:primary_pattern>
|
| 98 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826418">3</shared_stage:secondary_pattern>
|
| 99 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826420"/>
|
| 100 |
+
</shared_stage:gleason_grading>
|
| 101 |
+
<shared_stage:ann_arbor>
|
| 102 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 103 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 104 |
+
</shared_stage:ann_arbor>
|
| 105 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 106 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 107 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
</shared_stage:stage_event>
|
| 109 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 110 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 111 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 112 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826478"/>
|
| 113 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 114 |
+
<prad_nte:new_tumor_events>
|
| 115 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 116 |
+
</prad_nte:new_tumor_events>
|
| 117 |
+
<rx:drugs/>
|
| 118 |
+
<rad:radiations/>
|
| 119 |
+
<prad:follow_ups/>
|
| 120 |
+
</prad:patient>
|
| 121 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5750.xml
ADDED
|
@@ -0,0 +1,153 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">CAE0D4A3-44DE-4C6C-8AEE-56CB225D98B2</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828151">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828167">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828161">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828202">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="month" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-26389</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">396</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828165">WHITE</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5750</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5750</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">dc40cf49-b208-4f59-b5f0-cfbdd02970b2</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828172">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828220">YES</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828221">NO</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">72</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828170">2008</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828209">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828166">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828149">16</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828148">3</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828150">2012</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828152">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1828153" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828154">Peripheral Zone</prad:zone_of_origin>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828159">Bilateral</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828160"/>
|
| 55 |
+
</prad:tumor_levels>
|
| 56 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828171">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 57 |
+
<prad:days_to_bone_scan_performed precision="month" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">31</prad:days_to_bone_scan_performed>
|
| 58 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828180">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
|
| 59 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828181">YES</prad:diagnostic_ct_abd_pelvis_performed>
|
| 60 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="month" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">31</prad:days_to_diagnostic_computed_tomography_performed>
|
| 61 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 62 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828185">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
|
| 63 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 64 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828186">NO</prad:diagnostic_mri_performed>
|
| 65 |
+
<prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
|
| 66 |
+
<prad:diagnostic_mri_results>
|
| 67 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828190"/>
|
| 68 |
+
</prad:diagnostic_mri_results>
|
| 69 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828197">YES</prad:lymphnodes_examined>
|
| 70 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828199">7</prad:number_of_lymphnodes_examined>
|
| 71 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828200">0</prad:number_of_lymphnodes_positive_by_he>
|
| 72 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828201">R0</clin_shared:residual_tumor>
|
| 73 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828210"/>
|
| 74 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828211"/>
|
| 75 |
+
<shared_stage:stage_event system="AJCC">
|
| 76 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 77 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 78 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:tnm_categories>
|
| 80 |
+
<shared_stage:clinical_categories>
|
| 81 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1828173"/>
|
| 82 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 83 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828191">M0</shared_stage:clinical_M>
|
| 84 |
+
</shared_stage:clinical_categories>
|
| 85 |
+
<shared_stage:pathologic_categories>
|
| 86 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828193">T2c</shared_stage:pathologic_T>
|
| 87 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828198">N0</shared_stage:pathologic_N>
|
| 88 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 89 |
+
</shared_stage:pathologic_categories>
|
| 90 |
+
</shared_stage:tnm_categories>
|
| 91 |
+
<shared_stage:psa>
|
| 92 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828215">0.02</shared_stage:psa_value>
|
| 93 |
+
<shared_stage:days_to_psa precision="month" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">337</shared_stage:days_to_psa>
|
| 94 |
+
</shared_stage:psa>
|
| 95 |
+
<shared_stage:gleason_grading>
|
| 96 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828157">7</shared_stage:gleason_score>
|
| 97 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828155">3</shared_stage:primary_pattern>
|
| 98 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828156">4</shared_stage:secondary_pattern>
|
| 99 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828158"/>
|
| 100 |
+
</shared_stage:gleason_grading>
|
| 101 |
+
<shared_stage:ann_arbor>
|
| 102 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 103 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 104 |
+
</shared_stage:ann_arbor>
|
| 105 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 106 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 107 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
</shared_stage:stage_event>
|
| 109 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 110 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 111 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 112 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828216">NO</prad:biochemical_recurrence>
|
| 113 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 114 |
+
<prad_nte:new_tumor_events>
|
| 115 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 116 |
+
</prad_nte:new_tumor_events>
|
| 117 |
+
<rx:drugs/>
|
| 118 |
+
<rad:radiations/>
|
| 119 |
+
<prad:follow_ups>
|
| 120 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 121 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5750-F29002</clin_shared:bcr_followup_barcode>
|
| 122 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">e1cba76b-72f8-4f39-adc2-c7defb3f66dc</clin_shared:bcr_followup_uuid>
|
| 123 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778408">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 124 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 125 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778409">NO</clin_shared:radiation_therapy>
|
| 126 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778410">NO</clin_shared:postoperative_rx_tx>
|
| 127 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778412">Alive</clin_shared:vital_status>
|
| 128 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778411">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 129 |
+
<clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">396</clin_shared:days_to_last_followup>
|
| 130 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 131 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778419">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 132 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778420"/>
|
| 133 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778421"/>
|
| 134 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778442">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 135 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778422">NO</nte:new_tumor_event_after_initial_treatment>
|
| 136 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 137 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778423"/>
|
| 138 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778430"/>
|
| 139 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778431"/>
|
| 140 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778440"/>
|
| 141 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778441"/>
|
| 142 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 143 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 144 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 145 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778432"/>
|
| 146 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778433"/>
|
| 147 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778406">15</clin_shared:day_of_form_completion>
|
| 148 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778405">2</clin_shared:month_of_form_completion>
|
| 149 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778407">2012</clin_shared:year_of_form_completion>
|
| 150 |
+
</follow_up_v1.0:follow_up>
|
| 151 |
+
</prad:follow_ups>
|
| 152 |
+
</prad:patient>
|
| 153 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5751.xml
ADDED
|
@@ -0,0 +1,241 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">C877133B-25FA-4BC1-8244-4C533FFEC1C5</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826717">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826733">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826727">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826768">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="month" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-24957</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1065</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826731">WHITE</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5751</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5751</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">721e76d0-4b1d-4e78-adb8-1344b8030062</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826738">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826786">YES</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826787">NO</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">68</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826736">2006</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826775">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826732">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826715">16</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826714">3</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826716">2012</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826718">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1826719" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826720">Overlapping / Multiple Zones</prad:zone_of_origin>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826725">Bilateral</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826726"/>
|
| 55 |
+
</prad:tumor_levels>
|
| 56 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826737">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 57 |
+
<prad:days_to_bone_scan_performed precision="month" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">92</prad:days_to_bone_scan_performed>
|
| 58 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826746">Equivocal</prad:bone_scan_results>
|
| 59 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826747">YES</prad:diagnostic_ct_abd_pelvis_performed>
|
| 60 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="month" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">92</prad:days_to_diagnostic_computed_tomography_performed>
|
| 61 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 62 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826751">Equivocal</prad:diagnostic_ct_abd_pelvis_result>
|
| 63 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 64 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826752">YES</prad:diagnostic_mri_performed>
|
| 65 |
+
<prad:days_to_diagnostic_mri_performed precision="month" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Completed" preferred_name="days_to_mri" display_order="46" cde_ver="1.000">92</prad:days_to_diagnostic_mri_performed>
|
| 66 |
+
<prad:diagnostic_mri_results>
|
| 67 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826756">Equivocal</prad:diagnostic_mri_result>
|
| 68 |
+
</prad:diagnostic_mri_results>
|
| 69 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826763">YES</prad:lymphnodes_examined>
|
| 70 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826765">3</prad:number_of_lymphnodes_examined>
|
| 71 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826766">1</prad:number_of_lymphnodes_positive_by_he>
|
| 72 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826767">R1</clin_shared:residual_tumor>
|
| 73 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826776"/>
|
| 74 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826777"/>
|
| 75 |
+
<shared_stage:stage_event system="AJCC">
|
| 76 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 77 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 78 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:tnm_categories>
|
| 80 |
+
<shared_stage:clinical_categories>
|
| 81 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1826739"/>
|
| 82 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 83 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826757">M0</shared_stage:clinical_M>
|
| 84 |
+
</shared_stage:clinical_categories>
|
| 85 |
+
<shared_stage:pathologic_categories>
|
| 86 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826762">T4</shared_stage:pathologic_T>
|
| 87 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826764">N1</shared_stage:pathologic_N>
|
| 88 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 89 |
+
</shared_stage:pathologic_categories>
|
| 90 |
+
</shared_stage:tnm_categories>
|
| 91 |
+
<shared_stage:psa>
|
| 92 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826781">0.01</shared_stage:psa_value>
|
| 93 |
+
<shared_stage:days_to_psa precision="month" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">1004</shared_stage:days_to_psa>
|
| 94 |
+
</shared_stage:psa>
|
| 95 |
+
<shared_stage:gleason_grading>
|
| 96 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826723">10</shared_stage:gleason_score>
|
| 97 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826721">5</shared_stage:primary_pattern>
|
| 98 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826722">5</shared_stage:secondary_pattern>
|
| 99 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826724"/>
|
| 100 |
+
</shared_stage:gleason_grading>
|
| 101 |
+
<shared_stage:ann_arbor>
|
| 102 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 103 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 104 |
+
</shared_stage:ann_arbor>
|
| 105 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 106 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 107 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
</shared_stage:stage_event>
|
| 109 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 110 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 111 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 112 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826782">NO</prad:biochemical_recurrence>
|
| 113 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 114 |
+
<prad_nte:new_tumor_events>
|
| 115 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 116 |
+
</prad_nte:new_tumor_events>
|
| 117 |
+
<rx:drugs>
|
| 118 |
+
<rx:drug>
|
| 119 |
+
<rx:tx_on_clinical_trial preferred_name="" display_order="9999" cde="3925111" cde_ver="" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256024">NO</rx:tx_on_clinical_trial>
|
| 120 |
+
<rx:regimen_number preferred_name="" display_order="9999" cde="2744948" cde_ver="" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 121 |
+
<rx:bcr_drug_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5751-D37727</rx:bcr_drug_barcode>
|
| 122 |
+
<rx:bcr_drug_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">7C511DDA-B637-4FC2-B97F-E300227673B3</rx:bcr_drug_uuid>
|
| 123 |
+
<rx:total_dose preferred_name="total_dose" display_order="999" cde="1515" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 124 |
+
<rx:total_dose_units preferred_name="pharmaceutical_tx_total_dose_units" display_order="999" cde="3088785" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 125 |
+
<rx:prescribed_dose preferred_name="prescribed_dose" display_order="999" cde="2184728" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 126 |
+
<rx:prescribed_dose_units preferred_name="pharmaceutical_tx_dose_units" display_order="999" cde="3065815" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 127 |
+
<rx:number_cycles preferred_name="pharma_adjuvant_cycles_count" display_order="999" cde="62590" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 128 |
+
<rx:days_to_drug_therapy_start precision="month" xsd_ver="1.12" tier="2" cde="3392465" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_started_days_to" display_order="26" cde_ver="1.000">122</rx:days_to_drug_therapy_start>
|
| 129 |
+
<rx:days_to_drug_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3392470" owner="TSS" procurement_status="Not Available" preferred_name="pharmaceutical_tx_ended_days_to" display_order="16" cde_ver="1.000"/>
|
| 130 |
+
<rx:therapy_types>
|
| 131 |
+
<rx:therapy_type preferred_name="pharmaceutical_therapy_type" display_order="7" cde="2793530" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256027">Hormone Therapy</rx:therapy_type>
|
| 132 |
+
<rx:therapy_type_notes preferred_name="pharma_type_other" display_order="999" cde="2001762" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 133 |
+
</rx:therapy_types>
|
| 134 |
+
<rx:drug_name preferred_name="pharmaceutical_therapy_drug_name" display_order="22" cde="2975232" cde_ver="1.000" xsd_ver="1.10" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256025">Bicalutamide</rx:drug_name>
|
| 135 |
+
<rx:clinical_trail_drug_classification preferred_name="clinical_trial_drug_classification" display_order="6" cde="3378323" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256026">n/a</rx:clinical_trail_drug_classification>
|
| 136 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 137 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 138 |
+
<rx:route_of_administrations>
|
| 139 |
+
<rx:route_of_administration preferred_name="route_of_administration" display_order="999" cde="2003586" cde_ver="6.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 140 |
+
</rx:route_of_administrations>
|
| 141 |
+
<rx:therapy_ongoing preferred_name="pharmaceutical_tx_ongoing_indicator" display_order="12" cde="3103479" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256032">YES</rx:therapy_ongoing>
|
| 142 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="2256037" xsi:nil="true"/>
|
| 143 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">6</clin_shared:day_of_form_completion>
|
| 144 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">12</clin_shared:month_of_form_completion>
|
| 145 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2012</clin_shared:year_of_form_completion>
|
| 146 |
+
</rx:drug>
|
| 147 |
+
<rx:drug>
|
| 148 |
+
<rx:tx_on_clinical_trial preferred_name="" display_order="9999" cde="3925111" cde_ver="" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256058">NO</rx:tx_on_clinical_trial>
|
| 149 |
+
<rx:regimen_number preferred_name="" display_order="9999" cde="2744948" cde_ver="" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 150 |
+
<rx:bcr_drug_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5751-D37730</rx:bcr_drug_barcode>
|
| 151 |
+
<rx:bcr_drug_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">96ED97DC-8704-4EE2-A453-C2836B029E24</rx:bcr_drug_uuid>
|
| 152 |
+
<rx:total_dose preferred_name="total_dose" display_order="999" cde="1515" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 153 |
+
<rx:total_dose_units preferred_name="pharmaceutical_tx_total_dose_units" display_order="999" cde="3088785" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 154 |
+
<rx:prescribed_dose preferred_name="prescribed_dose" display_order="999" cde="2184728" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 155 |
+
<rx:prescribed_dose_units preferred_name="pharmaceutical_tx_dose_units" display_order="999" cde="3065815" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 156 |
+
<rx:number_cycles preferred_name="pharma_adjuvant_cycles_count" display_order="999" cde="62590" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 157 |
+
<rx:days_to_drug_therapy_start precision="month" xsd_ver="1.12" tier="2" cde="3392465" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_started_days_to" display_order="26" cde_ver="1.000">122</rx:days_to_drug_therapy_start>
|
| 158 |
+
<rx:days_to_drug_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3392470" owner="TSS" procurement_status="Not Available" preferred_name="pharmaceutical_tx_ended_days_to" display_order="16" cde_ver="1.000"/>
|
| 159 |
+
<rx:therapy_types>
|
| 160 |
+
<rx:therapy_type preferred_name="pharmaceutical_therapy_type" display_order="7" cde="2793530" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256061">Hormone Therapy</rx:therapy_type>
|
| 161 |
+
<rx:therapy_type_notes preferred_name="pharma_type_other" display_order="999" cde="2001762" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 162 |
+
</rx:therapy_types>
|
| 163 |
+
<rx:drug_name preferred_name="pharmaceutical_therapy_drug_name" display_order="22" cde="2975232" cde_ver="1.000" xsd_ver="1.10" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256059">Leuprorelin</rx:drug_name>
|
| 164 |
+
<rx:clinical_trail_drug_classification preferred_name="clinical_trial_drug_classification" display_order="6" cde="3378323" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256060">n/a</rx:clinical_trail_drug_classification>
|
| 165 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 166 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 167 |
+
<rx:route_of_administrations>
|
| 168 |
+
<rx:route_of_administration preferred_name="route_of_administration" display_order="999" cde="2003586" cde_ver="6.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 169 |
+
</rx:route_of_administrations>
|
| 170 |
+
<rx:therapy_ongoing preferred_name="pharmaceutical_tx_ongoing_indicator" display_order="12" cde="3103479" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256066">YES</rx:therapy_ongoing>
|
| 171 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="2256071" xsi:nil="true"/>
|
| 172 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">6</clin_shared:day_of_form_completion>
|
| 173 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">12</clin_shared:month_of_form_completion>
|
| 174 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2012</clin_shared:year_of_form_completion>
|
| 175 |
+
</rx:drug>
|
| 176 |
+
<rx:drug>
|
| 177 |
+
<rx:tx_on_clinical_trial preferred_name="" display_order="9999" cde="3925111" cde_ver="" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256075">NO</rx:tx_on_clinical_trial>
|
| 178 |
+
<rx:regimen_number preferred_name="" display_order="9999" cde="2744948" cde_ver="" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 179 |
+
<rx:bcr_drug_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5751-D37731</rx:bcr_drug_barcode>
|
| 180 |
+
<rx:bcr_drug_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">F97A29DB-3655-45F0-AFD3-E4CFBC126F63</rx:bcr_drug_uuid>
|
| 181 |
+
<rx:total_dose preferred_name="total_dose" display_order="999" cde="1515" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 182 |
+
<rx:total_dose_units preferred_name="pharmaceutical_tx_total_dose_units" display_order="999" cde="3088785" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 183 |
+
<rx:prescribed_dose preferred_name="prescribed_dose" display_order="999" cde="2184728" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 184 |
+
<rx:prescribed_dose_units preferred_name="pharmaceutical_tx_dose_units" display_order="999" cde="3065815" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 185 |
+
<rx:number_cycles preferred_name="pharma_adjuvant_cycles_count" display_order="999" cde="62590" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 186 |
+
<rx:days_to_drug_therapy_start precision="month" xsd_ver="1.12" tier="2" cde="3392465" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_started_days_to" display_order="26" cde_ver="1.000">245</rx:days_to_drug_therapy_start>
|
| 187 |
+
<rx:days_to_drug_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3392470" owner="TSS" procurement_status="Not Available" preferred_name="pharmaceutical_tx_ended_days_to" display_order="16" cde_ver="1.000"/>
|
| 188 |
+
<rx:therapy_types>
|
| 189 |
+
<rx:therapy_type preferred_name="pharmaceutical_therapy_type" display_order="7" cde="2793530" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256078">Ancillary</rx:therapy_type>
|
| 190 |
+
<rx:therapy_type_notes preferred_name="pharma_type_other" display_order="999" cde="2001762" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 191 |
+
</rx:therapy_types>
|
| 192 |
+
<rx:drug_name preferred_name="pharmaceutical_therapy_drug_name" display_order="22" cde="2975232" cde_ver="1.000" xsd_ver="1.10" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256076">Zoledronic acid</rx:drug_name>
|
| 193 |
+
<rx:clinical_trail_drug_classification preferred_name="clinical_trial_drug_classification" display_order="6" cde="3378323" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256077">n/a</rx:clinical_trail_drug_classification>
|
| 194 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 195 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 196 |
+
<rx:route_of_administrations>
|
| 197 |
+
<rx:route_of_administration preferred_name="route_of_administration" display_order="999" cde="2003586" cde_ver="6.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 198 |
+
</rx:route_of_administrations>
|
| 199 |
+
<rx:therapy_ongoing preferred_name="pharmaceutical_tx_ongoing_indicator" display_order="12" cde="3103479" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256083">YES</rx:therapy_ongoing>
|
| 200 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="2256088" xsi:nil="true"/>
|
| 201 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">6</clin_shared:day_of_form_completion>
|
| 202 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">12</clin_shared:month_of_form_completion>
|
| 203 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2012</clin_shared:year_of_form_completion>
|
| 204 |
+
</rx:drug>
|
| 205 |
+
</rx:drugs>
|
| 206 |
+
<rad:radiations/>
|
| 207 |
+
<prad:follow_ups>
|
| 208 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 209 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5751-F28978</clin_shared:bcr_followup_barcode>
|
| 210 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">348b5cd7-410b-428c-9ffd-424783054f08</clin_shared:bcr_followup_uuid>
|
| 211 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777560">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 212 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 213 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777561">NO</clin_shared:radiation_therapy>
|
| 214 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777562">YES</clin_shared:postoperative_rx_tx>
|
| 215 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777564">Alive</clin_shared:vital_status>
|
| 216 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777563">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 217 |
+
<clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1065</clin_shared:days_to_last_followup>
|
| 218 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 219 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777571">WITH TUMOR</clin_shared:person_neoplasm_cancer_status>
|
| 220 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777572"/>
|
| 221 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777573"/>
|
| 222 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777594">Stable Disease</clin_shared:followup_treatment_success>
|
| 223 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777574">YES</nte:new_tumor_event_after_initial_treatment>
|
| 224 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="month" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Completed" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000">365</nte:days_to_new_tumor_event_after_initial_treatment>
|
| 225 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777575">Distant Metastasis</nte:new_neoplasm_event_type>
|
| 226 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777582">Bone</nte:new_neoplasm_event_occurrence_anatomic_site>
|
| 227 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777583"/>
|
| 228 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777592">NO</nte:additional_radiation_therapy>
|
| 229 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777593">YES</nte:additional_pharmaceutical_therapy>
|
| 230 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 231 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 232 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 233 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777584">YES</prad_shared:tumor_progression_post_ht>
|
| 234 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777585">Distant Metastasis</follow_up_v1.0:type_ofprogression_of_disease_ht>
|
| 235 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777558">15</clin_shared:day_of_form_completion>
|
| 236 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777557">2</clin_shared:month_of_form_completion>
|
| 237 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777559">2012</clin_shared:year_of_form_completion>
|
| 238 |
+
</follow_up_v1.0:follow_up>
|
| 239 |
+
</prad:follow_ups>
|
| 240 |
+
</prad:patient>
|
| 241 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5752.xml
ADDED
|
@@ -0,0 +1,183 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">F926AF4E-078C-47BE-B164-FDAEB75FA5A4</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827087">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827103">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827097">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827138">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="month" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-24290</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">943</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827101">WHITE</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5752</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5752</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">d8f56d75-51ab-4a86-a502-c86e1dcd1eff</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827108">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827156">YES</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827157">NO</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">66</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827106">2006</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827145">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827102">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827085">16</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827084">3</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827086">2012</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827088">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1827089" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827090">Overlapping / Multiple Zones</prad:zone_of_origin>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827095">Bilateral</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827096"/>
|
| 55 |
+
</prad:tumor_levels>
|
| 56 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827107">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 57 |
+
<prad:days_to_bone_scan_performed precision="month" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">30</prad:days_to_bone_scan_performed>
|
| 58 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827116">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
|
| 59 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827117">YES</prad:diagnostic_ct_abd_pelvis_performed>
|
| 60 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="month" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">30</prad:days_to_diagnostic_computed_tomography_performed>
|
| 61 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 62 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827121">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
|
| 63 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 64 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827122">NO</prad:diagnostic_mri_performed>
|
| 65 |
+
<prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
|
| 66 |
+
<prad:diagnostic_mri_results>
|
| 67 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827126"/>
|
| 68 |
+
</prad:diagnostic_mri_results>
|
| 69 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827133">YES</prad:lymphnodes_examined>
|
| 70 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827135">9</prad:number_of_lymphnodes_examined>
|
| 71 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827136">0</prad:number_of_lymphnodes_positive_by_he>
|
| 72 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827137">R0</clin_shared:residual_tumor>
|
| 73 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827146"/>
|
| 74 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827147"/>
|
| 75 |
+
<shared_stage:stage_event system="AJCC">
|
| 76 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 77 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 78 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:tnm_categories>
|
| 80 |
+
<shared_stage:clinical_categories>
|
| 81 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1827109"/>
|
| 82 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 83 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827127">M0</shared_stage:clinical_M>
|
| 84 |
+
</shared_stage:clinical_categories>
|
| 85 |
+
<shared_stage:pathologic_categories>
|
| 86 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827131">T3a</shared_stage:pathologic_T>
|
| 87 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827134">N0</shared_stage:pathologic_N>
|
| 88 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 89 |
+
</shared_stage:pathologic_categories>
|
| 90 |
+
</shared_stage:tnm_categories>
|
| 91 |
+
<shared_stage:psa>
|
| 92 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827151">0.02</shared_stage:psa_value>
|
| 93 |
+
<shared_stage:days_to_psa precision="month" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">868</shared_stage:days_to_psa>
|
| 94 |
+
</shared_stage:psa>
|
| 95 |
+
<shared_stage:gleason_grading>
|
| 96 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827093">8</shared_stage:gleason_score>
|
| 97 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827091">4</shared_stage:primary_pattern>
|
| 98 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827092">4</shared_stage:secondary_pattern>
|
| 99 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827094"/>
|
| 100 |
+
</shared_stage:gleason_grading>
|
| 101 |
+
<shared_stage:ann_arbor>
|
| 102 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 103 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 104 |
+
</shared_stage:ann_arbor>
|
| 105 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 106 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 107 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
</shared_stage:stage_event>
|
| 109 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 110 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 111 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 112 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827152">NO</prad:biochemical_recurrence>
|
| 113 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 114 |
+
<prad_nte:new_tumor_events>
|
| 115 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 116 |
+
</prad_nte:new_tumor_events>
|
| 117 |
+
<rx:drugs>
|
| 118 |
+
<rx:drug>
|
| 119 |
+
<rx:tx_on_clinical_trial preferred_name="" display_order="9999" cde="3925111" cde_ver="" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256092">NO</rx:tx_on_clinical_trial>
|
| 120 |
+
<rx:regimen_number preferred_name="" display_order="9999" cde="2744948" cde_ver="" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 121 |
+
<rx:bcr_drug_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5752-D37732</rx:bcr_drug_barcode>
|
| 122 |
+
<rx:bcr_drug_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">69D28B65-0490-48ED-8428-097F98AD9B75</rx:bcr_drug_uuid>
|
| 123 |
+
<rx:total_dose preferred_name="total_dose" display_order="999" cde="1515" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 124 |
+
<rx:total_dose_units preferred_name="pharmaceutical_tx_total_dose_units" display_order="999" cde="3088785" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 125 |
+
<rx:prescribed_dose preferred_name="prescribed_dose" display_order="999" cde="2184728" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 126 |
+
<rx:prescribed_dose_units preferred_name="pharmaceutical_tx_dose_units" display_order="999" cde="3065815" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 127 |
+
<rx:number_cycles preferred_name="pharma_adjuvant_cycles_count" display_order="999" cde="62590" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 128 |
+
<rx:days_to_drug_therapy_start precision="month" xsd_ver="1.12" tier="2" cde="3392465" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_started_days_to" display_order="26" cde_ver="1.000">578</rx:days_to_drug_therapy_start>
|
| 129 |
+
<rx:days_to_drug_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3392470" owner="TSS" procurement_status="Not Available" preferred_name="pharmaceutical_tx_ended_days_to" display_order="16" cde_ver="1.000"/>
|
| 130 |
+
<rx:therapy_types>
|
| 131 |
+
<rx:therapy_type preferred_name="pharmaceutical_therapy_type" display_order="7" cde="2793530" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256095">Hormone Therapy</rx:therapy_type>
|
| 132 |
+
<rx:therapy_type_notes preferred_name="pharma_type_other" display_order="999" cde="2001762" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 133 |
+
</rx:therapy_types>
|
| 134 |
+
<rx:drug_name preferred_name="pharmaceutical_therapy_drug_name" display_order="22" cde="2975232" cde_ver="1.000" xsd_ver="1.10" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256093">Leuprorelin</rx:drug_name>
|
| 135 |
+
<rx:clinical_trail_drug_classification preferred_name="clinical_trial_drug_classification" display_order="6" cde="3378323" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256094">n/a</rx:clinical_trail_drug_classification>
|
| 136 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 137 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 138 |
+
<rx:route_of_administrations>
|
| 139 |
+
<rx:route_of_administration preferred_name="route_of_administration" display_order="999" cde="2003586" cde_ver="6.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 140 |
+
</rx:route_of_administrations>
|
| 141 |
+
<rx:therapy_ongoing preferred_name="pharmaceutical_tx_ongoing_indicator" display_order="12" cde="3103479" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256100">YES</rx:therapy_ongoing>
|
| 142 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="2256105" xsi:nil="true"/>
|
| 143 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">6</clin_shared:day_of_form_completion>
|
| 144 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">12</clin_shared:month_of_form_completion>
|
| 145 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2012</clin_shared:year_of_form_completion>
|
| 146 |
+
</rx:drug>
|
| 147 |
+
</rx:drugs>
|
| 148 |
+
<rad:radiations/>
|
| 149 |
+
<prad:follow_ups>
|
| 150 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 151 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5752-F28987</clin_shared:bcr_followup_barcode>
|
| 152 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">762f37b3-0606-4d9b-8022-4be93e8aabab</clin_shared:bcr_followup_uuid>
|
| 153 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777882">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 154 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 155 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777883">YES</clin_shared:radiation_therapy>
|
| 156 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777884">YES</clin_shared:postoperative_rx_tx>
|
| 157 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777886">Alive</clin_shared:vital_status>
|
| 158 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777885">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 159 |
+
<clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">943</clin_shared:days_to_last_followup>
|
| 160 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 161 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777893">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 162 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777894"/>
|
| 163 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777895"/>
|
| 164 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777916">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 165 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777896">NO</nte:new_tumor_event_after_initial_treatment>
|
| 166 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 167 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777897"/>
|
| 168 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777904"/>
|
| 169 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777905"/>
|
| 170 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777914"/>
|
| 171 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777915"/>
|
| 172 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 173 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 174 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 175 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777906"/>
|
| 176 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777907"/>
|
| 177 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777880">15</clin_shared:day_of_form_completion>
|
| 178 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777879">2</clin_shared:month_of_form_completion>
|
| 179 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777881">2012</clin_shared:year_of_form_completion>
|
| 180 |
+
</follow_up_v1.0:follow_up>
|
| 181 |
+
</prad:follow_ups>
|
| 182 |
+
</prad:patient>
|
| 183 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5753.xml
ADDED
|
@@ -0,0 +1,121 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">FEB4DFE7-01C0-4E2D-8637-3E2E182C0DA1</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828858">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828874">Yes</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828868">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828909">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="month" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-25780</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">31</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828872">WHITE</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5753</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5753</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">928c48a0-68ee-4e28-ae83-9832e52850ca</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828879">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828927">YES</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828928">NO</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">70</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828877">2008</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828916">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828873">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828856">21</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828855">3</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828857">2012</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828859">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1828860" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828861">Overlapping / Multiple Zones</prad:zone_of_origin>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828866">Bilateral</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828867"/>
|
| 55 |
+
</prad:tumor_levels>
|
| 56 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828878">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 57 |
+
<prad:days_to_bone_scan_performed precision="month" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">31</prad:days_to_bone_scan_performed>
|
| 58 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828887">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
|
| 59 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828888">YES</prad:diagnostic_ct_abd_pelvis_performed>
|
| 60 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="month" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">31</prad:days_to_diagnostic_computed_tomography_performed>
|
| 61 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 62 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828892">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
|
| 63 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 64 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828893">NO</prad:diagnostic_mri_performed>
|
| 65 |
+
<prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
|
| 66 |
+
<prad:diagnostic_mri_results>
|
| 67 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828897"/>
|
| 68 |
+
</prad:diagnostic_mri_results>
|
| 69 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828904">YES</prad:lymphnodes_examined>
|
| 70 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828906">10</prad:number_of_lymphnodes_examined>
|
| 71 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828907">3</prad:number_of_lymphnodes_positive_by_he>
|
| 72 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828908">R0</clin_shared:residual_tumor>
|
| 73 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828917"/>
|
| 74 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828918"/>
|
| 75 |
+
<shared_stage:stage_event system="AJCC">
|
| 76 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 77 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 78 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:tnm_categories>
|
| 80 |
+
<shared_stage:clinical_categories>
|
| 81 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1828880"/>
|
| 82 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 83 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828898">M0</shared_stage:clinical_M>
|
| 84 |
+
</shared_stage:clinical_categories>
|
| 85 |
+
<shared_stage:pathologic_categories>
|
| 86 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828902">T3b</shared_stage:pathologic_T>
|
| 87 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828905">N1</shared_stage:pathologic_N>
|
| 88 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 89 |
+
</shared_stage:pathologic_categories>
|
| 90 |
+
</shared_stage:tnm_categories>
|
| 91 |
+
<shared_stage:psa>
|
| 92 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828922">4.53</shared_stage:psa_value>
|
| 93 |
+
<shared_stage:days_to_psa precision="month" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">31</shared_stage:days_to_psa>
|
| 94 |
+
</shared_stage:psa>
|
| 95 |
+
<shared_stage:gleason_grading>
|
| 96 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828864">9</shared_stage:gleason_score>
|
| 97 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828862">4</shared_stage:primary_pattern>
|
| 98 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828863">5</shared_stage:secondary_pattern>
|
| 99 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828865"/>
|
| 100 |
+
</shared_stage:gleason_grading>
|
| 101 |
+
<shared_stage:ann_arbor>
|
| 102 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 103 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 104 |
+
</shared_stage:ann_arbor>
|
| 105 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 106 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 107 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
</shared_stage:stage_event>
|
| 109 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 110 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 111 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 112 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828923">NO</prad:biochemical_recurrence>
|
| 113 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 114 |
+
<prad_nte:new_tumor_events>
|
| 115 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 116 |
+
</prad_nte:new_tumor_events>
|
| 117 |
+
<rx:drugs/>
|
| 118 |
+
<rad:radiations/>
|
| 119 |
+
<prad:follow_ups/>
|
| 120 |
+
</prad:patient>
|
| 121 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5754.xml
ADDED
|
@@ -0,0 +1,121 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">3149A4D9-127F-497E-900C-E90EDB912804</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828782">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828798">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828792">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828833">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="month" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-23803</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">62</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828796">WHITE</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5754</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5754</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">0aad0abd-750a-400d-a34f-491da996d46c</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828803">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828851">YES</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828852">NO</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">65</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828801">2008</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828840">WITH TUMOR</clin_shared:person_neoplasm_cancer_status>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828797">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828780">21</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828779">3</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828781">2012</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828783">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1828784" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828785">Peripheral Zone</prad:zone_of_origin>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828790">Bilateral</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828791"/>
|
| 55 |
+
</prad:tumor_levels>
|
| 56 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828802">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 57 |
+
<prad:days_to_bone_scan_performed precision="month" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">62</prad:days_to_bone_scan_performed>
|
| 58 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828811">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
|
| 59 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828812">YES</prad:diagnostic_ct_abd_pelvis_performed>
|
| 60 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="month" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">62</prad:days_to_diagnostic_computed_tomography_performed>
|
| 61 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 62 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828816">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
|
| 63 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 64 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828817">NO</prad:diagnostic_mri_performed>
|
| 65 |
+
<prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
|
| 66 |
+
<prad:diagnostic_mri_results>
|
| 67 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828821"/>
|
| 68 |
+
</prad:diagnostic_mri_results>
|
| 69 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828828">YES</prad:lymphnodes_examined>
|
| 70 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828830">11</prad:number_of_lymphnodes_examined>
|
| 71 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828831">3</prad:number_of_lymphnodes_positive_by_he>
|
| 72 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828832">R1</clin_shared:residual_tumor>
|
| 73 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828841"/>
|
| 74 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828842"/>
|
| 75 |
+
<shared_stage:stage_event system="AJCC">
|
| 76 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 77 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 78 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:tnm_categories>
|
| 80 |
+
<shared_stage:clinical_categories>
|
| 81 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1828804"/>
|
| 82 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 83 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828822">M0</shared_stage:clinical_M>
|
| 84 |
+
</shared_stage:clinical_categories>
|
| 85 |
+
<shared_stage:pathologic_categories>
|
| 86 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828826">T3b</shared_stage:pathologic_T>
|
| 87 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828829">N1</shared_stage:pathologic_N>
|
| 88 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 89 |
+
</shared_stage:pathologic_categories>
|
| 90 |
+
</shared_stage:tnm_categories>
|
| 91 |
+
<shared_stage:psa>
|
| 92 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828846">37.36</shared_stage:psa_value>
|
| 93 |
+
<shared_stage:days_to_psa precision="month" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">62</shared_stage:days_to_psa>
|
| 94 |
+
</shared_stage:psa>
|
| 95 |
+
<shared_stage:gleason_grading>
|
| 96 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828788">9</shared_stage:gleason_score>
|
| 97 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828786">4</shared_stage:primary_pattern>
|
| 98 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828787">5</shared_stage:secondary_pattern>
|
| 99 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828789">3</shared_stage:tertiary_pattern>
|
| 100 |
+
</shared_stage:gleason_grading>
|
| 101 |
+
<shared_stage:ann_arbor>
|
| 102 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 103 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 104 |
+
</shared_stage:ann_arbor>
|
| 105 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 106 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 107 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
</shared_stage:stage_event>
|
| 109 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 110 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 111 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 112 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828847">NO</prad:biochemical_recurrence>
|
| 113 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 114 |
+
<prad_nte:new_tumor_events>
|
| 115 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 116 |
+
</prad_nte:new_tumor_events>
|
| 117 |
+
<rx:drugs/>
|
| 118 |
+
<rad:radiations/>
|
| 119 |
+
<prad:follow_ups/>
|
| 120 |
+
</prad:patient>
|
| 121 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5761.xml
ADDED
|
@@ -0,0 +1,121 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">970B70BC-052F-4986-B3CA-AEB24FFB3893</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827543">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827559">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827553">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827594">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="month" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-22433</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">28</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827557">WHITE</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5761</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5761</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">854a481b-71a2-4f23-80aa-e91e9f4069b1</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827564">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827612">YES</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827613">NO</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">61</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827562">2007</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827601">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827558">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827541">16</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827540">3</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827542">2012</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827544">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1827545" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827546">Peripheral Zone</prad:zone_of_origin>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827551">Left</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827552"/>
|
| 55 |
+
</prad:tumor_levels>
|
| 56 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827563">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 57 |
+
<prad:days_to_bone_scan_performed precision="month" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">28</prad:days_to_bone_scan_performed>
|
| 58 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827572">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
|
| 59 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827573">YES</prad:diagnostic_ct_abd_pelvis_performed>
|
| 60 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="month" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">28</prad:days_to_diagnostic_computed_tomography_performed>
|
| 61 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 62 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827577">Equivocal</prad:diagnostic_ct_abd_pelvis_result>
|
| 63 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 64 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827578">YES</prad:diagnostic_mri_performed>
|
| 65 |
+
<prad:days_to_diagnostic_mri_performed precision="month" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Completed" preferred_name="days_to_mri" display_order="46" cde_ver="1.000">28</prad:days_to_diagnostic_mri_performed>
|
| 66 |
+
<prad:diagnostic_mri_results>
|
| 67 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827582">Equivocal</prad:diagnostic_mri_result>
|
| 68 |
+
</prad:diagnostic_mri_results>
|
| 69 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827589">YES</prad:lymphnodes_examined>
|
| 70 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827591">5</prad:number_of_lymphnodes_examined>
|
| 71 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827592">0</prad:number_of_lymphnodes_positive_by_he>
|
| 72 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827593">R0</clin_shared:residual_tumor>
|
| 73 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827602"/>
|
| 74 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827603"/>
|
| 75 |
+
<shared_stage:stage_event system="AJCC">
|
| 76 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 77 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 78 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:tnm_categories>
|
| 80 |
+
<shared_stage:clinical_categories>
|
| 81 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1827565"/>
|
| 82 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 83 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827583">M0</shared_stage:clinical_M>
|
| 84 |
+
</shared_stage:clinical_categories>
|
| 85 |
+
<shared_stage:pathologic_categories>
|
| 86 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827587">T3b</shared_stage:pathologic_T>
|
| 87 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827590">N0</shared_stage:pathologic_N>
|
| 88 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 89 |
+
</shared_stage:pathologic_categories>
|
| 90 |
+
</shared_stage:tnm_categories>
|
| 91 |
+
<shared_stage:psa>
|
| 92 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827607">8.49</shared_stage:psa_value>
|
| 93 |
+
<shared_stage:days_to_psa precision="month" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">39</shared_stage:days_to_psa>
|
| 94 |
+
</shared_stage:psa>
|
| 95 |
+
<shared_stage:gleason_grading>
|
| 96 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827549">9</shared_stage:gleason_score>
|
| 97 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827547">5</shared_stage:primary_pattern>
|
| 98 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827548">4</shared_stage:secondary_pattern>
|
| 99 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827550">3</shared_stage:tertiary_pattern>
|
| 100 |
+
</shared_stage:gleason_grading>
|
| 101 |
+
<shared_stage:ann_arbor>
|
| 102 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 103 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 104 |
+
</shared_stage:ann_arbor>
|
| 105 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 106 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 107 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
</shared_stage:stage_event>
|
| 109 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 110 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 111 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 112 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827608">NO</prad:biochemical_recurrence>
|
| 113 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 114 |
+
<prad_nte:new_tumor_events>
|
| 115 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 116 |
+
</prad_nte:new_tumor_events>
|
| 117 |
+
<rx:drugs/>
|
| 118 |
+
<rad:radiations/>
|
| 119 |
+
<prad:follow_ups/>
|
| 120 |
+
</prad:patient>
|
| 121 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5762.xml
ADDED
|
@@ -0,0 +1,153 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">5D306570-B39B-43A0-985D-DBE73B9EC095</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826641">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826657">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826651">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826692">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="month" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-22068</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1339</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826655">WHITE</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5762</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5762</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">d4ffafdc-ee83-43df-aa3b-7326503c6438</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826662">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826710">YES</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826711">NO</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">60</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826660">2005</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Discrepancy" restricted="false" source_system_identifier="1826699" xsi:nil="true"/>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826656">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826639">16</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826638">3</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826640">2012</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826642">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1826643" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826644">Peripheral Zone</prad:zone_of_origin>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826649">Bilateral</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826650"/>
|
| 55 |
+
</prad:tumor_levels>
|
| 56 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826661">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 57 |
+
<prad:days_to_bone_scan_performed precision="month" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">92</prad:days_to_bone_scan_performed>
|
| 58 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826670">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
|
| 59 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826671">YES</prad:diagnostic_ct_abd_pelvis_performed>
|
| 60 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="month" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">92</prad:days_to_diagnostic_computed_tomography_performed>
|
| 61 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 62 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826675">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
|
| 63 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 64 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826676">NO</prad:diagnostic_mri_performed>
|
| 65 |
+
<prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
|
| 66 |
+
<prad:diagnostic_mri_results>
|
| 67 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826680"/>
|
| 68 |
+
</prad:diagnostic_mri_results>
|
| 69 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826687">YES</prad:lymphnodes_examined>
|
| 70 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826689">7</prad:number_of_lymphnodes_examined>
|
| 71 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826690">0</prad:number_of_lymphnodes_positive_by_he>
|
| 72 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826691">R1</clin_shared:residual_tumor>
|
| 73 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826700"/>
|
| 74 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826701"/>
|
| 75 |
+
<shared_stage:stage_event system="AJCC">
|
| 76 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 77 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 78 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:tnm_categories>
|
| 80 |
+
<shared_stage:clinical_categories>
|
| 81 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1826663"/>
|
| 82 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 83 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826681">M0</shared_stage:clinical_M>
|
| 84 |
+
</shared_stage:clinical_categories>
|
| 85 |
+
<shared_stage:pathologic_categories>
|
| 86 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826685">T3b</shared_stage:pathologic_T>
|
| 87 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826688">N0</shared_stage:pathologic_N>
|
| 88 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 89 |
+
</shared_stage:pathologic_categories>
|
| 90 |
+
</shared_stage:tnm_categories>
|
| 91 |
+
<shared_stage:psa>
|
| 92 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826705">.01</shared_stage:psa_value>
|
| 93 |
+
<shared_stage:days_to_psa precision="month" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">1313</shared_stage:days_to_psa>
|
| 94 |
+
</shared_stage:psa>
|
| 95 |
+
<shared_stage:gleason_grading>
|
| 96 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826647">7</shared_stage:gleason_score>
|
| 97 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826645">4</shared_stage:primary_pattern>
|
| 98 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826646">3</shared_stage:secondary_pattern>
|
| 99 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826648"/>
|
| 100 |
+
</shared_stage:gleason_grading>
|
| 101 |
+
<shared_stage:ann_arbor>
|
| 102 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 103 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 104 |
+
</shared_stage:ann_arbor>
|
| 105 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 106 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 107 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
</shared_stage:stage_event>
|
| 109 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 110 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 111 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 112 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826706">NO</prad:biochemical_recurrence>
|
| 113 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 114 |
+
<prad_nte:new_tumor_events>
|
| 115 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 116 |
+
</prad_nte:new_tumor_events>
|
| 117 |
+
<rx:drugs/>
|
| 118 |
+
<rad:radiations/>
|
| 119 |
+
<prad:follow_ups>
|
| 120 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 121 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5762-F28975</clin_shared:bcr_followup_barcode>
|
| 122 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">bdae05b3-8281-4ba4-8d6d-4616d304fef9</clin_shared:bcr_followup_uuid>
|
| 123 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777458">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 124 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 125 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777459">YES</clin_shared:radiation_therapy>
|
| 126 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777460">NO</clin_shared:postoperative_rx_tx>
|
| 127 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777462">Alive</clin_shared:vital_status>
|
| 128 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777461">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 129 |
+
<clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1339</clin_shared:days_to_last_followup>
|
| 130 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 131 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Discrepancy" restricted="false" source_system_identifier="1777469" xsi:nil="true"/>
|
| 132 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777470"/>
|
| 133 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777471"/>
|
| 134 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777492">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 135 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777472">NO</nte:new_tumor_event_after_initial_treatment>
|
| 136 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 137 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777473"/>
|
| 138 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777480"/>
|
| 139 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777481"/>
|
| 140 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777490"/>
|
| 141 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777491"/>
|
| 142 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 143 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 144 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 145 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777482"/>
|
| 146 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777483"/>
|
| 147 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777456">14</clin_shared:day_of_form_completion>
|
| 148 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777455">2</clin_shared:month_of_form_completion>
|
| 149 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777457">2012</clin_shared:year_of_form_completion>
|
| 150 |
+
</follow_up_v1.0:follow_up>
|
| 151 |
+
</prad:follow_ups>
|
| 152 |
+
</prad:patient>
|
| 153 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5763.xml
ADDED
|
@@ -0,0 +1,153 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">C39F0889-6590-4F8B-B741-506D1689CD49</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828488">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828504">Yes</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828498">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828539">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="month" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-24380</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">365</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828502">WHITE</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5763</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5763</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">18e79a01-07a2-4cd5-b700-71d41724e041</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828509">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828557">YES</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828558">NO</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">66</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828507">2008</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828546">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828503">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828486">16</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828485">3</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828487">2012</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828489">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1828490" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828491">Peripheral Zone</prad:zone_of_origin>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828496">Bilateral</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828497"/>
|
| 55 |
+
</prad:tumor_levels>
|
| 56 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828508">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 57 |
+
<prad:days_to_bone_scan_performed precision="month" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">0</prad:days_to_bone_scan_performed>
|
| 58 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828517">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
|
| 59 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828518">YES</prad:diagnostic_ct_abd_pelvis_performed>
|
| 60 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="month" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">0</prad:days_to_diagnostic_computed_tomography_performed>
|
| 61 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 62 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828522">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
|
| 63 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 64 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828523">NO</prad:diagnostic_mri_performed>
|
| 65 |
+
<prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
|
| 66 |
+
<prad:diagnostic_mri_results>
|
| 67 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828527"/>
|
| 68 |
+
</prad:diagnostic_mri_results>
|
| 69 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828534">YES</prad:lymphnodes_examined>
|
| 70 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828536">5</prad:number_of_lymphnodes_examined>
|
| 71 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828537">0</prad:number_of_lymphnodes_positive_by_he>
|
| 72 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828538">R0</clin_shared:residual_tumor>
|
| 73 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828547"/>
|
| 74 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828548"/>
|
| 75 |
+
<shared_stage:stage_event system="AJCC">
|
| 76 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 77 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 78 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:tnm_categories>
|
| 80 |
+
<shared_stage:clinical_categories>
|
| 81 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1828510"/>
|
| 82 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 83 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828528">M0</shared_stage:clinical_M>
|
| 84 |
+
</shared_stage:clinical_categories>
|
| 85 |
+
<shared_stage:pathologic_categories>
|
| 86 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828532">T3a</shared_stage:pathologic_T>
|
| 87 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828535">N0</shared_stage:pathologic_N>
|
| 88 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 89 |
+
</shared_stage:pathologic_categories>
|
| 90 |
+
</shared_stage:tnm_categories>
|
| 91 |
+
<shared_stage:psa>
|
| 92 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828552">0.1</shared_stage:psa_value>
|
| 93 |
+
<shared_stage:days_to_psa precision="month" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">360</shared_stage:days_to_psa>
|
| 94 |
+
</shared_stage:psa>
|
| 95 |
+
<shared_stage:gleason_grading>
|
| 96 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828494">7</shared_stage:gleason_score>
|
| 97 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828492">3</shared_stage:primary_pattern>
|
| 98 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828493">4</shared_stage:secondary_pattern>
|
| 99 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828495"/>
|
| 100 |
+
</shared_stage:gleason_grading>
|
| 101 |
+
<shared_stage:ann_arbor>
|
| 102 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 103 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 104 |
+
</shared_stage:ann_arbor>
|
| 105 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 106 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 107 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
</shared_stage:stage_event>
|
| 109 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 110 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 111 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 112 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828553">NO</prad:biochemical_recurrence>
|
| 113 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 114 |
+
<prad_nte:new_tumor_events>
|
| 115 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 116 |
+
</prad_nte:new_tumor_events>
|
| 117 |
+
<rx:drugs/>
|
| 118 |
+
<rad:radiations/>
|
| 119 |
+
<prad:follow_ups>
|
| 120 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 121 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5763-F28974</clin_shared:bcr_followup_barcode>
|
| 122 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">8bc71c57-3d08-445c-ace6-5bd3e201446b</clin_shared:bcr_followup_uuid>
|
| 123 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777418">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 124 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 125 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777419">NO</clin_shared:radiation_therapy>
|
| 126 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777420">NO</clin_shared:postoperative_rx_tx>
|
| 127 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777422">Alive</clin_shared:vital_status>
|
| 128 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777421">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 129 |
+
<clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">365</clin_shared:days_to_last_followup>
|
| 130 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 131 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777429">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 132 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777430"/>
|
| 133 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777431"/>
|
| 134 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777452">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 135 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777432">NO</nte:new_tumor_event_after_initial_treatment>
|
| 136 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 137 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777433"/>
|
| 138 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777440"/>
|
| 139 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777441"/>
|
| 140 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777450"/>
|
| 141 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777451"/>
|
| 142 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 143 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 144 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 145 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777442"/>
|
| 146 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777443"/>
|
| 147 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777416">14</clin_shared:day_of_form_completion>
|
| 148 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777415">2</clin_shared:month_of_form_completion>
|
| 149 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777417">2012</clin_shared:year_of_form_completion>
|
| 150 |
+
</follow_up_v1.0:follow_up>
|
| 151 |
+
</prad:follow_ups>
|
| 152 |
+
</prad:patient>
|
| 153 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5764.xml
ADDED
|
@@ -0,0 +1,121 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">74160F0D-C476-4AB9-9CF9-72821ED1A18D</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828673">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828689">Yes</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828683">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828724">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="month" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-24257</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">31</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828687">WHITE</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5764</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5764</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">ed73f136-42e8-4100-b432-d10370d07e8b</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828694">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828742">YES</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828743">NO</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">66</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828692">2008</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828731">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828688">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828671">16</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828670">3</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828672">2012</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828674">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1828675" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828676">Peripheral Zone</prad:zone_of_origin>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828681">Bilateral</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828682"/>
|
| 55 |
+
</prad:tumor_levels>
|
| 56 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828693">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 57 |
+
<prad:days_to_bone_scan_performed precision="month" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">31</prad:days_to_bone_scan_performed>
|
| 58 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828702">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
|
| 59 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828703">YES</prad:diagnostic_ct_abd_pelvis_performed>
|
| 60 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="month" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">31</prad:days_to_diagnostic_computed_tomography_performed>
|
| 61 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 62 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828707">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
|
| 63 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 64 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828708">NO</prad:diagnostic_mri_performed>
|
| 65 |
+
<prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
|
| 66 |
+
<prad:diagnostic_mri_results>
|
| 67 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828712"/>
|
| 68 |
+
</prad:diagnostic_mri_results>
|
| 69 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828719">YES</prad:lymphnodes_examined>
|
| 70 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828721">8</prad:number_of_lymphnodes_examined>
|
| 71 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828722">0</prad:number_of_lymphnodes_positive_by_he>
|
| 72 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828723">R0</clin_shared:residual_tumor>
|
| 73 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828732"/>
|
| 74 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828733"/>
|
| 75 |
+
<shared_stage:stage_event system="AJCC">
|
| 76 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 77 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 78 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:tnm_categories>
|
| 80 |
+
<shared_stage:clinical_categories>
|
| 81 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1828695"/>
|
| 82 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 83 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828713">M0</shared_stage:clinical_M>
|
| 84 |
+
</shared_stage:clinical_categories>
|
| 85 |
+
<shared_stage:pathologic_categories>
|
| 86 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828717">T3b</shared_stage:pathologic_T>
|
| 87 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828720">N0</shared_stage:pathologic_N>
|
| 88 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 89 |
+
</shared_stage:pathologic_categories>
|
| 90 |
+
</shared_stage:tnm_categories>
|
| 91 |
+
<shared_stage:psa>
|
| 92 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828737">13.95</shared_stage:psa_value>
|
| 93 |
+
<shared_stage:days_to_psa precision="month" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">29</shared_stage:days_to_psa>
|
| 94 |
+
</shared_stage:psa>
|
| 95 |
+
<shared_stage:gleason_grading>
|
| 96 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828679">7</shared_stage:gleason_score>
|
| 97 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828677">4</shared_stage:primary_pattern>
|
| 98 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828678">3</shared_stage:secondary_pattern>
|
| 99 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828680"/>
|
| 100 |
+
</shared_stage:gleason_grading>
|
| 101 |
+
<shared_stage:ann_arbor>
|
| 102 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 103 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 104 |
+
</shared_stage:ann_arbor>
|
| 105 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 106 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 107 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
</shared_stage:stage_event>
|
| 109 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 110 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 111 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 112 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828738">NO</prad:biochemical_recurrence>
|
| 113 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 114 |
+
<prad_nte:new_tumor_events>
|
| 115 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 116 |
+
</prad_nte:new_tumor_events>
|
| 117 |
+
<rx:drugs/>
|
| 118 |
+
<rad:radiations/>
|
| 119 |
+
<prad:follow_ups/>
|
| 120 |
+
</prad:patient>
|
| 121 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5765.xml
ADDED
|
@@ -0,0 +1,153 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">B39AC952-235B-48E6-9F58-10B0A317F7FC</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827391">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827407">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827401">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827442">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="year" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-20364</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="year" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">700</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827405">WHITE</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5765</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5765</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">716eb429-d7af-4d4f-bd8d-afcff1a323ee</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827412">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827460">YES</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827461">NO</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="year" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="year" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">55</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827410">2007</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827449">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827406">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827389">16</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827388">3</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827390">2012</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827392">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1827393" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1827394"/>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827399">Bilateral</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827400"/>
|
| 55 |
+
</prad:tumor_levels>
|
| 56 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827411">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 57 |
+
<prad:days_to_bone_scan_performed precision="year" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">31</prad:days_to_bone_scan_performed>
|
| 58 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827420">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
|
| 59 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827421">YES</prad:diagnostic_ct_abd_pelvis_performed>
|
| 60 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="year" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">31</prad:days_to_diagnostic_computed_tomography_performed>
|
| 61 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 62 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827425">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
|
| 63 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 64 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827426">NO</prad:diagnostic_mri_performed>
|
| 65 |
+
<prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
|
| 66 |
+
<prad:diagnostic_mri_results>
|
| 67 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827430"/>
|
| 68 |
+
</prad:diagnostic_mri_results>
|
| 69 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827437">YES</prad:lymphnodes_examined>
|
| 70 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827439">7</prad:number_of_lymphnodes_examined>
|
| 71 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827440">0</prad:number_of_lymphnodes_positive_by_he>
|
| 72 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827441">R0</clin_shared:residual_tumor>
|
| 73 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827450"/>
|
| 74 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827451"/>
|
| 75 |
+
<shared_stage:stage_event system="AJCC">
|
| 76 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 77 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 78 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:tnm_categories>
|
| 80 |
+
<shared_stage:clinical_categories>
|
| 81 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1827413"/>
|
| 82 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 83 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827431">M0</shared_stage:clinical_M>
|
| 84 |
+
</shared_stage:clinical_categories>
|
| 85 |
+
<shared_stage:pathologic_categories>
|
| 86 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827435">T3a</shared_stage:pathologic_T>
|
| 87 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827438">N0</shared_stage:pathologic_N>
|
| 88 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 89 |
+
</shared_stage:pathologic_categories>
|
| 90 |
+
</shared_stage:tnm_categories>
|
| 91 |
+
<shared_stage:psa>
|
| 92 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827455">0.02</shared_stage:psa_value>
|
| 93 |
+
<shared_stage:days_to_psa precision="year" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">694</shared_stage:days_to_psa>
|
| 94 |
+
</shared_stage:psa>
|
| 95 |
+
<shared_stage:gleason_grading>
|
| 96 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827397">7</shared_stage:gleason_score>
|
| 97 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827395">3</shared_stage:primary_pattern>
|
| 98 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827396">4</shared_stage:secondary_pattern>
|
| 99 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827398"/>
|
| 100 |
+
</shared_stage:gleason_grading>
|
| 101 |
+
<shared_stage:ann_arbor>
|
| 102 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 103 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 104 |
+
</shared_stage:ann_arbor>
|
| 105 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 106 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 107 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
</shared_stage:stage_event>
|
| 109 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 110 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 111 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 112 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827456">NO</prad:biochemical_recurrence>
|
| 113 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 114 |
+
<prad_nte:new_tumor_events>
|
| 115 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 116 |
+
</prad_nte:new_tumor_events>
|
| 117 |
+
<rx:drugs/>
|
| 118 |
+
<rad:radiations/>
|
| 119 |
+
<prad:follow_ups>
|
| 120 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 121 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5765-F28995</clin_shared:bcr_followup_barcode>
|
| 122 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">a35e8791-c35a-4c44-831c-0466098def97</clin_shared:bcr_followup_uuid>
|
| 123 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778136">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 124 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 125 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778137">NO</clin_shared:radiation_therapy>
|
| 126 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778138">NO</clin_shared:postoperative_rx_tx>
|
| 127 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778140">Alive</clin_shared:vital_status>
|
| 128 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778139">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 129 |
+
<clin_shared:days_to_last_followup precision="year" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">700</clin_shared:days_to_last_followup>
|
| 130 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 131 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778147">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 132 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778148"/>
|
| 133 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778149"/>
|
| 134 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778170">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 135 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778150">NO</nte:new_tumor_event_after_initial_treatment>
|
| 136 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 137 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778151"/>
|
| 138 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778158"/>
|
| 139 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778159"/>
|
| 140 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778168"/>
|
| 141 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778169"/>
|
| 142 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 143 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 144 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 145 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778160"/>
|
| 146 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778161"/>
|
| 147 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778134">15</clin_shared:day_of_form_completion>
|
| 148 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778133">2</clin_shared:month_of_form_completion>
|
| 149 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778135">2012</clin_shared:year_of_form_completion>
|
| 150 |
+
</follow_up_v1.0:follow_up>
|
| 151 |
+
</prad:follow_ups>
|
| 152 |
+
</prad:patient>
|
| 153 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5766.xml
ADDED
|
@@ -0,0 +1,121 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">990F4717-1DD9-42E3-9C0E-53582306CD04</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827771">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827787">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827781">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827822">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="month" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-20392</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">31</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827785">WHITE</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5766</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5766</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">a5c77ab6-6e98-4a3d-81c8-f3d5fabd31d2</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827792">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827840">YES</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827841">NO</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">55</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827790">2007</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827829">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827786">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827769">16</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827768">3</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827770">2012</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827772">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1827773" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827774">Peripheral Zone</prad:zone_of_origin>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827779">Bilateral</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827780"/>
|
| 55 |
+
</prad:tumor_levels>
|
| 56 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827791">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 57 |
+
<prad:days_to_bone_scan_performed precision="month" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">31</prad:days_to_bone_scan_performed>
|
| 58 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827800">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
|
| 59 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827801">YES</prad:diagnostic_ct_abd_pelvis_performed>
|
| 60 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="month" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">31</prad:days_to_diagnostic_computed_tomography_performed>
|
| 61 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 62 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827805">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
|
| 63 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 64 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827806">NO</prad:diagnostic_mri_performed>
|
| 65 |
+
<prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
|
| 66 |
+
<prad:diagnostic_mri_results>
|
| 67 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827810"/>
|
| 68 |
+
</prad:diagnostic_mri_results>
|
| 69 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827817">YES</prad:lymphnodes_examined>
|
| 70 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827819">4</prad:number_of_lymphnodes_examined>
|
| 71 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827820">1</prad:number_of_lymphnodes_positive_by_he>
|
| 72 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827821">R0</clin_shared:residual_tumor>
|
| 73 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827830"/>
|
| 74 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827831"/>
|
| 75 |
+
<shared_stage:stage_event system="AJCC">
|
| 76 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 77 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 78 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:tnm_categories>
|
| 80 |
+
<shared_stage:clinical_categories>
|
| 81 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1827793"/>
|
| 82 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 83 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827811">M0</shared_stage:clinical_M>
|
| 84 |
+
</shared_stage:clinical_categories>
|
| 85 |
+
<shared_stage:pathologic_categories>
|
| 86 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827815">T3a</shared_stage:pathologic_T>
|
| 87 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827818">N1</shared_stage:pathologic_N>
|
| 88 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 89 |
+
</shared_stage:pathologic_categories>
|
| 90 |
+
</shared_stage:tnm_categories>
|
| 91 |
+
<shared_stage:psa>
|
| 92 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827835">13.9</shared_stage:psa_value>
|
| 93 |
+
<shared_stage:days_to_psa precision="month" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">39</shared_stage:days_to_psa>
|
| 94 |
+
</shared_stage:psa>
|
| 95 |
+
<shared_stage:gleason_grading>
|
| 96 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827777">7</shared_stage:gleason_score>
|
| 97 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827775">4</shared_stage:primary_pattern>
|
| 98 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827776">3</shared_stage:secondary_pattern>
|
| 99 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827778"/>
|
| 100 |
+
</shared_stage:gleason_grading>
|
| 101 |
+
<shared_stage:ann_arbor>
|
| 102 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 103 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 104 |
+
</shared_stage:ann_arbor>
|
| 105 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 106 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 107 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
</shared_stage:stage_event>
|
| 109 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 110 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 111 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 112 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827836">NO</prad:biochemical_recurrence>
|
| 113 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 114 |
+
<prad_nte:new_tumor_events>
|
| 115 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 116 |
+
</prad_nte:new_tumor_events>
|
| 117 |
+
<rx:drugs/>
|
| 118 |
+
<rad:radiations/>
|
| 119 |
+
<prad:follow_ups/>
|
| 120 |
+
</prad:patient>
|
| 121 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5767.xml
ADDED
|
@@ -0,0 +1,153 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">62B44FD0-AC8C-4A20-ACF3-D610C83155C8</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">108.76.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827847">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827863">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827857">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827898">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="month" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-24287</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">458</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827861">WHITE</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5767</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5767</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">8dc53431-44ab-485e-b4e6-c3d06509506d</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827868">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827916">YES</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827917">NO</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">66</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827866">2007</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827905">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827862">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827845">16</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827844">3</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827846">2012</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827848">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1827849" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827850">Peripheral Zone</prad:zone_of_origin>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827855">Bilateral</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827856"/>
|
| 55 |
+
</prad:tumor_levels>
|
| 56 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827867">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 57 |
+
<prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Not Available" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000"/>
|
| 58 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827876"/>
|
| 59 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827877">NO</prad:diagnostic_ct_abd_pelvis_performed>
|
| 60 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Not Available" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000"/>
|
| 61 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 62 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827881"/>
|
| 63 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 64 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827882">NO</prad:diagnostic_mri_performed>
|
| 65 |
+
<prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
|
| 66 |
+
<prad:diagnostic_mri_results>
|
| 67 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827886"/>
|
| 68 |
+
</prad:diagnostic_mri_results>
|
| 69 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827893">YES</prad:lymphnodes_examined>
|
| 70 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827895">19</prad:number_of_lymphnodes_examined>
|
| 71 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827896">0</prad:number_of_lymphnodes_positive_by_he>
|
| 72 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827897">R0</clin_shared:residual_tumor>
|
| 73 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827906"/>
|
| 74 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827907"/>
|
| 75 |
+
<shared_stage:stage_event system="AJCC">
|
| 76 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 77 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 78 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:tnm_categories>
|
| 80 |
+
<shared_stage:clinical_categories>
|
| 81 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1827869"/>
|
| 82 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 83 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827887">M0</shared_stage:clinical_M>
|
| 84 |
+
</shared_stage:clinical_categories>
|
| 85 |
+
<shared_stage:pathologic_categories>
|
| 86 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827889">T2c</shared_stage:pathologic_T>
|
| 87 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827894">N0</shared_stage:pathologic_N>
|
| 88 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 89 |
+
</shared_stage:pathologic_categories>
|
| 90 |
+
</shared_stage:tnm_categories>
|
| 91 |
+
<shared_stage:psa>
|
| 92 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827911">0.04</shared_stage:psa_value>
|
| 93 |
+
<shared_stage:days_to_psa precision="month" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">377</shared_stage:days_to_psa>
|
| 94 |
+
</shared_stage:psa>
|
| 95 |
+
<shared_stage:gleason_grading>
|
| 96 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827853">7</shared_stage:gleason_score>
|
| 97 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827851">4</shared_stage:primary_pattern>
|
| 98 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827852">3</shared_stage:secondary_pattern>
|
| 99 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827854"/>
|
| 100 |
+
</shared_stage:gleason_grading>
|
| 101 |
+
<shared_stage:ann_arbor>
|
| 102 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 103 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 104 |
+
</shared_stage:ann_arbor>
|
| 105 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 106 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 107 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
</shared_stage:stage_event>
|
| 109 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 110 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 111 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 112 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827912">NO</prad:biochemical_recurrence>
|
| 113 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 114 |
+
<prad_nte:new_tumor_events>
|
| 115 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 116 |
+
</prad_nte:new_tumor_events>
|
| 117 |
+
<rx:drugs/>
|
| 118 |
+
<rad:radiations/>
|
| 119 |
+
<prad:follow_ups>
|
| 120 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 121 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5767-F28999</clin_shared:bcr_followup_barcode>
|
| 122 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">3f4b8d5e-9c1d-4120-afe3-758234fbbc6b</clin_shared:bcr_followup_uuid>
|
| 123 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778278">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 124 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 125 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778279">NO</clin_shared:radiation_therapy>
|
| 126 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778280">NO</clin_shared:postoperative_rx_tx>
|
| 127 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778282">Alive</clin_shared:vital_status>
|
| 128 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778281">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 129 |
+
<clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">458</clin_shared:days_to_last_followup>
|
| 130 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 131 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778289">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 132 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778290"/>
|
| 133 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778291"/>
|
| 134 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778312">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 135 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778292">NO</nte:new_tumor_event_after_initial_treatment>
|
| 136 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 137 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778293"/>
|
| 138 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778300"/>
|
| 139 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778301"/>
|
| 140 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778310"/>
|
| 141 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778311"/>
|
| 142 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 143 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 144 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 145 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778302"/>
|
| 146 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778303"/>
|
| 147 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778276">15</clin_shared:day_of_form_completion>
|
| 148 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778275">2</clin_shared:month_of_form_completion>
|
| 149 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778277">2012</clin_shared:year_of_form_completion>
|
| 150 |
+
</follow_up_v1.0:follow_up>
|
| 151 |
+
</prad:follow_ups>
|
| 152 |
+
</prad:patient>
|
| 153 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5768.xml
ADDED
|
@@ -0,0 +1,153 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">7874749D-16DE-4D1E-8E52-F734E4B4EA97</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827695">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827711">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827705">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827746">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="month" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-26480</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">731</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827709">WHITE</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5768</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5768</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">f6c61a22-a711-416d-9e65-6a1b957e5b2e</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827716">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827764">YES</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827765">NO</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">72</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827714">2007</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827753">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827710">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827693">16</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827692">3</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827694">2012</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827696">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1827697" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827698">Overlapping / Multiple Zones</prad:zone_of_origin>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827703">Bilateral</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827704"/>
|
| 55 |
+
</prad:tumor_levels>
|
| 56 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827715">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 57 |
+
<prad:days_to_bone_scan_performed precision="month" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">30</prad:days_to_bone_scan_performed>
|
| 58 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827724">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
|
| 59 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827725">YES</prad:diagnostic_ct_abd_pelvis_performed>
|
| 60 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="month" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">30</prad:days_to_diagnostic_computed_tomography_performed>
|
| 61 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 62 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827729">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
|
| 63 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 64 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827730">NO</prad:diagnostic_mri_performed>
|
| 65 |
+
<prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
|
| 66 |
+
<prad:diagnostic_mri_results>
|
| 67 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827734"/>
|
| 68 |
+
</prad:diagnostic_mri_results>
|
| 69 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827741">YES</prad:lymphnodes_examined>
|
| 70 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827743">16</prad:number_of_lymphnodes_examined>
|
| 71 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827744">0</prad:number_of_lymphnodes_positive_by_he>
|
| 72 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827745">R0</clin_shared:residual_tumor>
|
| 73 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827754"/>
|
| 74 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827755"/>
|
| 75 |
+
<shared_stage:stage_event system="AJCC">
|
| 76 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 77 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 78 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:tnm_categories>
|
| 80 |
+
<shared_stage:clinical_categories>
|
| 81 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1827717"/>
|
| 82 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 83 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827735">M0</shared_stage:clinical_M>
|
| 84 |
+
</shared_stage:clinical_categories>
|
| 85 |
+
<shared_stage:pathologic_categories>
|
| 86 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827739">T3a</shared_stage:pathologic_T>
|
| 87 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827742">N0</shared_stage:pathologic_N>
|
| 88 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 89 |
+
</shared_stage:pathologic_categories>
|
| 90 |
+
</shared_stage:tnm_categories>
|
| 91 |
+
<shared_stage:psa>
|
| 92 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827759">0.1</shared_stage:psa_value>
|
| 93 |
+
<shared_stage:days_to_psa precision="month" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">634</shared_stage:days_to_psa>
|
| 94 |
+
</shared_stage:psa>
|
| 95 |
+
<shared_stage:gleason_grading>
|
| 96 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827701">6</shared_stage:gleason_score>
|
| 97 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827699">2</shared_stage:primary_pattern>
|
| 98 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827700">4</shared_stage:secondary_pattern>
|
| 99 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827702">3</shared_stage:tertiary_pattern>
|
| 100 |
+
</shared_stage:gleason_grading>
|
| 101 |
+
<shared_stage:ann_arbor>
|
| 102 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 103 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 104 |
+
</shared_stage:ann_arbor>
|
| 105 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 106 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 107 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
</shared_stage:stage_event>
|
| 109 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 110 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 111 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 112 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827760">NO</prad:biochemical_recurrence>
|
| 113 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 114 |
+
<prad_nte:new_tumor_events>
|
| 115 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 116 |
+
</prad_nte:new_tumor_events>
|
| 117 |
+
<rx:drugs/>
|
| 118 |
+
<rad:radiations/>
|
| 119 |
+
<prad:follow_ups>
|
| 120 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 121 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5768-F28998</clin_shared:bcr_followup_barcode>
|
| 122 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">d9b4ec26-42ca-4305-9906-1b29416d423c</clin_shared:bcr_followup_uuid>
|
| 123 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778238">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 124 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 125 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778239">NO</clin_shared:radiation_therapy>
|
| 126 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778240">NO</clin_shared:postoperative_rx_tx>
|
| 127 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778242">Alive</clin_shared:vital_status>
|
| 128 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778241">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 129 |
+
<clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">731</clin_shared:days_to_last_followup>
|
| 130 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 131 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778249">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 132 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778250"/>
|
| 133 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778251"/>
|
| 134 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778272">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 135 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778252">NO</nte:new_tumor_event_after_initial_treatment>
|
| 136 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 137 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778253"/>
|
| 138 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778260"/>
|
| 139 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778261"/>
|
| 140 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778270"/>
|
| 141 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778271"/>
|
| 142 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 143 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 144 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 145 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778262"/>
|
| 146 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778263"/>
|
| 147 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778236">15</clin_shared:day_of_form_completion>
|
| 148 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778235">2</clin_shared:month_of_form_completion>
|
| 149 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778237">2012</clin_shared:year_of_form_completion>
|
| 150 |
+
</follow_up_v1.0:follow_up>
|
| 151 |
+
</prad:follow_ups>
|
| 152 |
+
</prad:patient>
|
| 153 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5769.xml
ADDED
|
@@ -0,0 +1,121 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">97F1CB56-E9EE-4499-A207-9E542C1BD7B7</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827923">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827939">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827933">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827974">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="month" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-17807</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">62</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827937">WHITE</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5769</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5769</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">a7b76662-8380-4f35-9307-99c0acacb904</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827944">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827992">YES</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827993">NO</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">48</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827942">2007</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827981">WITH TUMOR</clin_shared:person_neoplasm_cancer_status>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827938">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827921">16</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827920">3</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827922">2012</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827924">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1827925" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1827926"/>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827931">Bilateral</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827932"/>
|
| 55 |
+
</prad:tumor_levels>
|
| 56 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827943">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 57 |
+
<prad:days_to_bone_scan_performed precision="month" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">62</prad:days_to_bone_scan_performed>
|
| 58 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827952">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
|
| 59 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827953">YES</prad:diagnostic_ct_abd_pelvis_performed>
|
| 60 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="month" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">62</prad:days_to_diagnostic_computed_tomography_performed>
|
| 61 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 62 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827957">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
|
| 63 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 64 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827958">NO</prad:diagnostic_mri_performed>
|
| 65 |
+
<prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
|
| 66 |
+
<prad:diagnostic_mri_results>
|
| 67 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827962"/>
|
| 68 |
+
</prad:diagnostic_mri_results>
|
| 69 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827969">YES</prad:lymphnodes_examined>
|
| 70 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827971">8</prad:number_of_lymphnodes_examined>
|
| 71 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827972">0</prad:number_of_lymphnodes_positive_by_he>
|
| 72 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827973">R1</clin_shared:residual_tumor>
|
| 73 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827982"/>
|
| 74 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827983"/>
|
| 75 |
+
<shared_stage:stage_event system="AJCC">
|
| 76 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 77 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 78 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:tnm_categories>
|
| 80 |
+
<shared_stage:clinical_categories>
|
| 81 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1827945"/>
|
| 82 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 83 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827963">M0</shared_stage:clinical_M>
|
| 84 |
+
</shared_stage:clinical_categories>
|
| 85 |
+
<shared_stage:pathologic_categories>
|
| 86 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827967">T3b</shared_stage:pathologic_T>
|
| 87 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827970">N0</shared_stage:pathologic_N>
|
| 88 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 89 |
+
</shared_stage:pathologic_categories>
|
| 90 |
+
</shared_stage:tnm_categories>
|
| 91 |
+
<shared_stage:psa>
|
| 92 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827987">11.16</shared_stage:psa_value>
|
| 93 |
+
<shared_stage:days_to_psa precision="month" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">60</shared_stage:days_to_psa>
|
| 94 |
+
</shared_stage:psa>
|
| 95 |
+
<shared_stage:gleason_grading>
|
| 96 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827929">9</shared_stage:gleason_score>
|
| 97 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827927">5</shared_stage:primary_pattern>
|
| 98 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827928">4</shared_stage:secondary_pattern>
|
| 99 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827930"/>
|
| 100 |
+
</shared_stage:gleason_grading>
|
| 101 |
+
<shared_stage:ann_arbor>
|
| 102 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 103 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 104 |
+
</shared_stage:ann_arbor>
|
| 105 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 106 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 107 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
</shared_stage:stage_event>
|
| 109 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 110 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 111 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 112 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827988">NO</prad:biochemical_recurrence>
|
| 113 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 114 |
+
<prad_nte:new_tumor_events>
|
| 115 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 116 |
+
</prad_nte:new_tumor_events>
|
| 117 |
+
<rx:drugs/>
|
| 118 |
+
<rad:radiations/>
|
| 119 |
+
<prad:follow_ups/>
|
| 120 |
+
</prad:patient>
|
| 121 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5494.xml
ADDED
|
@@ -0,0 +1,185 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">2CF48C9F-C247-47F1-9553-E40D538FF87A</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819080">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819096">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819090">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819131">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-18596</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">378</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819094">WHITE</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5494</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">EJ</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5494</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">e27c50e2-2a41-4f8c-9ef8-2bc51fb0c23e</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819101">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819253">YES</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819254">NO</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">50</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819099">2009</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819138">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819095">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805659">29</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805658">3</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805660">2012</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819081">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1819082" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1819083"/>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819088">Bilateral</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819089">Apex</prad:tumor_level>
|
| 55 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819089">Middle</prad:tumor_level>
|
| 56 |
+
</prad:tumor_levels>
|
| 57 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819100">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 58 |
+
<prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Not Available" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000"/>
|
| 59 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1819109"/>
|
| 60 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1819110"/>
|
| 61 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Not Available" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000"/>
|
| 62 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 63 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1819114"/>
|
| 64 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 65 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1819115"/>
|
| 66 |
+
<prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
|
| 67 |
+
<prad:diagnostic_mri_results>
|
| 68 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1819119"/>
|
| 69 |
+
</prad:diagnostic_mri_results>
|
| 70 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819126">YES</prad:lymphnodes_examined>
|
| 71 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819128">17</prad:number_of_lymphnodes_examined>
|
| 72 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819129">0</prad:number_of_lymphnodes_positive_by_he>
|
| 73 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819130">R0</clin_shared:residual_tumor>
|
| 74 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1819139"/>
|
| 75 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1819140"/>
|
| 76 |
+
<shared_stage:stage_event system="AJCC">
|
| 77 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 78 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 80 |
+
<shared_stage:tnm_categories>
|
| 81 |
+
<shared_stage:clinical_categories>
|
| 82 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819103">T2a</shared_stage:clinical_T>
|
| 83 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 84 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819120">M0</shared_stage:clinical_M>
|
| 85 |
+
</shared_stage:clinical_categories>
|
| 86 |
+
<shared_stage:pathologic_categories>
|
| 87 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819124">T3a</shared_stage:pathologic_T>
|
| 88 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819127">N0</shared_stage:pathologic_N>
|
| 89 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 90 |
+
</shared_stage:pathologic_categories>
|
| 91 |
+
</shared_stage:tnm_categories>
|
| 92 |
+
<shared_stage:psa>
|
| 93 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1819248"/>
|
| 94 |
+
<shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">184</shared_stage:days_to_psa>
|
| 95 |
+
</shared_stage:psa>
|
| 96 |
+
<shared_stage:gleason_grading>
|
| 97 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819086">7</shared_stage:gleason_score>
|
| 98 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819084">4</shared_stage:primary_pattern>
|
| 99 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819085">3</shared_stage:secondary_pattern>
|
| 100 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819087">4</shared_stage:tertiary_pattern>
|
| 101 |
+
</shared_stage:gleason_grading>
|
| 102 |
+
<shared_stage:ann_arbor>
|
| 103 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 104 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 105 |
+
</shared_stage:ann_arbor>
|
| 106 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 107 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 109 |
+
</shared_stage:stage_event>
|
| 110 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 111 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 112 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 113 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819249">NO</prad:biochemical_recurrence>
|
| 114 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 115 |
+
<prad_nte:new_tumor_events>
|
| 116 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 117 |
+
</prad_nte:new_tumor_events>
|
| 118 |
+
<rx:drugs/>
|
| 119 |
+
<rad:radiations/>
|
| 120 |
+
<prad:follow_ups>
|
| 121 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 122 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5494-F46196</clin_shared:bcr_followup_barcode>
|
| 123 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">8BB308D6-BD5D-4A5E-BBD3-9401DC5E6044</clin_shared:bcr_followup_uuid>
|
| 124 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757076">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 125 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757077">NO</clin_shared:lost_follow_up>
|
| 126 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757078">NO</clin_shared:radiation_therapy>
|
| 127 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757079">NO</clin_shared:postoperative_rx_tx>
|
| 128 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757081">Alive</clin_shared:vital_status>
|
| 129 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757080">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 130 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">826</clin_shared:days_to_last_followup>
|
| 131 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 132 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757090">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 133 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757091"/>
|
| 134 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757092"/>
|
| 135 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757117">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 136 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757093">NO</nte:new_tumor_event_after_initial_treatment>
|
| 137 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 138 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757094"/>
|
| 139 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757103"/>
|
| 140 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757104"/>
|
| 141 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757115"/>
|
| 142 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757116"/>
|
| 143 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 144 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 145 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 146 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757105"/>
|
| 147 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757106"/>
|
| 148 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:day_of_form_completion>
|
| 149 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8</clin_shared:month_of_form_completion>
|
| 150 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
|
| 151 |
+
</follow_up_v1.0:follow_up>
|
| 152 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="2">
|
| 153 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5494-F71910</clin_shared:bcr_followup_barcode>
|
| 154 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">95A5F4AC-25DD-4FAB-A814-CE49A444E0AA</clin_shared:bcr_followup_uuid>
|
| 155 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142019">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 156 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142020">NO</clin_shared:lost_follow_up>
|
| 157 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142021">NO</clin_shared:radiation_therapy>
|
| 158 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142022">NO</clin_shared:postoperative_rx_tx>
|
| 159 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142024">Alive</clin_shared:vital_status>
|
| 160 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142023">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 161 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1477</clin_shared:days_to_last_followup>
|
| 162 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 163 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142033">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 164 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142034"/>
|
| 165 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142035"/>
|
| 166 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142060">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 167 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142036">NO</nte:new_tumor_event_after_initial_treatment>
|
| 168 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 169 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142037"/>
|
| 170 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142046"/>
|
| 171 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142047"/>
|
| 172 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142058"/>
|
| 173 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142059"/>
|
| 174 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 175 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 176 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 177 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142048"/>
|
| 178 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142049"/>
|
| 179 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">31</clin_shared:day_of_form_completion>
|
| 180 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
|
| 181 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2015</clin_shared:year_of_form_completion>
|
| 182 |
+
</follow_up_v1.0:follow_up>
|
| 183 |
+
</prad:follow_ups>
|
| 184 |
+
</prad:patient>
|
| 185 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5495.xml
ADDED
|
@@ -0,0 +1,185 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">793C267C-7319-405C-B81E-C2672D7FFC7F</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819597">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819613">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819607">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819648">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-24904</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">606</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819611">WHITE</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5495</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">EJ</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5495</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">962dd3d5-8501-4658-8cb9-2424b476124c</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819618">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819672">YES</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819673">NO</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">68</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819616">2009</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819655">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819612">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819518">29</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819517">3</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819519">2012</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819598">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1819599" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1819600"/>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819605">Bilateral</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819606">Middle</prad:tumor_level>
|
| 55 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819606">Base</prad:tumor_level>
|
| 56 |
+
</prad:tumor_levels>
|
| 57 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819617">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 58 |
+
<prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">26</prad:days_to_bone_scan_performed>
|
| 59 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819626">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
|
| 60 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819627">NO</prad:diagnostic_ct_abd_pelvis_performed>
|
| 61 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Not Available" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000"/>
|
| 62 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 63 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1819631"/>
|
| 64 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 65 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819632">NO</prad:diagnostic_mri_performed>
|
| 66 |
+
<prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
|
| 67 |
+
<prad:diagnostic_mri_results>
|
| 68 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1819636"/>
|
| 69 |
+
</prad:diagnostic_mri_results>
|
| 70 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819643">YES</prad:lymphnodes_examined>
|
| 71 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819645">18</prad:number_of_lymphnodes_examined>
|
| 72 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819646">1</prad:number_of_lymphnodes_positive_by_he>
|
| 73 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819647">R0</clin_shared:residual_tumor>
|
| 74 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1819656"/>
|
| 75 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1819657"/>
|
| 76 |
+
<shared_stage:stage_event system="AJCC">
|
| 77 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 78 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 80 |
+
<shared_stage:tnm_categories>
|
| 81 |
+
<shared_stage:clinical_categories>
|
| 82 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819619">T1c</shared_stage:clinical_T>
|
| 83 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 84 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819637">M0</shared_stage:clinical_M>
|
| 85 |
+
</shared_stage:clinical_categories>
|
| 86 |
+
<shared_stage:pathologic_categories>
|
| 87 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819641">T3b</shared_stage:pathologic_T>
|
| 88 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819644">N1</shared_stage:pathologic_N>
|
| 89 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 90 |
+
</shared_stage:pathologic_categories>
|
| 91 |
+
</shared_stage:tnm_categories>
|
| 92 |
+
<shared_stage:psa>
|
| 93 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819667">0.13</shared_stage:psa_value>
|
| 94 |
+
<shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">606</shared_stage:days_to_psa>
|
| 95 |
+
</shared_stage:psa>
|
| 96 |
+
<shared_stage:gleason_grading>
|
| 97 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819603">8</shared_stage:gleason_score>
|
| 98 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819601">5</shared_stage:primary_pattern>
|
| 99 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819602">3</shared_stage:secondary_pattern>
|
| 100 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819604">4</shared_stage:tertiary_pattern>
|
| 101 |
+
</shared_stage:gleason_grading>
|
| 102 |
+
<shared_stage:ann_arbor>
|
| 103 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 104 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 105 |
+
</shared_stage:ann_arbor>
|
| 106 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 107 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 109 |
+
</shared_stage:stage_event>
|
| 110 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 111 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 112 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 113 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819668">NO</prad:biochemical_recurrence>
|
| 114 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 115 |
+
<prad_nte:new_tumor_events>
|
| 116 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 117 |
+
</prad_nte:new_tumor_events>
|
| 118 |
+
<rx:drugs/>
|
| 119 |
+
<rad:radiations/>
|
| 120 |
+
<prad:follow_ups>
|
| 121 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 122 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5495-F46197</clin_shared:bcr_followup_barcode>
|
| 123 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">BDDE4025-238B-40A9-BCBC-9892909359FA</clin_shared:bcr_followup_uuid>
|
| 124 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757121">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 125 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757122">NO</clin_shared:lost_follow_up>
|
| 126 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757123">NO</clin_shared:radiation_therapy>
|
| 127 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757124">NO</clin_shared:postoperative_rx_tx>
|
| 128 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757126">Alive</clin_shared:vital_status>
|
| 129 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757125">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 130 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1007</clin_shared:days_to_last_followup>
|
| 131 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 132 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757135">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 133 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757136"/>
|
| 134 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757137"/>
|
| 135 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757162">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 136 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757138">NO</nte:new_tumor_event_after_initial_treatment>
|
| 137 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 138 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757139"/>
|
| 139 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757148"/>
|
| 140 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757149"/>
|
| 141 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757160"/>
|
| 142 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757161"/>
|
| 143 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 144 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 145 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 146 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757150"/>
|
| 147 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757151"/>
|
| 148 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:day_of_form_completion>
|
| 149 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8</clin_shared:month_of_form_completion>
|
| 150 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
|
| 151 |
+
</follow_up_v1.0:follow_up>
|
| 152 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="2">
|
| 153 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5495-F71913</clin_shared:bcr_followup_barcode>
|
| 154 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">645F9163-A5B3-40E9-8594-437AB1E4A245</clin_shared:bcr_followup_uuid>
|
| 155 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142112">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 156 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142113">NO</clin_shared:lost_follow_up>
|
| 157 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142114">NO</clin_shared:radiation_therapy>
|
| 158 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142115">NO</clin_shared:postoperative_rx_tx>
|
| 159 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142117">Alive</clin_shared:vital_status>
|
| 160 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142116">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 161 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1760</clin_shared:days_to_last_followup>
|
| 162 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 163 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142126">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 164 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142127"/>
|
| 165 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142128"/>
|
| 166 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142159">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 167 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142129">NO</nte:new_tumor_event_after_initial_treatment>
|
| 168 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 169 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142130"/>
|
| 170 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142139"/>
|
| 171 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142140"/>
|
| 172 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142157"/>
|
| 173 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142158"/>
|
| 174 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 175 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 176 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 177 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142141"/>
|
| 178 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142142"/>
|
| 179 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">31</clin_shared:day_of_form_completion>
|
| 180 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
|
| 181 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2015</clin_shared:year_of_form_completion>
|
| 182 |
+
</follow_up_v1.0:follow_up>
|
| 183 |
+
</prad:follow_ups>
|
| 184 |
+
</prad:patient>
|
| 185 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5496.xml
ADDED
|
@@ -0,0 +1,186 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">AC08AF68-E22C-4DE9-8DAA-A717D1DE4DD4</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820768">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820784">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820778">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820819">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-21897</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">595</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820782">WHITE</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5496</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">EJ</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5496</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">6755c231-355f-4cc3-85f1-6306c7f5d44b</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820789">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820855">YES</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820856">NO</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">59</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820787">2009</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820826">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820783">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820700">30</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820699">3</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820701">2012</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820769">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1820770" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820771">Overlapping / Multiple Zones</prad:zone_of_origin>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820776">Bilateral</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820777">Apex</prad:tumor_level>
|
| 55 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820777">Middle</prad:tumor_level>
|
| 56 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820777">Base</prad:tumor_level>
|
| 57 |
+
</prad:tumor_levels>
|
| 58 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820788">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 59 |
+
<prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">15</prad:days_to_bone_scan_performed>
|
| 60 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820797">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
|
| 61 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820798">YES</prad:diagnostic_ct_abd_pelvis_performed>
|
| 62 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">15</prad:days_to_diagnostic_computed_tomography_performed>
|
| 63 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 64 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820802">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
|
| 65 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 66 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820803">NO</prad:diagnostic_mri_performed>
|
| 67 |
+
<prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
|
| 68 |
+
<prad:diagnostic_mri_results>
|
| 69 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1820807"/>
|
| 70 |
+
</prad:diagnostic_mri_results>
|
| 71 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820814">YES</prad:lymphnodes_examined>
|
| 72 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820816">26</prad:number_of_lymphnodes_examined>
|
| 73 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820817">0</prad:number_of_lymphnodes_positive_by_he>
|
| 74 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820818">R0</clin_shared:residual_tumor>
|
| 75 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1820827"/>
|
| 76 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1820828"/>
|
| 77 |
+
<shared_stage:stage_event system="AJCC">
|
| 78 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 80 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 81 |
+
<shared_stage:tnm_categories>
|
| 82 |
+
<shared_stage:clinical_categories>
|
| 83 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820790">T1c</shared_stage:clinical_T>
|
| 84 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 85 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820808">M0</shared_stage:clinical_M>
|
| 86 |
+
</shared_stage:clinical_categories>
|
| 87 |
+
<shared_stage:pathologic_categories>
|
| 88 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820810">T2c</shared_stage:pathologic_T>
|
| 89 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820815">N0</shared_stage:pathologic_N>
|
| 90 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 91 |
+
</shared_stage:pathologic_categories>
|
| 92 |
+
</shared_stage:tnm_categories>
|
| 93 |
+
<shared_stage:psa>
|
| 94 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820850">0.1</shared_stage:psa_value>
|
| 95 |
+
<shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">595</shared_stage:days_to_psa>
|
| 96 |
+
</shared_stage:psa>
|
| 97 |
+
<shared_stage:gleason_grading>
|
| 98 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820774">7</shared_stage:gleason_score>
|
| 99 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820772">3</shared_stage:primary_pattern>
|
| 100 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820773">4</shared_stage:secondary_pattern>
|
| 101 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820775">4</shared_stage:tertiary_pattern>
|
| 102 |
+
</shared_stage:gleason_grading>
|
| 103 |
+
<shared_stage:ann_arbor>
|
| 104 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 105 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 106 |
+
</shared_stage:ann_arbor>
|
| 107 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 109 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 110 |
+
</shared_stage:stage_event>
|
| 111 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 112 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 113 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 114 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820851">NO</prad:biochemical_recurrence>
|
| 115 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 116 |
+
<prad_nte:new_tumor_events>
|
| 117 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 118 |
+
</prad_nte:new_tumor_events>
|
| 119 |
+
<rx:drugs/>
|
| 120 |
+
<rad:radiations/>
|
| 121 |
+
<prad:follow_ups>
|
| 122 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 123 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5496-F46198</clin_shared:bcr_followup_barcode>
|
| 124 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">C458C599-0391-4932-85C6-D1709F8306A6</clin_shared:bcr_followup_uuid>
|
| 125 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757166">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 126 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757167">NO</clin_shared:lost_follow_up>
|
| 127 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757168">NO</clin_shared:radiation_therapy>
|
| 128 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757169">NO</clin_shared:postoperative_rx_tx>
|
| 129 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757171">Alive</clin_shared:vital_status>
|
| 130 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757170">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 131 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">595</clin_shared:days_to_last_followup>
|
| 132 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 133 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757180">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 134 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757181"/>
|
| 135 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757182"/>
|
| 136 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757207">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 137 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757183">NO</nte:new_tumor_event_after_initial_treatment>
|
| 138 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 139 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757184"/>
|
| 140 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757193"/>
|
| 141 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757194"/>
|
| 142 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757205"/>
|
| 143 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757206"/>
|
| 144 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 145 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 146 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 147 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757195"/>
|
| 148 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757196"/>
|
| 149 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:day_of_form_completion>
|
| 150 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8</clin_shared:month_of_form_completion>
|
| 151 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
|
| 152 |
+
</follow_up_v1.0:follow_up>
|
| 153 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="2">
|
| 154 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5496-F60309</clin_shared:bcr_followup_barcode>
|
| 155 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">11FC2DD4-B17C-44B5-9CC6-3BDE16AD446E</clin_shared:bcr_followup_uuid>
|
| 156 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3634322">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 157 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3634323">YES</clin_shared:lost_follow_up>
|
| 158 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634324"/>
|
| 159 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634325"/>
|
| 160 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634327"/>
|
| 161 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634326"/>
|
| 162 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">595</clin_shared:days_to_last_followup>
|
| 163 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 164 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3634336">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 165 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634337"/>
|
| 166 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634338"/>
|
| 167 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3634363">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 168 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="3634339"/>
|
| 169 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 170 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634340"/>
|
| 171 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634349"/>
|
| 172 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634350"/>
|
| 173 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634361"/>
|
| 174 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634362"/>
|
| 175 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 176 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 177 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 178 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634351"/>
|
| 179 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634352"/>
|
| 180 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">5</clin_shared:day_of_form_completion>
|
| 181 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">6</clin_shared:month_of_form_completion>
|
| 182 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
|
| 183 |
+
</follow_up_v1.0:follow_up>
|
| 184 |
+
</prad:follow_ups>
|
| 185 |
+
</prad:patient>
|
| 186 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5497.xml
ADDED
|
@@ -0,0 +1,184 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">F525BF7C-A40B-4ECE-9F9F-9E64B34BFDDC</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821302">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821318">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821312">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821353">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="month" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-17523</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">405</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821316">WHITE</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5497</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">EJ</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5497</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">dee02265-d8dd-4379-ae08-72d72b03a570</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821323">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821559">YES</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821560">NO</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">47</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821321">2009</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821360">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821317">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821152">30</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821151">3</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821153">2012</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821303">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1821304" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821305">Overlapping / Multiple Zones</prad:zone_of_origin>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821310">Bilateral</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821311">Middle</prad:tumor_level>
|
| 55 |
+
</prad:tumor_levels>
|
| 56 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821322">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 57 |
+
<prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Not Available" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000"/>
|
| 58 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1821331"/>
|
| 59 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821332">NO</prad:diagnostic_ct_abd_pelvis_performed>
|
| 60 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Not Available" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000"/>
|
| 61 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 62 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1821336"/>
|
| 63 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 64 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821337">NO</prad:diagnostic_mri_performed>
|
| 65 |
+
<prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
|
| 66 |
+
<prad:diagnostic_mri_results>
|
| 67 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1821341"/>
|
| 68 |
+
</prad:diagnostic_mri_results>
|
| 69 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821348">YES</prad:lymphnodes_examined>
|
| 70 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821350">10</prad:number_of_lymphnodes_examined>
|
| 71 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821351">0</prad:number_of_lymphnodes_positive_by_he>
|
| 72 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821352">R0</clin_shared:residual_tumor>
|
| 73 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1821361"/>
|
| 74 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1821362"/>
|
| 75 |
+
<shared_stage:stage_event system="AJCC">
|
| 76 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 77 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 78 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:tnm_categories>
|
| 80 |
+
<shared_stage:clinical_categories>
|
| 81 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821325">T2c</shared_stage:clinical_T>
|
| 82 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 83 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821342">M0</shared_stage:clinical_M>
|
| 84 |
+
</shared_stage:clinical_categories>
|
| 85 |
+
<shared_stage:pathologic_categories>
|
| 86 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821344">T2c</shared_stage:pathologic_T>
|
| 87 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821349">N0</shared_stage:pathologic_N>
|
| 88 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 89 |
+
</shared_stage:pathologic_categories>
|
| 90 |
+
</shared_stage:tnm_categories>
|
| 91 |
+
<shared_stage:psa>
|
| 92 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821554">0.1</shared_stage:psa_value>
|
| 93 |
+
<shared_stage:days_to_psa precision="month" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">204</shared_stage:days_to_psa>
|
| 94 |
+
</shared_stage:psa>
|
| 95 |
+
<shared_stage:gleason_grading>
|
| 96 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821308">7</shared_stage:gleason_score>
|
| 97 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821306">3</shared_stage:primary_pattern>
|
| 98 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821307">4</shared_stage:secondary_pattern>
|
| 99 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821309">3</shared_stage:tertiary_pattern>
|
| 100 |
+
</shared_stage:gleason_grading>
|
| 101 |
+
<shared_stage:ann_arbor>
|
| 102 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 103 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 104 |
+
</shared_stage:ann_arbor>
|
| 105 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 106 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 107 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
</shared_stage:stage_event>
|
| 109 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 110 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 111 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 112 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821555">NO</prad:biochemical_recurrence>
|
| 113 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 114 |
+
<prad_nte:new_tumor_events>
|
| 115 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 116 |
+
</prad_nte:new_tumor_events>
|
| 117 |
+
<rx:drugs/>
|
| 118 |
+
<rad:radiations/>
|
| 119 |
+
<prad:follow_ups>
|
| 120 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 121 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5497-F46199</clin_shared:bcr_followup_barcode>
|
| 122 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">680F390D-3704-4B35-98D4-FF11E3FD0BD0</clin_shared:bcr_followup_uuid>
|
| 123 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757211">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 124 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757212">NO</clin_shared:lost_follow_up>
|
| 125 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757213">NO</clin_shared:radiation_therapy>
|
| 126 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757214">NO</clin_shared:postoperative_rx_tx>
|
| 127 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757216">Alive</clin_shared:vital_status>
|
| 128 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757215">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 129 |
+
<clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">405</clin_shared:days_to_last_followup>
|
| 130 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 131 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757225">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 132 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757226"/>
|
| 133 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757227"/>
|
| 134 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757252">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 135 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757228">NO</nte:new_tumor_event_after_initial_treatment>
|
| 136 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 137 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757229"/>
|
| 138 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757238"/>
|
| 139 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757239"/>
|
| 140 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757250"/>
|
| 141 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757251"/>
|
| 142 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 143 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 144 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 145 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757240"/>
|
| 146 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757241"/>
|
| 147 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:day_of_form_completion>
|
| 148 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8</clin_shared:month_of_form_completion>
|
| 149 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
|
| 150 |
+
</follow_up_v1.0:follow_up>
|
| 151 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="2">
|
| 152 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5497-F60311</clin_shared:bcr_followup_barcode>
|
| 153 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">58F1853F-A9FD-4CF7-830D-096A80579A7E</clin_shared:bcr_followup_uuid>
|
| 154 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3634462">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 155 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3634463">YES</clin_shared:lost_follow_up>
|
| 156 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634464"/>
|
| 157 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634465"/>
|
| 158 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634467"/>
|
| 159 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634466"/>
|
| 160 |
+
<clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">405</clin_shared:days_to_last_followup>
|
| 161 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 162 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3634476">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 163 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634477"/>
|
| 164 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634478"/>
|
| 165 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3634503">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 166 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="3634479"/>
|
| 167 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 168 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634480"/>
|
| 169 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634489"/>
|
| 170 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634490"/>
|
| 171 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634501"/>
|
| 172 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634502"/>
|
| 173 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 174 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 175 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 176 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634491"/>
|
| 177 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634492"/>
|
| 178 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">5</clin_shared:day_of_form_completion>
|
| 179 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">6</clin_shared:month_of_form_completion>
|
| 180 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
|
| 181 |
+
</follow_up_v1.0:follow_up>
|
| 182 |
+
</prad:follow_ups>
|
| 183 |
+
</prad:patient>
|
| 184 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5498.xml
ADDED
|
@@ -0,0 +1,184 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">A9918CDB-80EA-4025-84C4-0018666236C4</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821764">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821780">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821774">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821815">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-20472</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">537</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821778">WHITE</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5498</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">EJ</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5498</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">79ec7468-9aaf-4bb0-94c7-72be4f497868</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821785">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821833">YES</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821834">NO</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">56</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821783">2010</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821822">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821779">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821762">30</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821761">3</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821763">2012</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821765">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1821766" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821767">Overlapping / Multiple Zones</prad:zone_of_origin>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821772">Bilateral</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821773">Middle</prad:tumor_level>
|
| 55 |
+
</prad:tumor_levels>
|
| 56 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821784">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 57 |
+
<prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">12</prad:days_to_bone_scan_performed>
|
| 58 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821793">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
|
| 59 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821794">YES</prad:diagnostic_ct_abd_pelvis_performed>
|
| 60 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">12</prad:days_to_diagnostic_computed_tomography_performed>
|
| 61 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 62 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821798">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
|
| 63 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 64 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821799">NO</prad:diagnostic_mri_performed>
|
| 65 |
+
<prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
|
| 66 |
+
<prad:diagnostic_mri_results>
|
| 67 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1821803"/>
|
| 68 |
+
</prad:diagnostic_mri_results>
|
| 69 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821810">YES</prad:lymphnodes_examined>
|
| 70 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821812">26</prad:number_of_lymphnodes_examined>
|
| 71 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821813">0</prad:number_of_lymphnodes_positive_by_he>
|
| 72 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821814">R0</clin_shared:residual_tumor>
|
| 73 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1821823"/>
|
| 74 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1821824"/>
|
| 75 |
+
<shared_stage:stage_event system="AJCC">
|
| 76 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 77 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 78 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:tnm_categories>
|
| 80 |
+
<shared_stage:clinical_categories>
|
| 81 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821787">T2c</shared_stage:clinical_T>
|
| 82 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 83 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1821804"/>
|
| 84 |
+
</shared_stage:clinical_categories>
|
| 85 |
+
<shared_stage:pathologic_categories>
|
| 86 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821806">T2c</shared_stage:pathologic_T>
|
| 87 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821811">N0</shared_stage:pathologic_N>
|
| 88 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 89 |
+
</shared_stage:pathologic_categories>
|
| 90 |
+
</shared_stage:tnm_categories>
|
| 91 |
+
<shared_stage:psa>
|
| 92 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821828">0.1</shared_stage:psa_value>
|
| 93 |
+
<shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">537</shared_stage:days_to_psa>
|
| 94 |
+
</shared_stage:psa>
|
| 95 |
+
<shared_stage:gleason_grading>
|
| 96 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821770">7</shared_stage:gleason_score>
|
| 97 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821768">4</shared_stage:primary_pattern>
|
| 98 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821769">3</shared_stage:secondary_pattern>
|
| 99 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821771">3</shared_stage:tertiary_pattern>
|
| 100 |
+
</shared_stage:gleason_grading>
|
| 101 |
+
<shared_stage:ann_arbor>
|
| 102 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 103 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 104 |
+
</shared_stage:ann_arbor>
|
| 105 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 106 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 107 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
</shared_stage:stage_event>
|
| 109 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 110 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 111 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 112 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821829">NO</prad:biochemical_recurrence>
|
| 113 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 114 |
+
<prad_nte:new_tumor_events>
|
| 115 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 116 |
+
</prad_nte:new_tumor_events>
|
| 117 |
+
<rx:drugs/>
|
| 118 |
+
<rad:radiations/>
|
| 119 |
+
<prad:follow_ups>
|
| 120 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 121 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5498-F46200</clin_shared:bcr_followup_barcode>
|
| 122 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">C0E97F6E-6B21-4761-887A-06D59D419638</clin_shared:bcr_followup_uuid>
|
| 123 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757256">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 124 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757257">NO</clin_shared:lost_follow_up>
|
| 125 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757258">NO</clin_shared:radiation_therapy>
|
| 126 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757259">NO</clin_shared:postoperative_rx_tx>
|
| 127 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757261">Alive</clin_shared:vital_status>
|
| 128 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757260">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 129 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">906</clin_shared:days_to_last_followup>
|
| 130 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 131 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757270">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 132 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757271"/>
|
| 133 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757272"/>
|
| 134 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757297">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 135 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757273">NO</nte:new_tumor_event_after_initial_treatment>
|
| 136 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 137 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757274"/>
|
| 138 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757283"/>
|
| 139 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757284"/>
|
| 140 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757295"/>
|
| 141 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757296"/>
|
| 142 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 143 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 144 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 145 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757285"/>
|
| 146 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757286"/>
|
| 147 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:day_of_form_completion>
|
| 148 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8</clin_shared:month_of_form_completion>
|
| 149 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
|
| 150 |
+
</follow_up_v1.0:follow_up>
|
| 151 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="2">
|
| 152 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5498-F71919</clin_shared:bcr_followup_barcode>
|
| 153 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">40E1D852-8D43-4FB2-9FFB-21E2D103D19D</clin_shared:bcr_followup_uuid>
|
| 154 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142259">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 155 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142260">NO</clin_shared:lost_follow_up>
|
| 156 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142261">NO</clin_shared:radiation_therapy>
|
| 157 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142262">NO</clin_shared:postoperative_rx_tx>
|
| 158 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142264">Alive</clin_shared:vital_status>
|
| 159 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142263">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 160 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1720</clin_shared:days_to_last_followup>
|
| 161 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 162 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142273">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 163 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142274"/>
|
| 164 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142275"/>
|
| 165 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142300">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 166 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142276">NO</nte:new_tumor_event_after_initial_treatment>
|
| 167 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 168 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142277"/>
|
| 169 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142286"/>
|
| 170 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142287"/>
|
| 171 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142298"/>
|
| 172 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142299"/>
|
| 173 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 174 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 175 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 176 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142288"/>
|
| 177 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142289"/>
|
| 178 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">31</clin_shared:day_of_form_completion>
|
| 179 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
|
| 180 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2015</clin_shared:year_of_form_completion>
|
| 181 |
+
</follow_up_v1.0:follow_up>
|
| 182 |
+
</prad:follow_ups>
|
| 183 |
+
</prad:patient>
|
| 184 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5499.xml
ADDED
|
@@ -0,0 +1,186 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">56753EEA-2AA1-4742-A299-49E315BC3584</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822029">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822045">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822039">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822080">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-22286</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">533</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822043">ASIAN</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5499</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">EJ</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5499</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">fd1aa612-df86-4d48-892d-2acebd76ea96</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822050">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822098">YES</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822099">NO</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">61</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822048">2010</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822087">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822044">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822027">30</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822026">3</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822028">2012</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822030">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1822031" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822032">Overlapping / Multiple Zones</prad:zone_of_origin>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822037">Bilateral</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822038">Apex</prad:tumor_level>
|
| 55 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822038">Middle</prad:tumor_level>
|
| 56 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822038">Base</prad:tumor_level>
|
| 57 |
+
</prad:tumor_levels>
|
| 58 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822049">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 59 |
+
<prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Not Available" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000"/>
|
| 60 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1822058"/>
|
| 61 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1822059"/>
|
| 62 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Not Available" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000"/>
|
| 63 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 64 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1822063"/>
|
| 65 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 66 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1822064"/>
|
| 67 |
+
<prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
|
| 68 |
+
<prad:diagnostic_mri_results>
|
| 69 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1822068"/>
|
| 70 |
+
</prad:diagnostic_mri_results>
|
| 71 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822075">YES</prad:lymphnodes_examined>
|
| 72 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822077">19</prad:number_of_lymphnodes_examined>
|
| 73 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822078">0</prad:number_of_lymphnodes_positive_by_he>
|
| 74 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822079">R0</clin_shared:residual_tumor>
|
| 75 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1822088"/>
|
| 76 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1822089"/>
|
| 77 |
+
<shared_stage:stage_event system="AJCC">
|
| 78 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 80 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 81 |
+
<shared_stage:tnm_categories>
|
| 82 |
+
<shared_stage:clinical_categories>
|
| 83 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822052">T2b</shared_stage:clinical_T>
|
| 84 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 85 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822069">M0</shared_stage:clinical_M>
|
| 86 |
+
</shared_stage:clinical_categories>
|
| 87 |
+
<shared_stage:pathologic_categories>
|
| 88 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822073">T3a</shared_stage:pathologic_T>
|
| 89 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822076">N0</shared_stage:pathologic_N>
|
| 90 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 91 |
+
</shared_stage:pathologic_categories>
|
| 92 |
+
</shared_stage:tnm_categories>
|
| 93 |
+
<shared_stage:psa>
|
| 94 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822093">0.1</shared_stage:psa_value>
|
| 95 |
+
<shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">533</shared_stage:days_to_psa>
|
| 96 |
+
</shared_stage:psa>
|
| 97 |
+
<shared_stage:gleason_grading>
|
| 98 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822035">7</shared_stage:gleason_score>
|
| 99 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822033">4</shared_stage:primary_pattern>
|
| 100 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822034">3</shared_stage:secondary_pattern>
|
| 101 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822036">3</shared_stage:tertiary_pattern>
|
| 102 |
+
</shared_stage:gleason_grading>
|
| 103 |
+
<shared_stage:ann_arbor>
|
| 104 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 105 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 106 |
+
</shared_stage:ann_arbor>
|
| 107 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 109 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 110 |
+
</shared_stage:stage_event>
|
| 111 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 112 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 113 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 114 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822094">NO</prad:biochemical_recurrence>
|
| 115 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 116 |
+
<prad_nte:new_tumor_events>
|
| 117 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 118 |
+
</prad_nte:new_tumor_events>
|
| 119 |
+
<rx:drugs/>
|
| 120 |
+
<rad:radiations/>
|
| 121 |
+
<prad:follow_ups>
|
| 122 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 123 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5499-F46201</clin_shared:bcr_followup_barcode>
|
| 124 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">5687A1AE-AD09-447E-88EA-1F13ADA4A0FB</clin_shared:bcr_followup_uuid>
|
| 125 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757301">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 126 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757302">NO</clin_shared:lost_follow_up>
|
| 127 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757303">NO</clin_shared:radiation_therapy>
|
| 128 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757304">NO</clin_shared:postoperative_rx_tx>
|
| 129 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757306">Alive</clin_shared:vital_status>
|
| 130 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757305">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 131 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">533</clin_shared:days_to_last_followup>
|
| 132 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 133 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757315">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 134 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757316"/>
|
| 135 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757317"/>
|
| 136 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757342">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 137 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757318">NO</nte:new_tumor_event_after_initial_treatment>
|
| 138 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 139 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757319"/>
|
| 140 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757328"/>
|
| 141 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757329"/>
|
| 142 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757340"/>
|
| 143 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757341"/>
|
| 144 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 145 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 146 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 147 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757330"/>
|
| 148 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757331"/>
|
| 149 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:day_of_form_completion>
|
| 150 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8</clin_shared:month_of_form_completion>
|
| 151 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
|
| 152 |
+
</follow_up_v1.0:follow_up>
|
| 153 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="2">
|
| 154 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5499-F60312</clin_shared:bcr_followup_barcode>
|
| 155 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">C4FC4D67-0767-43BC-A337-060C8263FCB7</clin_shared:bcr_followup_uuid>
|
| 156 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3634517">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 157 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3634518">NO</clin_shared:lost_follow_up>
|
| 158 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3634519">NO</clin_shared:radiation_therapy>
|
| 159 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3634520">NO</clin_shared:postoperative_rx_tx>
|
| 160 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3634522">Alive</clin_shared:vital_status>
|
| 161 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3634521">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 162 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1415</clin_shared:days_to_last_followup>
|
| 163 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 164 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3634531">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 165 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634532"/>
|
| 166 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634533"/>
|
| 167 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3634558">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 168 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3634534">NO</nte:new_tumor_event_after_initial_treatment>
|
| 169 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 170 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634535"/>
|
| 171 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634544"/>
|
| 172 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634545"/>
|
| 173 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634556"/>
|
| 174 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634557"/>
|
| 175 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 176 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 177 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 178 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634546"/>
|
| 179 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634547"/>
|
| 180 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">5</clin_shared:day_of_form_completion>
|
| 181 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">6</clin_shared:month_of_form_completion>
|
| 182 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
|
| 183 |
+
</follow_up_v1.0:follow_up>
|
| 184 |
+
</prad:follow_ups>
|
| 185 |
+
</prad:patient>
|
| 186 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5501.xml
ADDED
|
@@ -0,0 +1,185 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">82E8C87D-5FE1-44E9-8B0B-016BB9946DED</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822210">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822226">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822220">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822261">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-20409</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">729</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822224">WHITE</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5501</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">EJ</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5501</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">8df0c1e8-966c-4f46-ad15-fae9e745a32e</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822231">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822279">YES</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822280">NO</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">55</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822229">2010</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822268">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822225">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822182">30</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822181">3</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822183">2012</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822211">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1822212" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822213">Overlapping / Multiple Zones</prad:zone_of_origin>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822218">Bilateral</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822219">Middle</prad:tumor_level>
|
| 55 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822219">Base</prad:tumor_level>
|
| 56 |
+
</prad:tumor_levels>
|
| 57 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822230">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 58 |
+
<prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">9</prad:days_to_bone_scan_performed>
|
| 59 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822239">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
|
| 60 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822240">YES</prad:diagnostic_ct_abd_pelvis_performed>
|
| 61 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">9</prad:days_to_diagnostic_computed_tomography_performed>
|
| 62 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 63 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822244">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
|
| 64 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 65 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822245">NO</prad:diagnostic_mri_performed>
|
| 66 |
+
<prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
|
| 67 |
+
<prad:diagnostic_mri_results>
|
| 68 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1822249"/>
|
| 69 |
+
</prad:diagnostic_mri_results>
|
| 70 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822256">YES</prad:lymphnodes_examined>
|
| 71 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822258">11</prad:number_of_lymphnodes_examined>
|
| 72 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822259">0</prad:number_of_lymphnodes_positive_by_he>
|
| 73 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822260">R0</clin_shared:residual_tumor>
|
| 74 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1822269"/>
|
| 75 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1822270"/>
|
| 76 |
+
<shared_stage:stage_event system="AJCC">
|
| 77 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 78 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 80 |
+
<shared_stage:tnm_categories>
|
| 81 |
+
<shared_stage:clinical_categories>
|
| 82 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822233">T2b</shared_stage:clinical_T>
|
| 83 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 84 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822250">M0</shared_stage:clinical_M>
|
| 85 |
+
</shared_stage:clinical_categories>
|
| 86 |
+
<shared_stage:pathologic_categories>
|
| 87 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822254">T3b</shared_stage:pathologic_T>
|
| 88 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822257">N0</shared_stage:pathologic_N>
|
| 89 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 90 |
+
</shared_stage:pathologic_categories>
|
| 91 |
+
</shared_stage:tnm_categories>
|
| 92 |
+
<shared_stage:psa>
|
| 93 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822274">0.1</shared_stage:psa_value>
|
| 94 |
+
<shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">729</shared_stage:days_to_psa>
|
| 95 |
+
</shared_stage:psa>
|
| 96 |
+
<shared_stage:gleason_grading>
|
| 97 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822216">7</shared_stage:gleason_score>
|
| 98 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822214">4</shared_stage:primary_pattern>
|
| 99 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822215">3</shared_stage:secondary_pattern>
|
| 100 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822217">5</shared_stage:tertiary_pattern>
|
| 101 |
+
</shared_stage:gleason_grading>
|
| 102 |
+
<shared_stage:ann_arbor>
|
| 103 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 104 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 105 |
+
</shared_stage:ann_arbor>
|
| 106 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 107 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 109 |
+
</shared_stage:stage_event>
|
| 110 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 111 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 112 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 113 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822275">NO</prad:biochemical_recurrence>
|
| 114 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 115 |
+
<prad_nte:new_tumor_events>
|
| 116 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 117 |
+
</prad_nte:new_tumor_events>
|
| 118 |
+
<rx:drugs/>
|
| 119 |
+
<rad:radiations/>
|
| 120 |
+
<prad:follow_ups>
|
| 121 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 122 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5501-F46202</clin_shared:bcr_followup_barcode>
|
| 123 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">888320E4-BDAE-4601-8105-9B8669942A38</clin_shared:bcr_followup_uuid>
|
| 124 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757346">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 125 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757347">NO</clin_shared:lost_follow_up>
|
| 126 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757348">NO</clin_shared:radiation_therapy>
|
| 127 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757349">NO</clin_shared:postoperative_rx_tx>
|
| 128 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757351">Alive</clin_shared:vital_status>
|
| 129 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757350">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 130 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">937</clin_shared:days_to_last_followup>
|
| 131 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 132 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757360">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 133 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757361"/>
|
| 134 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757362"/>
|
| 135 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757387">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 136 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757363">NO</nte:new_tumor_event_after_initial_treatment>
|
| 137 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 138 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757364"/>
|
| 139 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757373"/>
|
| 140 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757374"/>
|
| 141 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757385"/>
|
| 142 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757386"/>
|
| 143 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 144 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 145 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 146 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757375"/>
|
| 147 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757376"/>
|
| 148 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:day_of_form_completion>
|
| 149 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8</clin_shared:month_of_form_completion>
|
| 150 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
|
| 151 |
+
</follow_up_v1.0:follow_up>
|
| 152 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="2">
|
| 153 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5501-F60313</clin_shared:bcr_followup_barcode>
|
| 154 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">32D86851-E857-4DF2-AAEF-2489FAA38F43</clin_shared:bcr_followup_uuid>
|
| 155 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3634604">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 156 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3634605">NO</clin_shared:lost_follow_up>
|
| 157 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634606"/>
|
| 158 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634607"/>
|
| 159 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3634609">Alive</clin_shared:vital_status>
|
| 160 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634608"/>
|
| 161 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1365</clin_shared:days_to_last_followup>
|
| 162 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 163 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3634618">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 164 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634619"/>
|
| 165 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634620"/>
|
| 166 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3634645">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 167 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3634621">NO</nte:new_tumor_event_after_initial_treatment>
|
| 168 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 169 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634622"/>
|
| 170 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634631"/>
|
| 171 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634632"/>
|
| 172 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634643"/>
|
| 173 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634644"/>
|
| 174 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 175 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 176 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 177 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634633"/>
|
| 178 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634634"/>
|
| 179 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">5</clin_shared:day_of_form_completion>
|
| 180 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">6</clin_shared:month_of_form_completion>
|
| 181 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
|
| 182 |
+
</follow_up_v1.0:follow_up>
|
| 183 |
+
</prad:follow_ups>
|
| 184 |
+
</prad:patient>
|
| 185 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5502.xml
ADDED
|
@@ -0,0 +1,185 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">28CB850D-2299-4372-8FF0-636A0E247570</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822722">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822738">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822732">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822773">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-18447</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">245</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1822736"/>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5502</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">EJ</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5502</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">48e83a4c-c602-494a-80cd-e2f4b4dd701e</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822743">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822791">YES</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822792">NO</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">50</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822741">2010</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822780">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1822737"/>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822720">30</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822719">3</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822721">2012</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822723">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1822724" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822725">Overlapping / Multiple Zones</prad:zone_of_origin>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822730">Bilateral</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822731">Middle</prad:tumor_level>
|
| 55 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822731">Base</prad:tumor_level>
|
| 56 |
+
</prad:tumor_levels>
|
| 57 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822742">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 58 |
+
<prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">7</prad:days_to_bone_scan_performed>
|
| 59 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822751">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
|
| 60 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822752">YES</prad:diagnostic_ct_abd_pelvis_performed>
|
| 61 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">7</prad:days_to_diagnostic_computed_tomography_performed>
|
| 62 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 63 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822756">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
|
| 64 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 65 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822757">NO</prad:diagnostic_mri_performed>
|
| 66 |
+
<prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
|
| 67 |
+
<prad:diagnostic_mri_results>
|
| 68 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1822761"/>
|
| 69 |
+
</prad:diagnostic_mri_results>
|
| 70 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822768">YES</prad:lymphnodes_examined>
|
| 71 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822770">11</prad:number_of_lymphnodes_examined>
|
| 72 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822771">0</prad:number_of_lymphnodes_positive_by_he>
|
| 73 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822772">R0</clin_shared:residual_tumor>
|
| 74 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1822781"/>
|
| 75 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1822782"/>
|
| 76 |
+
<shared_stage:stage_event system="AJCC">
|
| 77 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 78 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 80 |
+
<shared_stage:tnm_categories>
|
| 81 |
+
<shared_stage:clinical_categories>
|
| 82 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822745">T2c</shared_stage:clinical_T>
|
| 83 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 84 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822762">M0</shared_stage:clinical_M>
|
| 85 |
+
</shared_stage:clinical_categories>
|
| 86 |
+
<shared_stage:pathologic_categories>
|
| 87 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822764">T2c</shared_stage:pathologic_T>
|
| 88 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822769">N0</shared_stage:pathologic_N>
|
| 89 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 90 |
+
</shared_stage:pathologic_categories>
|
| 91 |
+
</shared_stage:tnm_categories>
|
| 92 |
+
<shared_stage:psa>
|
| 93 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822786">0.1</shared_stage:psa_value>
|
| 94 |
+
<shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">603</shared_stage:days_to_psa>
|
| 95 |
+
</shared_stage:psa>
|
| 96 |
+
<shared_stage:gleason_grading>
|
| 97 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822728">7</shared_stage:gleason_score>
|
| 98 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822726">4</shared_stage:primary_pattern>
|
| 99 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822727">3</shared_stage:secondary_pattern>
|
| 100 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822729">3</shared_stage:tertiary_pattern>
|
| 101 |
+
</shared_stage:gleason_grading>
|
| 102 |
+
<shared_stage:ann_arbor>
|
| 103 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 104 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 105 |
+
</shared_stage:ann_arbor>
|
| 106 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 107 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 109 |
+
</shared_stage:stage_event>
|
| 110 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 111 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 112 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 113 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822787">NO</prad:biochemical_recurrence>
|
| 114 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 115 |
+
<prad_nte:new_tumor_events>
|
| 116 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 117 |
+
</prad_nte:new_tumor_events>
|
| 118 |
+
<rx:drugs/>
|
| 119 |
+
<rad:radiations/>
|
| 120 |
+
<prad:follow_ups>
|
| 121 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 122 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5502-F46203</clin_shared:bcr_followup_barcode>
|
| 123 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">FBF12F0D-ED5E-4A8B-8264-3A4563C2CA4E</clin_shared:bcr_followup_uuid>
|
| 124 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757391">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 125 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757392">NO</clin_shared:lost_follow_up>
|
| 126 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757393">NO</clin_shared:radiation_therapy>
|
| 127 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757394">NO</clin_shared:postoperative_rx_tx>
|
| 128 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757396">Alive</clin_shared:vital_status>
|
| 129 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757395">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 130 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">800</clin_shared:days_to_last_followup>
|
| 131 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 132 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757405">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 133 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757406"/>
|
| 134 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757407"/>
|
| 135 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757432">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 136 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757408">NO</nte:new_tumor_event_after_initial_treatment>
|
| 137 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 138 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757409"/>
|
| 139 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757418"/>
|
| 140 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757419"/>
|
| 141 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757430"/>
|
| 142 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757431"/>
|
| 143 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 144 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 145 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 146 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757420"/>
|
| 147 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757421"/>
|
| 148 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:day_of_form_completion>
|
| 149 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8</clin_shared:month_of_form_completion>
|
| 150 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
|
| 151 |
+
</follow_up_v1.0:follow_up>
|
| 152 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="2">
|
| 153 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5502-F71921</clin_shared:bcr_followup_barcode>
|
| 154 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">CB9EF708-2D68-4BBC-96E3-A92B637940EE</clin_shared:bcr_followup_uuid>
|
| 155 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142373">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 156 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142374">NO</clin_shared:lost_follow_up>
|
| 157 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142375">NO</clin_shared:radiation_therapy>
|
| 158 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142376">NO</clin_shared:postoperative_rx_tx>
|
| 159 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142382">Alive</clin_shared:vital_status>
|
| 160 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142377">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 161 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1171</clin_shared:days_to_last_followup>
|
| 162 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 163 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142391">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 164 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142392"/>
|
| 165 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142393"/>
|
| 166 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142418">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 167 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142394">NO</nte:new_tumor_event_after_initial_treatment>
|
| 168 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 169 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142395"/>
|
| 170 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142404"/>
|
| 171 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142405"/>
|
| 172 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142416"/>
|
| 173 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142417"/>
|
| 174 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 175 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 176 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 177 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142406"/>
|
| 178 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142407"/>
|
| 179 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">31</clin_shared:day_of_form_completion>
|
| 180 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
|
| 181 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2015</clin_shared:year_of_form_completion>
|
| 182 |
+
</follow_up_v1.0:follow_up>
|
| 183 |
+
</prad:follow_ups>
|
| 184 |
+
</prad:patient>
|
| 185 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5503.xml
ADDED
|
@@ -0,0 +1,185 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">B565F73C-B169-41A9-83BC-B6B56DC78127</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823257">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823273">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823267">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823308">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-18395</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">530</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823271">WHITE</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5503</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">EJ</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5503</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">aa252f78-ebf3-42f9-86af-bb6e57345706</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823278">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823370">YES</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823371">NO</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">50</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823276">2010</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823315">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823272">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823105">30</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823104">3</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823106">2012</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823258">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1823259" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823260">Overlapping / Multiple Zones</prad:zone_of_origin>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823265">Bilateral</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823266">Middle</prad:tumor_level>
|
| 55 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823266">Base</prad:tumor_level>
|
| 56 |
+
</prad:tumor_levels>
|
| 57 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823277">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 58 |
+
<prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">31</prad:days_to_bone_scan_performed>
|
| 59 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823286">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
|
| 60 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823287">YES</prad:diagnostic_ct_abd_pelvis_performed>
|
| 61 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">31</prad:days_to_diagnostic_computed_tomography_performed>
|
| 62 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 63 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823291">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
|
| 64 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 65 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823292">NO</prad:diagnostic_mri_performed>
|
| 66 |
+
<prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
|
| 67 |
+
<prad:diagnostic_mri_results>
|
| 68 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1823296"/>
|
| 69 |
+
</prad:diagnostic_mri_results>
|
| 70 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823303">YES</prad:lymphnodes_examined>
|
| 71 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823305">21</prad:number_of_lymphnodes_examined>
|
| 72 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823306">0</prad:number_of_lymphnodes_positive_by_he>
|
| 73 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823307">R0</clin_shared:residual_tumor>
|
| 74 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1823316"/>
|
| 75 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1823317"/>
|
| 76 |
+
<shared_stage:stage_event system="AJCC">
|
| 77 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 78 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 80 |
+
<shared_stage:tnm_categories>
|
| 81 |
+
<shared_stage:clinical_categories>
|
| 82 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823280">T2b</shared_stage:clinical_T>
|
| 83 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 84 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823297">M0</shared_stage:clinical_M>
|
| 85 |
+
</shared_stage:clinical_categories>
|
| 86 |
+
<shared_stage:pathologic_categories>
|
| 87 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823301">T3a</shared_stage:pathologic_T>
|
| 88 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823304">N0</shared_stage:pathologic_N>
|
| 89 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 90 |
+
</shared_stage:pathologic_categories>
|
| 91 |
+
</shared_stage:tnm_categories>
|
| 92 |
+
<shared_stage:psa>
|
| 93 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823365">0.1</shared_stage:psa_value>
|
| 94 |
+
<shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">530</shared_stage:days_to_psa>
|
| 95 |
+
</shared_stage:psa>
|
| 96 |
+
<shared_stage:gleason_grading>
|
| 97 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823263">8</shared_stage:gleason_score>
|
| 98 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823261">5</shared_stage:primary_pattern>
|
| 99 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823262">3</shared_stage:secondary_pattern>
|
| 100 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823264">4</shared_stage:tertiary_pattern>
|
| 101 |
+
</shared_stage:gleason_grading>
|
| 102 |
+
<shared_stage:ann_arbor>
|
| 103 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 104 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 105 |
+
</shared_stage:ann_arbor>
|
| 106 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 107 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 109 |
+
</shared_stage:stage_event>
|
| 110 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 111 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 112 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 113 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823366">NO</prad:biochemical_recurrence>
|
| 114 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 115 |
+
<prad_nte:new_tumor_events>
|
| 116 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 117 |
+
</prad_nte:new_tumor_events>
|
| 118 |
+
<rx:drugs/>
|
| 119 |
+
<rad:radiations/>
|
| 120 |
+
<prad:follow_ups>
|
| 121 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 122 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5503-F46204</clin_shared:bcr_followup_barcode>
|
| 123 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">E09A254F-1C32-44B5-A628-DD29C5E27C3E</clin_shared:bcr_followup_uuid>
|
| 124 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757436">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 125 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757437">NO</clin_shared:lost_follow_up>
|
| 126 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757438">NO</clin_shared:radiation_therapy>
|
| 127 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757439">NO</clin_shared:postoperative_rx_tx>
|
| 128 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757441">Alive</clin_shared:vital_status>
|
| 129 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757440">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 130 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">716</clin_shared:days_to_last_followup>
|
| 131 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 132 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757450">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 133 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757451"/>
|
| 134 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757452"/>
|
| 135 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757477">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 136 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757453">NO</nte:new_tumor_event_after_initial_treatment>
|
| 137 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 138 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757454"/>
|
| 139 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757463"/>
|
| 140 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757464"/>
|
| 141 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757475"/>
|
| 142 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757476"/>
|
| 143 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 144 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 145 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 146 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757465"/>
|
| 147 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757466"/>
|
| 148 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:day_of_form_completion>
|
| 149 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8</clin_shared:month_of_form_completion>
|
| 150 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
|
| 151 |
+
</follow_up_v1.0:follow_up>
|
| 152 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="2">
|
| 153 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5503-F60037</clin_shared:bcr_followup_barcode>
|
| 154 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">26A25DCA-6024-4434-9890-198114671D32</clin_shared:bcr_followup_uuid>
|
| 155 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3621189">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 156 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3621190">NO</clin_shared:lost_follow_up>
|
| 157 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3621191">NO</clin_shared:radiation_therapy>
|
| 158 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3621192">NO</clin_shared:postoperative_rx_tx>
|
| 159 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3621194">Alive</clin_shared:vital_status>
|
| 160 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3621193">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 161 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1391</clin_shared:days_to_last_followup>
|
| 162 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 163 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3621203">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 164 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3621204"/>
|
| 165 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3621205"/>
|
| 166 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3621230">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 167 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3621206">NO</nte:new_tumor_event_after_initial_treatment>
|
| 168 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 169 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3621207"/>
|
| 170 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3621216"/>
|
| 171 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3621217"/>
|
| 172 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3621228"/>
|
| 173 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3621229"/>
|
| 174 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 175 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 176 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 177 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3621218"/>
|
| 178 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3621219"/>
|
| 179 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">28</clin_shared:day_of_form_completion>
|
| 180 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">5</clin_shared:month_of_form_completion>
|
| 181 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
|
| 182 |
+
</follow_up_v1.0:follow_up>
|
| 183 |
+
</prad:follow_ups>
|
| 184 |
+
</prad:patient>
|
| 185 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5504.xml
ADDED
|
@@ -0,0 +1,186 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">A828FB32-08EA-4738-87C0-1810723EE639</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833711">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833727">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833721">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833762">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-24072</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">229</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833725">WHITE</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5504</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">EJ</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5504</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">e1c3d1bd-cf8f-4fa4-ac8e-bf9e54f7aad4</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833732">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833824">YES</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833825">NO</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">65</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833730">2010</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833769">WITH TUMOR</clin_shared:person_neoplasm_cancer_status>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833726">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833709">2</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833708">4</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833710">2012</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833712">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1833713" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833714">Overlapping / Multiple Zones</prad:zone_of_origin>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833719">Bilateral</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833720">Apex</prad:tumor_level>
|
| 55 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833720">Middle</prad:tumor_level>
|
| 56 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833720">Base</prad:tumor_level>
|
| 57 |
+
</prad:tumor_levels>
|
| 58 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833731">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 59 |
+
<prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">25</prad:days_to_bone_scan_performed>
|
| 60 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833740">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
|
| 61 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833741">YES</prad:diagnostic_ct_abd_pelvis_performed>
|
| 62 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">25</prad:days_to_diagnostic_computed_tomography_performed>
|
| 63 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 64 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833745">Extraprostatic Extension (regional lymphadenopathy)[e.g. cN1]</prad:diagnostic_ct_abd_pelvis_result>
|
| 65 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 66 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833746">NO</prad:diagnostic_mri_performed>
|
| 67 |
+
<prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
|
| 68 |
+
<prad:diagnostic_mri_results>
|
| 69 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1833750"/>
|
| 70 |
+
</prad:diagnostic_mri_results>
|
| 71 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833757">YES</prad:lymphnodes_examined>
|
| 72 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833759">18</prad:number_of_lymphnodes_examined>
|
| 73 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833760">1</prad:number_of_lymphnodes_positive_by_he>
|
| 74 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833761">R1</clin_shared:residual_tumor>
|
| 75 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1833770"/>
|
| 76 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1833771"/>
|
| 77 |
+
<shared_stage:stage_event system="AJCC">
|
| 78 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 80 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 81 |
+
<shared_stage:tnm_categories>
|
| 82 |
+
<shared_stage:clinical_categories>
|
| 83 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833734">T2c</shared_stage:clinical_T>
|
| 84 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 85 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833751">M0</shared_stage:clinical_M>
|
| 86 |
+
</shared_stage:clinical_categories>
|
| 87 |
+
<shared_stage:pathologic_categories>
|
| 88 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833755">T3a</shared_stage:pathologic_T>
|
| 89 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833758">N1</shared_stage:pathologic_N>
|
| 90 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 91 |
+
</shared_stage:pathologic_categories>
|
| 92 |
+
</shared_stage:tnm_categories>
|
| 93 |
+
<shared_stage:psa>
|
| 94 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833819">1.0</shared_stage:psa_value>
|
| 95 |
+
<shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">77</shared_stage:days_to_psa>
|
| 96 |
+
</shared_stage:psa>
|
| 97 |
+
<shared_stage:gleason_grading>
|
| 98 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833717">7</shared_stage:gleason_score>
|
| 99 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833715">4</shared_stage:primary_pattern>
|
| 100 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833716">3</shared_stage:secondary_pattern>
|
| 101 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833718">5</shared_stage:tertiary_pattern>
|
| 102 |
+
</shared_stage:gleason_grading>
|
| 103 |
+
<shared_stage:ann_arbor>
|
| 104 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 105 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 106 |
+
</shared_stage:ann_arbor>
|
| 107 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 109 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 110 |
+
</shared_stage:stage_event>
|
| 111 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 112 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 113 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 114 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833820">YES</prad:biochemical_recurrence>
|
| 115 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Completed" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000">77</prad:days_to_first_biochemical_recurrence>
|
| 116 |
+
<prad_nte:new_tumor_events>
|
| 117 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 118 |
+
</prad_nte:new_tumor_events>
|
| 119 |
+
<rx:drugs/>
|
| 120 |
+
<rad:radiations/>
|
| 121 |
+
<prad:follow_ups>
|
| 122 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 123 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5504-F46205</clin_shared:bcr_followup_barcode>
|
| 124 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">E27457FB-2F9A-40CB-8FCA-21AD85F9E33D</clin_shared:bcr_followup_uuid>
|
| 125 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757481">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 126 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757482">NO</clin_shared:lost_follow_up>
|
| 127 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757483">NO</clin_shared:radiation_therapy>
|
| 128 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757484">NO</clin_shared:postoperative_rx_tx>
|
| 129 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757486">Alive</clin_shared:vital_status>
|
| 130 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757485">Progressive Disease</clin_shared:primary_therapy_outcome_success>
|
| 131 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">880</clin_shared:days_to_last_followup>
|
| 132 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 133 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757495">WITH TUMOR</clin_shared:person_neoplasm_cancer_status>
|
| 134 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757496"/>
|
| 135 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757497"/>
|
| 136 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757522">Progressive Disease</clin_shared:followup_treatment_success>
|
| 137 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757498">YES</nte:new_tumor_event_after_initial_treatment>
|
| 138 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 139 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757499">Biochemical evidence of disease</nte:new_neoplasm_event_type>
|
| 140 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757508"/>
|
| 141 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757509"/>
|
| 142 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757520">NO</nte:additional_radiation_therapy>
|
| 143 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757521">NO</nte:additional_pharmaceutical_therapy>
|
| 144 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Completed" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000">77</follow_up_v1.0:days_to_first_biochemical_recurrence>
|
| 145 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Completed" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000">736</follow_up_v1.0:days_to_second_biochemical_recurrence>
|
| 146 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 147 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757510"/>
|
| 148 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757511"/>
|
| 149 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:day_of_form_completion>
|
| 150 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8</clin_shared:month_of_form_completion>
|
| 151 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
|
| 152 |
+
</follow_up_v1.0:follow_up>
|
| 153 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="2">
|
| 154 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5504-F71923</clin_shared:bcr_followup_barcode>
|
| 155 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">C65034B8-D6EB-444C-A897-B9553B335E6F</clin_shared:bcr_followup_uuid>
|
| 156 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142471">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 157 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142472">NO</clin_shared:lost_follow_up>
|
| 158 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142473">NO</clin_shared:radiation_therapy>
|
| 159 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142474">NO</clin_shared:postoperative_rx_tx>
|
| 160 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142476">Alive</clin_shared:vital_status>
|
| 161 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142475">Progressive Disease</clin_shared:primary_therapy_outcome_success>
|
| 162 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1427</clin_shared:days_to_last_followup>
|
| 163 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 164 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142485">WITH TUMOR</clin_shared:person_neoplasm_cancer_status>
|
| 165 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142486"/>
|
| 166 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142487"/>
|
| 167 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142512">Progressive Disease</clin_shared:followup_treatment_success>
|
| 168 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142488">NO</nte:new_tumor_event_after_initial_treatment>
|
| 169 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 170 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142489"/>
|
| 171 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142498"/>
|
| 172 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142499"/>
|
| 173 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142510"/>
|
| 174 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142511"/>
|
| 175 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 176 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 177 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 178 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142500"/>
|
| 179 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142501"/>
|
| 180 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">31</clin_shared:day_of_form_completion>
|
| 181 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
|
| 182 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2015</clin_shared:year_of_form_completion>
|
| 183 |
+
</follow_up_v1.0:follow_up>
|
| 184 |
+
</prad:follow_ups>
|
| 185 |
+
</prad:patient>
|
| 186 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5505.xml
ADDED
|
@@ -0,0 +1,155 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">8374339D-2BD9-45EB-891E-22A44FBF4E46</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834059">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834075">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834069">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834110">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-21164</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">448</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834073">WHITE</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5505</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">EJ</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5505</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">1ea3b879-5451-49fb-b930-16e9b5627f18</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834080">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834128">YES</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834129">NO</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">57</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834078">2010</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834117">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834074">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834032">2</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834031">4</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834033">2012</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834060">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1834061" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1834062"/>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834067">Bilateral</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834068">Apex</prad:tumor_level>
|
| 55 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834068">Middle</prad:tumor_level>
|
| 56 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834068">Base</prad:tumor_level>
|
| 57 |
+
</prad:tumor_levels>
|
| 58 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834079">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 59 |
+
<prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">12</prad:days_to_bone_scan_performed>
|
| 60 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834088">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
|
| 61 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834089">YES</prad:diagnostic_ct_abd_pelvis_performed>
|
| 62 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">12</prad:days_to_diagnostic_computed_tomography_performed>
|
| 63 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 64 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834093">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
|
| 65 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 66 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834094">NO</prad:diagnostic_mri_performed>
|
| 67 |
+
<prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
|
| 68 |
+
<prad:diagnostic_mri_results>
|
| 69 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1834098"/>
|
| 70 |
+
</prad:diagnostic_mri_results>
|
| 71 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834105">YES</prad:lymphnodes_examined>
|
| 72 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834107">24</prad:number_of_lymphnodes_examined>
|
| 73 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834108">0</prad:number_of_lymphnodes_positive_by_he>
|
| 74 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834109">R0</clin_shared:residual_tumor>
|
| 75 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1834118"/>
|
| 76 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1834119"/>
|
| 77 |
+
<shared_stage:stage_event system="AJCC">
|
| 78 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 80 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 81 |
+
<shared_stage:tnm_categories>
|
| 82 |
+
<shared_stage:clinical_categories>
|
| 83 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834081">T1c</shared_stage:clinical_T>
|
| 84 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 85 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834099">M0</shared_stage:clinical_M>
|
| 86 |
+
</shared_stage:clinical_categories>
|
| 87 |
+
<shared_stage:pathologic_categories>
|
| 88 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834101">T2c</shared_stage:pathologic_T>
|
| 89 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834106">N0</shared_stage:pathologic_N>
|
| 90 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 91 |
+
</shared_stage:pathologic_categories>
|
| 92 |
+
</shared_stage:tnm_categories>
|
| 93 |
+
<shared_stage:psa>
|
| 94 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834123">0.1</shared_stage:psa_value>
|
| 95 |
+
<shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">448</shared_stage:days_to_psa>
|
| 96 |
+
</shared_stage:psa>
|
| 97 |
+
<shared_stage:gleason_grading>
|
| 98 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834065">7</shared_stage:gleason_score>
|
| 99 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834063">4</shared_stage:primary_pattern>
|
| 100 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834064">3</shared_stage:secondary_pattern>
|
| 101 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834066">3</shared_stage:tertiary_pattern>
|
| 102 |
+
</shared_stage:gleason_grading>
|
| 103 |
+
<shared_stage:ann_arbor>
|
| 104 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 105 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 106 |
+
</shared_stage:ann_arbor>
|
| 107 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 109 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 110 |
+
</shared_stage:stage_event>
|
| 111 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 112 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 113 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 114 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834124">NO</prad:biochemical_recurrence>
|
| 115 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 116 |
+
<prad_nte:new_tumor_events>
|
| 117 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 118 |
+
</prad_nte:new_tumor_events>
|
| 119 |
+
<rx:drugs/>
|
| 120 |
+
<rad:radiations/>
|
| 121 |
+
<prad:follow_ups>
|
| 122 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 123 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5505-F46206</clin_shared:bcr_followup_barcode>
|
| 124 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">7272BBED-E69B-42D3-852B-4AFC6879D750</clin_shared:bcr_followup_uuid>
|
| 125 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757526">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 126 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757527">NO</clin_shared:lost_follow_up>
|
| 127 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757528">NO</clin_shared:radiation_therapy>
|
| 128 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757529">NO</clin_shared:postoperative_rx_tx>
|
| 129 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757531">Alive</clin_shared:vital_status>
|
| 130 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757530">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 131 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">922</clin_shared:days_to_last_followup>
|
| 132 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 133 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757540">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 134 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757541"/>
|
| 135 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757542"/>
|
| 136 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757567">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 137 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757543">NO</nte:new_tumor_event_after_initial_treatment>
|
| 138 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 139 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757544"/>
|
| 140 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757553"/>
|
| 141 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757554"/>
|
| 142 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757565"/>
|
| 143 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757566"/>
|
| 144 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 145 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 146 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 147 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757555"/>
|
| 148 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757556"/>
|
| 149 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:day_of_form_completion>
|
| 150 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8</clin_shared:month_of_form_completion>
|
| 151 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
|
| 152 |
+
</follow_up_v1.0:follow_up>
|
| 153 |
+
</prad:follow_ups>
|
| 154 |
+
</prad:patient>
|
| 155 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5506.xml
ADDED
|
@@ -0,0 +1,186 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">34D053EE-05E8-4A90-BD0F-54DEF598DDD7</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834241">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834257">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834251">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834292">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-24617</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">356</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834255">WHITE</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5506</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">EJ</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5506</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">e5e4d3b6-8e58-4dcf-8f67-a00e656a8e27</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834262">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834310">YES</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834311">NO</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">67</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834260">2010</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834299">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834256">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834213">2</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834212">4</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834214">2012</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834242">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1834243" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1834244"/>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834249">Bilateral</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834250">Apex</prad:tumor_level>
|
| 55 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834250">Middle</prad:tumor_level>
|
| 56 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834250">Base</prad:tumor_level>
|
| 57 |
+
</prad:tumor_levels>
|
| 58 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834261">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 59 |
+
<prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Not Available" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000"/>
|
| 60 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1834270"/>
|
| 61 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834271">NO</prad:diagnostic_ct_abd_pelvis_performed>
|
| 62 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Not Available" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000"/>
|
| 63 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 64 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1834275"/>
|
| 65 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 66 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834276">NO</prad:diagnostic_mri_performed>
|
| 67 |
+
<prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
|
| 68 |
+
<prad:diagnostic_mri_results>
|
| 69 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1834280"/>
|
| 70 |
+
</prad:diagnostic_mri_results>
|
| 71 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834287">YES</prad:lymphnodes_examined>
|
| 72 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834289">7</prad:number_of_lymphnodes_examined>
|
| 73 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834290">1</prad:number_of_lymphnodes_positive_by_he>
|
| 74 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834291">RX</clin_shared:residual_tumor>
|
| 75 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1834300"/>
|
| 76 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1834301"/>
|
| 77 |
+
<shared_stage:stage_event system="AJCC">
|
| 78 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 80 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 81 |
+
<shared_stage:tnm_categories>
|
| 82 |
+
<shared_stage:clinical_categories>
|
| 83 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834265">T3b</shared_stage:clinical_T>
|
| 84 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 85 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834281">M0</shared_stage:clinical_M>
|
| 86 |
+
</shared_stage:clinical_categories>
|
| 87 |
+
<shared_stage:pathologic_categories>
|
| 88 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834285">T3b</shared_stage:pathologic_T>
|
| 89 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834288">N1</shared_stage:pathologic_N>
|
| 90 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 91 |
+
</shared_stage:pathologic_categories>
|
| 92 |
+
</shared_stage:tnm_categories>
|
| 93 |
+
<shared_stage:psa>
|
| 94 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834305">0.1</shared_stage:psa_value>
|
| 95 |
+
<shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">356</shared_stage:days_to_psa>
|
| 96 |
+
</shared_stage:psa>
|
| 97 |
+
<shared_stage:gleason_grading>
|
| 98 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834247">8</shared_stage:gleason_score>
|
| 99 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834245">5</shared_stage:primary_pattern>
|
| 100 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834246">3</shared_stage:secondary_pattern>
|
| 101 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834248">4</shared_stage:tertiary_pattern>
|
| 102 |
+
</shared_stage:gleason_grading>
|
| 103 |
+
<shared_stage:ann_arbor>
|
| 104 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 105 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 106 |
+
</shared_stage:ann_arbor>
|
| 107 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 109 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 110 |
+
</shared_stage:stage_event>
|
| 111 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 112 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 113 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 114 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834306">NO</prad:biochemical_recurrence>
|
| 115 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 116 |
+
<prad_nte:new_tumor_events>
|
| 117 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 118 |
+
</prad_nte:new_tumor_events>
|
| 119 |
+
<rx:drugs/>
|
| 120 |
+
<rad:radiations/>
|
| 121 |
+
<prad:follow_ups>
|
| 122 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 123 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5506-F46207</clin_shared:bcr_followup_barcode>
|
| 124 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">464D58E9-F998-4142-B43E-DEF506845044</clin_shared:bcr_followup_uuid>
|
| 125 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757571">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 126 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757572">NO</clin_shared:lost_follow_up>
|
| 127 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757573">NO</clin_shared:radiation_therapy>
|
| 128 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757574">NO</clin_shared:postoperative_rx_tx>
|
| 129 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757576">Alive</clin_shared:vital_status>
|
| 130 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757575">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 131 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">827</clin_shared:days_to_last_followup>
|
| 132 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 133 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757585">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 134 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757586"/>
|
| 135 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757587"/>
|
| 136 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757612">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 137 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757588">NO</nte:new_tumor_event_after_initial_treatment>
|
| 138 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 139 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757589"/>
|
| 140 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757598"/>
|
| 141 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757599"/>
|
| 142 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757610"/>
|
| 143 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757611"/>
|
| 144 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 145 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 146 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 147 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757600"/>
|
| 148 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757601"/>
|
| 149 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:day_of_form_completion>
|
| 150 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8</clin_shared:month_of_form_completion>
|
| 151 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
|
| 152 |
+
</follow_up_v1.0:follow_up>
|
| 153 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="2">
|
| 154 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5506-F71924</clin_shared:bcr_followup_barcode>
|
| 155 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">9D8D5AF9-1C96-48A9-AFC3-9AD88E0AFD92</clin_shared:bcr_followup_uuid>
|
| 156 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142516">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 157 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142517">NO</clin_shared:lost_follow_up>
|
| 158 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142518">NO</clin_shared:radiation_therapy>
|
| 159 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142519">NO</clin_shared:postoperative_rx_tx>
|
| 160 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142521">Alive</clin_shared:vital_status>
|
| 161 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142520">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 162 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1381</clin_shared:days_to_last_followup>
|
| 163 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 164 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142530">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 165 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142531"/>
|
| 166 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142532"/>
|
| 167 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142557">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 168 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142533">NO</nte:new_tumor_event_after_initial_treatment>
|
| 169 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 170 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142534"/>
|
| 171 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142543"/>
|
| 172 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142544"/>
|
| 173 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142555"/>
|
| 174 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142556"/>
|
| 175 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 176 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 177 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 178 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142545"/>
|
| 179 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142546"/>
|
| 180 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">31</clin_shared:day_of_form_completion>
|
| 181 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
|
| 182 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2015</clin_shared:year_of_form_completion>
|
| 183 |
+
</follow_up_v1.0:follow_up>
|
| 184 |
+
</prad:follow_ups>
|
| 185 |
+
</prad:patient>
|
| 186 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5507.xml
ADDED
|
@@ -0,0 +1,186 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">A5412427-7433-4D43-936C-97BD0692D9E1</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834612">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834628">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834622">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834663">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-19759</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">182</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834626">WHITE</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5507</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">EJ</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5507</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">607200f5-df80-4f5d-90fb-fdc455a7415b</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834633">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834681">YES</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834682">NO</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">54</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834631">2010</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834670">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834627">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834610">2</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834609">4</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834611">2012</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834613">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1834614" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1834615"/>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834620">Bilateral</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834621">Apex</prad:tumor_level>
|
| 55 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834621">Middle</prad:tumor_level>
|
| 56 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834621">Base</prad:tumor_level>
|
| 57 |
+
</prad:tumor_levels>
|
| 58 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834632">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 59 |
+
<prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Not Available" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000"/>
|
| 60 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1834641"/>
|
| 61 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834642">NO</prad:diagnostic_ct_abd_pelvis_performed>
|
| 62 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Not Available" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000"/>
|
| 63 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 64 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1834646"/>
|
| 65 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 66 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834647">NO</prad:diagnostic_mri_performed>
|
| 67 |
+
<prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
|
| 68 |
+
<prad:diagnostic_mri_results>
|
| 69 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1834651"/>
|
| 70 |
+
</prad:diagnostic_mri_results>
|
| 71 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834658">YES</prad:lymphnodes_examined>
|
| 72 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834660">21</prad:number_of_lymphnodes_examined>
|
| 73 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834661">2</prad:number_of_lymphnodes_positive_by_he>
|
| 74 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834662">R0</clin_shared:residual_tumor>
|
| 75 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1834671"/>
|
| 76 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1834672"/>
|
| 77 |
+
<shared_stage:stage_event system="AJCC">
|
| 78 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 80 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 81 |
+
<shared_stage:tnm_categories>
|
| 82 |
+
<shared_stage:clinical_categories>
|
| 83 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834635">T2c</shared_stage:clinical_T>
|
| 84 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 85 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834652">M0</shared_stage:clinical_M>
|
| 86 |
+
</shared_stage:clinical_categories>
|
| 87 |
+
<shared_stage:pathologic_categories>
|
| 88 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834656">T3b</shared_stage:pathologic_T>
|
| 89 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834659">N1</shared_stage:pathologic_N>
|
| 90 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 91 |
+
</shared_stage:pathologic_categories>
|
| 92 |
+
</shared_stage:tnm_categories>
|
| 93 |
+
<shared_stage:psa>
|
| 94 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834676">0.1</shared_stage:psa_value>
|
| 95 |
+
<shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">182</shared_stage:days_to_psa>
|
| 96 |
+
</shared_stage:psa>
|
| 97 |
+
<shared_stage:gleason_grading>
|
| 98 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834618">9</shared_stage:gleason_score>
|
| 99 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834616">4</shared_stage:primary_pattern>
|
| 100 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834617">5</shared_stage:secondary_pattern>
|
| 101 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834619">4</shared_stage:tertiary_pattern>
|
| 102 |
+
</shared_stage:gleason_grading>
|
| 103 |
+
<shared_stage:ann_arbor>
|
| 104 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 105 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 106 |
+
</shared_stage:ann_arbor>
|
| 107 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 109 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 110 |
+
</shared_stage:stage_event>
|
| 111 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 112 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 113 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 114 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834677">NO</prad:biochemical_recurrence>
|
| 115 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 116 |
+
<prad_nte:new_tumor_events>
|
| 117 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 118 |
+
</prad_nte:new_tumor_events>
|
| 119 |
+
<rx:drugs/>
|
| 120 |
+
<rad:radiations/>
|
| 121 |
+
<prad:follow_ups>
|
| 122 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 123 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5507-F46208</clin_shared:bcr_followup_barcode>
|
| 124 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">5A965AB0-241A-4188-9526-23359A1829F6</clin_shared:bcr_followup_uuid>
|
| 125 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757616">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 126 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757617">NO</clin_shared:lost_follow_up>
|
| 127 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757618">NO</clin_shared:radiation_therapy>
|
| 128 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757619">NO</clin_shared:postoperative_rx_tx>
|
| 129 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757621">Alive</clin_shared:vital_status>
|
| 130 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757620">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 131 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">727</clin_shared:days_to_last_followup>
|
| 132 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 133 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757630">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 134 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757631"/>
|
| 135 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757632"/>
|
| 136 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757657">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 137 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757633">NO</nte:new_tumor_event_after_initial_treatment>
|
| 138 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 139 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757634"/>
|
| 140 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757643"/>
|
| 141 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757644"/>
|
| 142 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757655"/>
|
| 143 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757656"/>
|
| 144 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 145 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 146 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 147 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757645"/>
|
| 148 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757646"/>
|
| 149 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:day_of_form_completion>
|
| 150 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8</clin_shared:month_of_form_completion>
|
| 151 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
|
| 152 |
+
</follow_up_v1.0:follow_up>
|
| 153 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="2">
|
| 154 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5507-F71926</clin_shared:bcr_followup_barcode>
|
| 155 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">A099ED2D-CD15-4EE5-9F37-D8B9CDEA44DC</clin_shared:bcr_followup_uuid>
|
| 156 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142564">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 157 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142565">NO</clin_shared:lost_follow_up>
|
| 158 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142566">NO</clin_shared:radiation_therapy>
|
| 159 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142567">NO</clin_shared:postoperative_rx_tx>
|
| 160 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142569">Alive</clin_shared:vital_status>
|
| 161 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142568">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 162 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1457</clin_shared:days_to_last_followup>
|
| 163 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 164 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142578">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 165 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142579"/>
|
| 166 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142580"/>
|
| 167 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142605">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 168 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142581">NO</nte:new_tumor_event_after_initial_treatment>
|
| 169 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 170 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142582"/>
|
| 171 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142591"/>
|
| 172 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142592"/>
|
| 173 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142603"/>
|
| 174 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142604"/>
|
| 175 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 176 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 177 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 178 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142593"/>
|
| 179 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142594"/>
|
| 180 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">31</clin_shared:day_of_form_completion>
|
| 181 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
|
| 182 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2015</clin_shared:year_of_form_completion>
|
| 183 |
+
</follow_up_v1.0:follow_up>
|
| 184 |
+
</prad:follow_ups>
|
| 185 |
+
</prad:patient>
|
| 186 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5508.xml
ADDED
|
@@ -0,0 +1,185 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">6F6B8E92-2C69-4623-8E99-C35B2CE0FF33</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834690">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834706">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834700">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834741">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-23758</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">907</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834704">WHITE</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5508</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">EJ</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5508</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">bd18dd01-d894-4bdd-9ce2-e25705a52a57</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834711">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834759">YES</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834760">NO</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">65</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834709">2008</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834748">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834705">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834688">2</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834687">4</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834689">2012</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834691">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1834692" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1834693"/>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834698">Bilateral</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834699">Middle</prad:tumor_level>
|
| 55 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834699">Base</prad:tumor_level>
|
| 56 |
+
</prad:tumor_levels>
|
| 57 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834710">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 58 |
+
<prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Not Available" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000"/>
|
| 59 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1834719"/>
|
| 60 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834720">NO</prad:diagnostic_ct_abd_pelvis_performed>
|
| 61 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Not Available" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000"/>
|
| 62 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 63 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1834724"/>
|
| 64 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 65 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834725">NO</prad:diagnostic_mri_performed>
|
| 66 |
+
<prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
|
| 67 |
+
<prad:diagnostic_mri_results>
|
| 68 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1834729"/>
|
| 69 |
+
</prad:diagnostic_mri_results>
|
| 70 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834736">YES</prad:lymphnodes_examined>
|
| 71 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834738">17</prad:number_of_lymphnodes_examined>
|
| 72 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834739">0</prad:number_of_lymphnodes_positive_by_he>
|
| 73 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834740">R0</clin_shared:residual_tumor>
|
| 74 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1834749"/>
|
| 75 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1834750"/>
|
| 76 |
+
<shared_stage:stage_event system="AJCC">
|
| 77 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 78 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 80 |
+
<shared_stage:tnm_categories>
|
| 81 |
+
<shared_stage:clinical_categories>
|
| 82 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834712">T1c</shared_stage:clinical_T>
|
| 83 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 84 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834730">M0</shared_stage:clinical_M>
|
| 85 |
+
</shared_stage:clinical_categories>
|
| 86 |
+
<shared_stage:pathologic_categories>
|
| 87 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834734">T3a</shared_stage:pathologic_T>
|
| 88 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834737">N0</shared_stage:pathologic_N>
|
| 89 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 90 |
+
</shared_stage:pathologic_categories>
|
| 91 |
+
</shared_stage:tnm_categories>
|
| 92 |
+
<shared_stage:psa>
|
| 93 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834754">0.1</shared_stage:psa_value>
|
| 94 |
+
<shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">907</shared_stage:days_to_psa>
|
| 95 |
+
</shared_stage:psa>
|
| 96 |
+
<shared_stage:gleason_grading>
|
| 97 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834696">7</shared_stage:gleason_score>
|
| 98 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834694">3</shared_stage:primary_pattern>
|
| 99 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834695">4</shared_stage:secondary_pattern>
|
| 100 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834697">4</shared_stage:tertiary_pattern>
|
| 101 |
+
</shared_stage:gleason_grading>
|
| 102 |
+
<shared_stage:ann_arbor>
|
| 103 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 104 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 105 |
+
</shared_stage:ann_arbor>
|
| 106 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 107 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 109 |
+
</shared_stage:stage_event>
|
| 110 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 111 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 112 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 113 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834755">NO</prad:biochemical_recurrence>
|
| 114 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 115 |
+
<prad_nte:new_tumor_events>
|
| 116 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 117 |
+
</prad_nte:new_tumor_events>
|
| 118 |
+
<rx:drugs/>
|
| 119 |
+
<rad:radiations/>
|
| 120 |
+
<prad:follow_ups>
|
| 121 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 122 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5508-F46209</clin_shared:bcr_followup_barcode>
|
| 123 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">FE909C1B-A3A6-40AD-929B-3266091DEACD</clin_shared:bcr_followup_uuid>
|
| 124 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757661">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 125 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757662">NO</clin_shared:lost_follow_up>
|
| 126 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757663">NO</clin_shared:radiation_therapy>
|
| 127 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757664">NO</clin_shared:postoperative_rx_tx>
|
| 128 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757666">Alive</clin_shared:vital_status>
|
| 129 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757665">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 130 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1184</clin_shared:days_to_last_followup>
|
| 131 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 132 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757675">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 133 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757676"/>
|
| 134 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757677"/>
|
| 135 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757702">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 136 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757678">NO</nte:new_tumor_event_after_initial_treatment>
|
| 137 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 138 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757679"/>
|
| 139 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757688"/>
|
| 140 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757689"/>
|
| 141 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757700"/>
|
| 142 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757701"/>
|
| 143 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 144 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 145 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 146 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757690"/>
|
| 147 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757691"/>
|
| 148 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:day_of_form_completion>
|
| 149 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8</clin_shared:month_of_form_completion>
|
| 150 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
|
| 151 |
+
</follow_up_v1.0:follow_up>
|
| 152 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="2">
|
| 153 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5508-F71929</clin_shared:bcr_followup_barcode>
|
| 154 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">B8B943A6-1B6C-47EC-9443-98CD0728338F</clin_shared:bcr_followup_uuid>
|
| 155 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142615">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 156 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142616">NO</clin_shared:lost_follow_up>
|
| 157 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142617">NO</clin_shared:radiation_therapy>
|
| 158 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142618">NO</clin_shared:postoperative_rx_tx>
|
| 159 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142620">Alive</clin_shared:vital_status>
|
| 160 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142619">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 161 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1965</clin_shared:days_to_last_followup>
|
| 162 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 163 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142629">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 164 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142630"/>
|
| 165 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142631"/>
|
| 166 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142656">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 167 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142632">NO</nte:new_tumor_event_after_initial_treatment>
|
| 168 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 169 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142633"/>
|
| 170 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142642"/>
|
| 171 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142643"/>
|
| 172 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142654"/>
|
| 173 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142655"/>
|
| 174 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 175 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 176 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 177 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142644"/>
|
| 178 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142645"/>
|
| 179 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">31</clin_shared:day_of_form_completion>
|
| 180 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
|
| 181 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2015</clin_shared:year_of_form_completion>
|
| 182 |
+
</follow_up_v1.0:follow_up>
|
| 183 |
+
</prad:follow_ups>
|
| 184 |
+
</prad:patient>
|
| 185 |
+
</prad:tcga_bcr>
|
biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5509.xml
ADDED
|
@@ -0,0 +1,186 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">58E592FF-3F5F-4C41-9ED5-BABA68C685AF</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<prad:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834766">Prostate</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834782">No</shared:other_dx>
|
| 22 |
+
<shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834776">MALE</shared:gender>
|
| 23 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834817">Alive</clin_shared:vital_status>
|
| 24 |
+
<clin_shared:days_to_birth precision="month" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-23368</clin_shared:days_to_birth>
|
| 25 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 26 |
+
<clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1102</clin_shared:days_to_last_followup>
|
| 27 |
+
<clin_shared:race_list>
|
| 28 |
+
<clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834780">WHITE</clin_shared:race>
|
| 29 |
+
</clin_shared:race_list>
|
| 30 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5509</shared:bcr_patient_barcode>
|
| 31 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">EJ</shared:tissue_source_site>
|
| 32 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5509</shared:patient_id>
|
| 33 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">13ce70a8-785c-4b59-b073-41922cb201f9</shared:bcr_patient_uuid>
|
| 34 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834787">No</shared:history_of_neoadjuvant_treatment>
|
| 35 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 36 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
|
| 37 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
|
| 38 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
|
| 39 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834835">YES</clin_shared:tissue_prospective_collection_indicator>
|
| 40 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834836">NO</clin_shared:tissue_retrospective_collection_indicator>
|
| 41 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 42 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">63</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 43 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834785">2009</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834824">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 45 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834781">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 46 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834764">2</clin_shared:day_of_form_completion>
|
| 47 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834763">4</clin_shared:month_of_form_completion>
|
| 48 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834765">2012</clin_shared:year_of_form_completion>
|
| 49 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834767">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
|
| 50 |
+
<shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1834768" xsi:nil="true"/>
|
| 51 |
+
<prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1834769"/>
|
| 52 |
+
<clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834774">Bilateral</clin_shared:laterality>
|
| 53 |
+
<prad:tumor_levels>
|
| 54 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834775">Apex</prad:tumor_level>
|
| 55 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834775">Middle</prad:tumor_level>
|
| 56 |
+
<prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834775">Base</prad:tumor_level>
|
| 57 |
+
</prad:tumor_levels>
|
| 58 |
+
<clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834786">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
|
| 59 |
+
<prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Not Available" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000"/>
|
| 60 |
+
<prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1834795"/>
|
| 61 |
+
<prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834796">NO</prad:diagnostic_ct_abd_pelvis_performed>
|
| 62 |
+
<prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Not Available" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000"/>
|
| 63 |
+
<prad:diagnostic_ct_abd_pelvis_results>
|
| 64 |
+
<prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1834800"/>
|
| 65 |
+
</prad:diagnostic_ct_abd_pelvis_results>
|
| 66 |
+
<prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834801">NO</prad:diagnostic_mri_performed>
|
| 67 |
+
<prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
|
| 68 |
+
<prad:diagnostic_mri_results>
|
| 69 |
+
<prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1834805"/>
|
| 70 |
+
</prad:diagnostic_mri_results>
|
| 71 |
+
<prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834812">YES</prad:lymphnodes_examined>
|
| 72 |
+
<prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834814">10</prad:number_of_lymphnodes_examined>
|
| 73 |
+
<prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834815">0</prad:number_of_lymphnodes_positive_by_he>
|
| 74 |
+
<clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834816">R0</clin_shared:residual_tumor>
|
| 75 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1834825"/>
|
| 76 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1834826"/>
|
| 77 |
+
<shared_stage:stage_event system="AJCC">
|
| 78 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 79 |
+
<shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 80 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 81 |
+
<shared_stage:tnm_categories>
|
| 82 |
+
<shared_stage:clinical_categories>
|
| 83 |
+
<shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834789">T2a</shared_stage:clinical_T>
|
| 84 |
+
<shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 85 |
+
<shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834806">M0</shared_stage:clinical_M>
|
| 86 |
+
</shared_stage:clinical_categories>
|
| 87 |
+
<shared_stage:pathologic_categories>
|
| 88 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834808">T2c</shared_stage:pathologic_T>
|
| 89 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834813">N0</shared_stage:pathologic_N>
|
| 90 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 91 |
+
</shared_stage:pathologic_categories>
|
| 92 |
+
</shared_stage:tnm_categories>
|
| 93 |
+
<shared_stage:psa>
|
| 94 |
+
<shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834830">0.1</shared_stage:psa_value>
|
| 95 |
+
<shared_stage:days_to_psa precision="month" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">1102</shared_stage:days_to_psa>
|
| 96 |
+
</shared_stage:psa>
|
| 97 |
+
<shared_stage:gleason_grading>
|
| 98 |
+
<shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834772">7</shared_stage:gleason_score>
|
| 99 |
+
<shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834770">3</shared_stage:primary_pattern>
|
| 100 |
+
<shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834771">4</shared_stage:secondary_pattern>
|
| 101 |
+
<shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834773">3</shared_stage:tertiary_pattern>
|
| 102 |
+
</shared_stage:gleason_grading>
|
| 103 |
+
<shared_stage:ann_arbor>
|
| 104 |
+
<shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 105 |
+
<shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 106 |
+
</shared_stage:ann_arbor>
|
| 107 |
+
<shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 108 |
+
<shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 109 |
+
<shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 110 |
+
</shared_stage:stage_event>
|
| 111 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 112 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 113 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 114 |
+
<prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834831">NO</prad:biochemical_recurrence>
|
| 115 |
+
<prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 116 |
+
<prad_nte:new_tumor_events>
|
| 117 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 118 |
+
</prad_nte:new_tumor_events>
|
| 119 |
+
<rx:drugs/>
|
| 120 |
+
<rad:radiations/>
|
| 121 |
+
<prad:follow_ups>
|
| 122 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 123 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5509-F46210</clin_shared:bcr_followup_barcode>
|
| 124 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">908BE10F-7A02-4722-948E-FAF4DF8DDAC1</clin_shared:bcr_followup_uuid>
|
| 125 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757706">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 126 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757707">NO</clin_shared:lost_follow_up>
|
| 127 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757708">NO</clin_shared:radiation_therapy>
|
| 128 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757709">NO</clin_shared:postoperative_rx_tx>
|
| 129 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757711">Alive</clin_shared:vital_status>
|
| 130 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757710">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 131 |
+
<clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1102</clin_shared:days_to_last_followup>
|
| 132 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 133 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757720">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 134 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757721"/>
|
| 135 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757722"/>
|
| 136 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757747">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 137 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757723">NO</nte:new_tumor_event_after_initial_treatment>
|
| 138 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 139 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757724"/>
|
| 140 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757733"/>
|
| 141 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757734"/>
|
| 142 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757745"/>
|
| 143 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757746"/>
|
| 144 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 145 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 146 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 147 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757735"/>
|
| 148 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757736"/>
|
| 149 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:day_of_form_completion>
|
| 150 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8</clin_shared:month_of_form_completion>
|
| 151 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
|
| 152 |
+
</follow_up_v1.0:follow_up>
|
| 153 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="2">
|
| 154 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5509-F60376</clin_shared:bcr_followup_barcode>
|
| 155 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">36B6AD0F-1CCA-486B-8474-FA95C5817FD9</clin_shared:bcr_followup_uuid>
|
| 156 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3637731">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 157 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3637732">NO</clin_shared:lost_follow_up>
|
| 158 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3637733">NO</clin_shared:radiation_therapy>
|
| 159 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3637734">NO</clin_shared:postoperative_rx_tx>
|
| 160 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3637736">Alive</clin_shared:vital_status>
|
| 161 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3637735">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 162 |
+
<clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1464</clin_shared:days_to_last_followup>
|
| 163 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
|
| 164 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3637745">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 165 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3637746"/>
|
| 166 |
+
<clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3637747"/>
|
| 167 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3637772">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 168 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3637748">NO</nte:new_tumor_event_after_initial_treatment>
|
| 169 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
|
| 170 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3637749"/>
|
| 171 |
+
<nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3637758"/>
|
| 172 |
+
<nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3637759"/>
|
| 173 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3637770"/>
|
| 174 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3637771"/>
|
| 175 |
+
<follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
|
| 176 |
+
<follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
|
| 177 |
+
<follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
|
| 178 |
+
<prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3637760"/>
|
| 179 |
+
<follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3637761"/>
|
| 180 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">6</clin_shared:day_of_form_completion>
|
| 181 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">6</clin_shared:month_of_form_completion>
|
| 182 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
|
| 183 |
+
</follow_up_v1.0:follow_up>
|
| 184 |
+
</prad:follow_ups>
|
| 185 |
+
</prad:patient>
|
| 186 |
+
</prad:tcga_bcr>
|